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SUMMARY
The work in this thesis has been performed as part of an investigation into the upregulation of 
flux through the shikimate pathway of Streptomyces coelicolor, in order to produce higher 
levels of substrates for the synthesis of secondary metabolites.
Disruption of the aroQ gene, which encodes the type II dehydroquinase (the third enzyme in 
this pathway) was attempted to block the pathway, and allow analysis of flux through the 
first two steps of the pathway. However, these experiments were not successful.
Overexpression of the aroQ gene in S.coelicolor may cause an upregulation of this step, and 
possibly the whole pathway. To achieve such overexpression, a 3 kb fragment containing the 
aroQ gene was subcloned into a high copy-number streptomycete vector, and transformed 
into S.lividans prior to transformation into S.coelicolor. The plasmid produced causes a 7- 
fold increase in the activity of dehydroquinase. Since only a single protein appears to be 
overexpressed from this plasmid, it appears that the aroQ  gene is not transcriptionally 
coupled to any other genes. However, this plasmid could not be isolated from S.lividans 
cells for transformation into S.coelicolor.
The aroA gene encodes EPSP synthase, the enzyme which catalyses the fifth step of the 
pathway. Cloning of this gene was attempted by designing oligonucleotide primers against 
regions of similarity from the amino acid sequences of EPSP synthases from other species, 
with the oligonucleotides being used to clone the gene via PCR and probing of genomic blots 
and a A,-library. All efforts at cloning aroA were unsuccessful.
The aroD gene from E.coli, which encodes the type I dehydroquinase, was subcloned onto a 
bifunctional vector under the control of the hybrid tac promoter. The plasmid produced was 
transformed into S.coelicolor. It caused an approximately 40-fold increase in the activity of 
dehydroquinase. The overexpressed protein (the type I dehydroquinase) was thermolabile as 
expected, but showed much higher resistance to inhibition by Cl" anions than anticipated. It 
appears to be overexpressed only around the point of transition from exponential to stationary 
phase, presumably due to the protein containing the rare TTA codon (encoding a leucine). 
The incorporation of leucine at this point in the polypeptide is controlled at the translational 
level by the presence of the tRNAuuA* which is encoded by the bldA gene, and is apparently 
only expressed at significant levels at the end of the growth phase.
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1.1 Introduction to Strevtom vces
Streptomyces are filamentous, aerobic, Gram-positive eubacteria which grow as a 
mycelial mat consisting of unseptated vegetative (substrate) hyphae with an 
approximate diameter of 0-5 pm, and contain numerous copies of the genome. Their 
natural environment is typically soil, where they exist saprophytically, feeding on 
decaying organic material. They therefore secrete a large number of extracellular 
enzymes, including proteases, cellulases, lipases and nucleases, to assist in the 
breakdown of this organic material.
Streptomyces show a complex life-cycle and, under conditions of substrate limitation 
which induce a stringent response, differentiate to produce aerial hyphae. These aerial 
mycelia subsequently develop to produce septa and spores (Figure 1.1). Each spore 
contains only a single copy of the chromosome, and the spores may become dispersed 
to allow growth under more suitable conditions.
Two distinct sets of genes have been identified as being involved in the differentiation 
process: the bid genes are involved in the production of aerial hyphae from the 
substrate mycelia; the whi genes have been implicated in the production of spores from 
these aerial mycelia. Certain sigma factors, including owhlG, appear to funciion in the 
regulation of the differentiation process. These sigma factors are concerned with the 
activation of transcription of those genes involved in the differentiation process and its 
regulation, and in the production of the secondary metabolites. Some of thjse genes 
contain an extremely rare TTA codon which appears not to be present in genes involved 
in the primary metabolic pathways [Chater, 1989]. Although the bldA gene, encoding 
the leucine tRNAxTA, appears to be transcribed at all developmental stages, his tRNA 
appears to be active only when the cell undergoes a stringent response, caused by 
growth in adverse conditions which induces differentiation [Leskiw etal.,1%1].
Although Streptomyces are bacteria, they appear to be more closely related to imgi than 
to other prokaryotes. Their habitat and growth cycle are more similar to thost of fungi 
than of most bacteria, and the dehydroquinase enzyme of S.coelicolor shows no 
similarity to this enzyme from most bacteria (for example E.coli), but shows extensive 
sequence similarity and functional identity to the dehydroquinase from tht quinate 
pathways of the fungi Aspergillus nidulans and Neurospora crassa [White et cl., 1990].
2
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1.1.1 Taxonomy of Streptomyces
According to the classical method of taxonomy, streptomycetes wee believed to be 
closely related to the lower eukaryotes, particularly the filamentous fungi, due to their 
physiology, morphology, complex growth cycle including differentiation and 
sporulation, and due to their synthesis of secondary metabolites (antibiotics). 
However, through numerical taxonomy (the comparison of a large number of 
characteristics between different organisms), due to their positive response to the 
Gram stain (implying that they are Gram-positive), their whole cell organisation (lack 
of organelles such as nucleus and mitochondria), absence of chromatin and lack of 
nucleosomes (hence absence of mitosis) and presence of bacterial ribosomes 
(especially rRNA (16 and 23S)), streptomycetes have been redefined as bacteria.
Molecular taxonomy investigates the degree of genetic relatedness between species 
by comparison of their DNA composition (percentage G + C content, the ability of 
similar sequences to cross-hybridise and particularly rRNA identity. rRNA genes 
appear to have been extremely well conserved during evolution and therefore the 
most suitable sequences for comparison. Little work has been performed on the 
ribosomal genes of Streptomyces, although there has been some recent activity on the 
topic (Mehling eta l (1995) Microbiology 141: 2139-2147.
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Figure 1.1.1 The Universal Phylogenetic Tree, taken from Glazer & Nikkaidpa. 
1995
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1.2 The Streptom yces  genome
Streptomyces DNA has a high G+C content, between 70-74% (approximately 73% for 
S.coelicolor), which is not due to repetitive satellite DNA. This bias produces a non- 
random codon usage, with almost exclusive use of G or C in the third position [Wright 
& Bibb, 1992]. The S.coelicolor genome has been estimated at 8  Mb, and has been 
mapped by pulse-field gel electrophoresis (PFGE) using three "rare-cutter" restriction 
endonucleases (whose restriction sites consist of only A or T nucleotides) [Kieser et al., 
1992; van Wezel et al., 1995]. The S.coelicolor genome consists of four quadrants, 
two of which (at 3 o'clock and 9 o'clock) are considered to be "silent regions", and to 
which very few cloned genes have been assigned [Hopwood & Kieser, 1990].
The chromosome of S.lividans has also been physically mapped using "rare-cutter" 
restriction endonucleases and PFGE, and its size estimated at approximately 8  Mb 
[Leblond et al., 1993]. These authors were, however, unable to clone linking 
segments between a pair of fragments for each of the two enzymes used. They 
therefore suggested that the S.lividans chromosome may be linear, and not circular as 
anticipated from its circular linkage map. They also showed, by cross-hybridisation, 
that S.lividans and S.coelicolor are very closely-related strains.
Lin et al. [1993] identified an incomplete copy of the linear plasmid SLP1 integrated 
into the S.lividans chromosome, evidently at the end of a linear molecule, and identified 
two restriction fragments which apparently contain the free chromosomal ends, 
confirming that the chromosome of S.lividans is linear. They also showed that the free 
ends are bound together by terminally-bound protein molecules. Each terminus 
contains four inverted repeat sequences (palindromes), with all of the palindromes 
having a 3 nt unpaired centre. These authors proposed that these palindromes may be 
involved in recognition of the termini by DNA polymerase or the terminally-bound 
proteins. They also showed that deletions across the termini, followed by fusion of the 
two new chromosomal ends, could produce a circular molecule which is able to 
replicate stably, presumably utilising the oriC which has previously been identified in 
the S.lividans chromosome [Zakrzewska-Czerwinska & Schrempf, 1992]. It is 
therefore likely that chromosomal replication may be performed on either a circular or 
linear template.
The chromosomes from six other species of streptomycete (including S.coelicolor) 
were also shown to be likely to exist in a linear form [Lin et al., 1993], and a number 
of Streptomyces strains contain a region homologous to the oriC from S.lividans. The 
oriC of S.coelicolor has since been cloned [Calcutt & Schmidt, 1992], and shows over
4
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99% identity to the oriC of S.lividans. Linear chromosomes are typically associated 
with eukaryotes, and have so far been found in only one other bacterial genus, the 
Borrelia spirochetes, as shown initially in B.burgdorferi [Casjens & Huang, 1993].
Streptomyces chromosomes appear not to contain completely clustered genes for 
synthesis of the secondary metabolites, although some of the genes implicated in such a 
pathway are often clustered together. Genes from the same biosynthetic pathway 
frequently lie on opposite quarters of the chromosome when it is viewed as a circular 
molecule. This has been suggested as being due to ancient duplication events, followed 
by either loss of one of the pair of duplicated genes or evolution, with one of the pair 
altering its activity to become a new enzyme [Hopwood & Kieser, 1990]. The genes 
for secondary metabolic pathways appear, however, to be clustered in Streptomyces.
S.coelicolor contains a number of extra-chromosomal DNA molecules. SCP1, a giant 
(-350 kb) linear plasmid, may replicate autonomously, or may integrate into the 
chromosome. SLP1 may also exists as an integrated molecule, although it may form a 
stable circular molecule in S.lividans. It is thought to be related to the temperate 
bacteriophages due to its int and xis genes, encoding the enzymes which accomplish 
integration and excision events respectively, and its attP  site, through which it 
integrates via a homologous recombination event with the chromosomal attB site, 
which overlaps with a gene encoding a tRNATyr [Vogtli & Cohen, 1992]. S.coelicolor 
also contains a minicircle which can either replicate autonomously or integrate at two 
distinct sites, and acts as host for the temperate bacteriophage 0C31, which can infect 
lytically (replicating autonomously, and lysing the cell to release its progeny phage) or 
lysogenically (integrating into the chromosome at the attB site).
1.3 Streptom yces secondary metabolites
Streptomyces produce numerous strain-specific compounds which are not metabolised 
or utilised for cell production, and are typically excreted from the cells. These 
compounds are termed secondary metabolites, and they are synthesised at the 
"idiophase", the point at which the development of aerial mycelia is initiated. 
Therefore, the secondary metabolites are associated with differentiation. Streptomyces 
coelicolor, the strain on which the work described in this thesis has been undertaken, is 
the most thoroughly investigated streptomycete, and produces five secondary 
metabolites: actinorhodin, undecylprodigiosin and CD A (calcium-dependent antibiotic) 
are chromosomally-encoded antibiotics; methylenomycin is an antibiotic whose 
biosynthesis is encoded by genes contained on the plasmid SCP1 [Hopwood &
5
Chapter 1
Wright, 1983]; A-factor is an autoregulatory factor involved in the initiation of 
secondary metabolism. None of the antibiotics is of industrial significance.
The secondary metabolites from Streptomyces often have antibacterial, anti-tumour, 
anti-parasitic or anti-helminthic activity, or function as immunosuppressants, animal 
growth promotants, vasodilators, enzyme inhibitors, herbicides, pesticides or 
insecticides [Demain, 1983]. Streptomyces produce over 70% of known antibiotics 
and, therefore, are industrially-important micro-organisms.
It has been postulated that antibiotics sterilise the soil, precluding the growth of other 
micro-organisms in the immediate environment, and preventing them from utilising the 
products of the breakdown of the streptomycete vegetative mycelia, which provide the 
substrates for aerial mycelia production [Davies et al., 1992]. It is also possible that, 
with the cessation of vegetative growth, there is a build-up of metabolic intermediates 
which may be toxic in such high concentrations. Secondary metabolites may represent 
the end-products of an alternative metabolism of toxic intermediates. Therefore, 
excretion of secondary metabolites may provide a route for removal of such toxic 
compounds. They may also have evolved as biochemical modulators or effectors.
1.4 RNA polymerase heterogeneity in Streptom yces
Unlike eukaryotes, prokaryotes appear to contain only a single core RNA polymerase 
enzyme, which is responsible for the transcription of genes to produce the mRNA's 
used as templates for the synthesis of proteins. However, core RNA polymerase 
requires the presence of an extra protein, known as a sigma (ct) factor, to provide 
promoter specificity to the core enzyme. Together, core RNA polymerase and a sigma 
factor constitute the RNA polymerase holoenzyme [Stragier et al., 1985].
Different genes are transcribed by different RNA polymerase holoenzymes, due to the 
presence in the holoenzyme of differing sigma factors, which direct the core enzyme to 
a promoter and instigate transcription from the promoter. Bacteria contain a group of 
principal sigma factors which direct expression from the housekeeping genes, and 
various minor sigma factors, which appear to be involved in the transcription of those 
genes whose products are not expressed throughout the growth cycle, for instance the 
heat-shock genes and those involved in secondary metabolism.
In certain differentiating bacteria, it has been proposed that regulation of the 
differentiation processes is effected via the presence of varying sigma factors (or their
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relative amounts) at different stages of the life cycle. This theory has been extensively 
investigated in the Gram-positive, sporulating bacterium Bacillus subtilis, in which 
differentiation is known to be controlled by a cascade of sigma factors, and even by 
anti-sigma factors which have been implicated in the inhibition of certain sigma factors 
[Errington, 1993]. Recent studies suggest that a cascade of sigma factors may regulate 
differentiation in Streptomyces.
The existence of multiple sigma factors in Streptomyces was first proposed with the 
discovery that the veg and etc genes from B. subtilis are transcribed by different 
holoenzymes in S.coelicolor [Westpheling et al., 1985]. Two distinct proteins were 
discovered to be associated with the core polymerase; one of Mr 35000 which allowed 
transcription of the veg gene (a 35), and one of Mr 49000 (a 49) which stimulated 
transcription of etc. a 35 was proposed as being analogous to the principal (or major) 
bacterial sigma factors (typified by Eg70, encoded in E.coli by the rpoD gene).
Four homologues of G70, hrdA-hrdD, have been cloned from S.coelicolor [Tanaka et 
al., 1988; Buttner et al., 1990], and show significant identity to the family of principal 
sigma factors [Tanaka et al., 1991]. Disruption of three of these genes, hrdA, hrdC 
and hrdD, has no apparent effect on growth, differentiation or secondary metabolism in 
S.coelicolor, although hrdB disruptants were not obtained, suggesting that such cells 
are not viable, and that inactivation of a HrdB is a lethal event. It was demonstrated, by 
SI nuclease protection, that hrdB and hrdD are transcribed when S.coelicolor is grown 
in liquid culture [Buttner et al., 1990]. The hrdC gene may also be disrupted without 
any deleterious effects in S.lividans [Takahashi et al., 1988]. Pairwise disruption of 
hrdA, hrdC and hrdD, and even simultaneous disruption of all three genes, has no 
apparent effect on S.coelicolor [Buttner & Lewis, 1992], suggesting that they may all 
be functionally redundant.
Four genes encoding putative sigma factors have been identified in S.aureofaciens 
[Kormanec et al., 1992], all of which contain the rpoD box [Tanaka et al., 1988], thus 
identifying them as putatively encoding principal sigma factors. Three of these bear 
significant similarities to three of the hrd genes of S.coelicolor, and were therefore 
named hrdA, hrdB and hrdD', the other gene was named hrdE, although it also bears 
significant similarity to hrdB of S.coelicolor (74% identity at the amino acid level). All 
four deduced protein products show similarity to the principal sigma factors, with 
(jHrdB showing the greatest identity to G70. This suggests that GHrdB is the functional 
homologue of the principal sigma factors in S.aureofaciens as well as in S.coelicolor.
The principal sigma factors contain numerous completely conserved amino acids.
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However, the sequences of the products of the hrdA and hrdD genes of S.aureofaciens 
differ at several of these residues, suggesting that their products may have a different 
function. HrdE only differs at two of these positions, with both changes being 
conservative substitutions. However, hrdE contains two inverted repeats in its coding 
sequence which may prevent its expression. As with S.coelicolor, only HrdB and 
HrdD were shown to be strongly expressed by Northern blotting when S.aureofaciens 
was grown in minimal medium, with slight expression of HrdA occurring. There are 
four transcriptional start sites lying upstream of hrdB, possibly suggesting a complex 
pattern of regulation of expression.
Using SI nuclease mapping, hrdA, hrdB  and hrdD  all show transcription in 
S.aureofaciens from tandem promoters at various stages of development [Kormanec & 
Farkasovsky, 1993]. Transcription from the tandem promoters of hrdB occurs during 
all stages of the life cycle, with the tandem promoters of hrdD only being active in 
vegetative mycelia, and those of hrdA only during the formation of aerial mycelia. 
hrdB  also contains a promoter internal to its coding region. It is possible that 
temporally-regulated expression of sigma factors is a general method of the control of 
development, as it is in B. subtilis.
The dagA  gene, encoding an extracellular agarase enzyme, has been cloned in 
S.coelicolor [Kendall & Cullum, 1984]. It is transcribed from four separate promoters 
[Buttner et al., 1987], at least three of which require distinct sigma factors for their 
transcription [Buttner et al., 1988], although two of these sigma factors support 
transcription from the veg or etc promoters from B.subtilis, and are likely to be those 
identified previously [Westpheling et al., 1985]. The novel sigma factor was named 
a 28. Transcription from the promoters -pi, -p2 and -p4 appears to be developmentally 
regulated, being significantly enhanced at the onset of formation of aerial mycelia 
[Servin-Gonzalez etal., 1994].
Transcription from the dagA-p4 promoter is stimulated by a 56 kDa sigma factor which 
also directs transcription of the B.subtilis veg gene in S.coelicolor. This protein has 
been identified as the product of the hrdB gene [Brown et al., 1992]. It is possible that 
a 35, which had previously been identified as supporting transcription from the veg 
promoter [Westpheling et al., 1985], is a separate sigma factor, or a proteolytic 
fragment of a HrdB which retains some activity.
In both S.coelicolor and S.lividans, the galactose operon is transcribed from two 
separate promoters, gal-pl which is a promoter induced by galactose but repressed by 
glucose, and gal-p2, a low-level constitutive promoter which lies internal to the operon.
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Transcription from the -pi and -p2 promoters is controlled by separate sigma factors, 
possibly a 35 and c 28 respectively [Westpheling & Brawner, 1989].
The whi genes are involved in sporulation, and hence in differentiation, whi mutants 
do not produce spores, although they do produce aerial mycelia. The whiG gene has 
been cloned [Mendez & Chater, 1987] and found to encode a sigma factor, a whiG, 
which is closely related to a minor motility sigma factor from B. subtilis [Chater et al.,
1989]. As anticipated, disruption of whiG has no effect on vegetative growth and 
prevents sporulation from aerial mycelia, but overexpression of its product causes the 
production of spores from substrate mycelium, and a reduction in the synthesis of the 
secondary metabolites. This latter observation is likely to be due to the lysing of the 
vegetative mycelium which allows this unusual sporulation event before aerial hyphae 
are able to form, and therefore prior to synthesis of antibiotics. Thus, the level of 
active a whiG in a cell appears to control the initiation of sporulation. Therefore, it is 
likely that the production of active a WhiG is, itself, developmentally-regulated.
1.5 Activators of secondary metabolism
In actinomycetes, these effectors have wide-ranging or even global regulatory effects 
on the synthesis of secondary metabolites, and possibly on differentiation. They are 
analogous to the eukaryotic hormones or sexual pheromones, and are able to function at 
extremely low concentrations. The first such identified compound was A-factor [2-(6'- 
methylheptanoyl)-3R-hydroxymethyl-4-butanolide], which was detected initially in 
S.griseus due to its ability to positively regulate the synthesis of the antibiotic 
streptomycin and the formation of aerial mycelia. It also has similar activity in 
S.coelicolor and S.lividans. A-factor is a member of the y-butyrolactone family, a 
group of compounds which are distributed widely throughout the actinomycetes, and 
which often have similar activities.
A-factor is synthesised at an early stage in the cell cycle but is not active at this time, 
suggesting the existence of a negative effector [Horinouchi & Beppu, 1990]. It is 
believed to function by stimulating mRNA synthesis from specific genes. Its 
biosynthesis is regulated by a protein encoded by afsA, which is carried on an unstable 
extra-chromosomal element, and was originally cloned from S.griseus. In 
S.coelicolor, the product of another gene, afsB, is required for the transcription of 
afsA. Although the afsB gene has not yet been cloned, mutations disabling its activity 
have been complemented by the afsR gene [Horinouchi et al., 1990], the product of 
which, AfsR, promotes the production of secondary metabolites. Mutations in afsR, or
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its disruption, reduce the synthesis of the secondary metabolites, but do not affect 
differentiation and sporulation. AfsR contains two separate consensus ATP binding 
sites towards its N-terminus, and is activated by phosphorylation, accepting the y- 
phosphate of ATP from cell lysates of S.coelicolor and S.lividans [Hong et al., 1991]. 
A protein capable of phosphorylating AfsR has also been discovered in S.lividans, 
although this activity could not be found in S.griseus. It has been suggested that AfsR 
is the second protein of a two-component regulatory system, with the first protein being 
autophosphorylated.
Mutations in absA prevent synthesis of all antibiotics in S.coelicolor, but have no 
significant effect on sporulation, differentiation or growth rate [Adamidis et al., 1990]. 
This locus was shown to be unrelated to any of the bid or afs loci, and these authors 
have proposed that mutations in absA may deregulate a repressor or produce an 
inhibitory activity. Unusually, absA mutants still retain resistance to methylenomycin, 
suggesting that not all antibiotic resistance genes are co-ordinately regulated with the 
respective production genes.
Another two-component regulatory system which stimulates the production of 
antibiotics and A-factor has been identified in S.coelicolor [Ishizuka et al., 1992]. The 
two genes involved in this system, afsQl and afsQ2, are transcriptionally coupled. The 
product of afsQ l shows similarity to the response regulators of prokaryotic two- 
component systems, and the product of afsQ2 shows similarity to the protein kinases of 
such combinations. Thus, the product of afsQ2, which is likely to be membrane- 
bound, is capable of phosphorylating the product of afsQ l, which functions as a 
positive regulator when phosphorylated. Their transcription begins immediately before 
the production of actinorhodin. Although disruption of this gene pair has no effect on 
secondary metabolism or differentiation in otherwise wild-type S.coelicolor, they are 
capable of suppression of mutations in absA.
The gene abaA has also been identified as encoding a positive regulator of secondary 
metabolism in S .co e lic o lo r ,  inducing the production of actinorhodin, 
undecylprodigiosin and, to some extent, CDA. However, it has no effect on the 
synthesis of methylenomycin [Fernandez-Moreno et al., 1992], It has been proposed 
that the product of abaA is involved further down the regulatory network than other 
global regulators, for example AfsR. An open reading frame ORFA, which may also 
be involved in the control of secondary metabolism, occurs immediately upstream of 
abaA, and may be transcriptionally coupled to it.
From the work described above, it appears that a number of regulatory cascades, which
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may well function in a set progression, are involved in the control of differentiation and 
the biosynthesis of the secondary metabolites in Streptomyces.
1.6 The shikimate pathway
The shikimate pathway is a primary metabolic pathway consisting of seven enzymes 
(DAHP synthase, DHQ synthase, dehydroquinase, shikimate dehydrogenase, 
shikimate kinase, EPSP synthase and chorismate synthase) which catalyse the 
conversion of erythrose-4-phosphate (E4P) and phosphoenolpyruvate (PEP) to 
chorismate (Figure 1.2). E4P is synthesised from glucose via the pentose phosphate 
cycle; PEP is also produced from glucose via the Embden-Meyerhof pathway 
(Mandelstam et al., 1982). Chorismate is used as a precursor for the synthesis of the 
aromatic amino acids (phenylalanine, tyrosine and tryptophan), p-aminobenzoate (pAB: 
precursor of folic acid), 2,3-dihydroxybenzoate (DHB: precursor of the iron chelator 
enterochelin), p-hydroxybenzoate (precursor of ubiquinone), o-succinylbenzoate 
(precursor of the menaquinones), plastoquinone, chloramphenicol, and the vitamins E 
and K (Figure 1.3). Shikimate is a precursor for the synthesis of the ansamycin and 
rifamycin antibiotics. DAHP may be an intermediate in the synthesis of 3-hydroxy-5- 
aminobenzoate, and DHQ in the production of 3-aminobenzoate, both of which are 
precursors of the ansamycins (which have antibacterial, antiviral and antitumour 
activities) and the immunosuppressant FK506. The aromatic ring derived from the 
shikimate pathway may also be incorporated into the coumarin antibiotics, of which 
there are approximately one thousand currently known, p-aminobenzoate and 2,3- 
dihydroxybenzoate are components in bacterial cell walls, and are precursors for lignin 
synthesis in higher plants (Bentley, 1990).
The shikimate pathway is present in the bacteria, plants and lower eukaryotes, but is 
absent from the vertebrates, which must therefore be provided with exogenous aromatic 
amino acids (although they are able to synthesise tyrosine by hydroxylation of 
phenylalanine). In plants, the shikimate pathway is localised in, or targeted to, the 
chloroplast.
1.7 The ARQM polypeptide
As early as 1967, a gene cluster encoding a pentafunctional AROM polypeptide (Mr 
-200,000) encoding the enzymes cataly sing steps two to six of the shikimate pathway 
(dehydroquinate synthase to EPSP synthase), the arom gene cluster, was identified in
11
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Figure 1.3 Products of chorismate metabolism.
13
Chapter 1
the mould N.crassa  [Giles et al., 1967] (Figure 1.4). The presence of two 
dehydroquinase activities, one constitutive and occurring as part of the AROM 
polypeptide, the other inducible and part of a degradative pathway, was reported 
[Hautala et al., 1975], It was proposed that the enzyme aggregate may provide a 
channelling mechanism for the substrates of these two enzymes. The inducible enzyme 
was purified, and was found to be thermostable at 80°C, but was inhibited by 
guanidine chloride.
The AROM polypeptide was purified [Gaertner & Cole, 1977] and shown by SDS- 
PAGE to have an Mr of -150,000. The native molecular weight was estimated at 
300,000, suggesting that the polypeptide functions as a homodimer. This confirmed 
earlier reports [Case & Giles, 1971] which had also demonstrated that each monomer 
can dissociate into two distinct sub-aggregates: one containing the dehydroquinate 
(DHQ) synthase and the EPSP synthase activities; the other containing the 
dehydroquinase, shikimate kinase and shikimate dehydrogenase domains.
A 4 kb fragment containing part of the arom cluster encoding the AROM polypeptide 
from N.crassa was cloned by complementation of an E.coli aroD mutant, producing a 
thermolabile dehydroquinase activity [Catcheside et a l,  1985]. This sequence also 
complements the qa-2 and aro-9 dehydroquinase mutations in N.crassa.
The AROM polypeptide has most recently been observed as having an Mr of 165,000 
[Smith & Coggins, 1983]. As the arom cluster of N.crassa consists of a single 4-8 kb 
ORF encoding a protein of estimated Mr -175,000 [Charles et al., 1986], it appears 
that the cluster contains only small, or even no introns. Limited proteolysis produces 
two separable polypeptides of Mr 68,000 and 110,000, the smaller of which retains the 
dehydroquinase and shikimate dehydrogenase activities.
Ahmed & Giles [1969] used centrifugation in sucrose density gradients to show that six 
more fungi (Rhizobus stolonifer, Phycomyces nitens, Absidia glauca, Aspergillus 
nidulans, Coprinus lagopus and Ustilago maydis) also contained the activities 
catalysing steps two to six of the shikimate pathway as part of a pentafunctional 
polypeptide. All six had a thermolabile dehydroquinase activity, but only two showed 
the thermostable activity. The blue-green algae typically have separable (or at least 
partially separable) shikimate pathway enzymes, but Euglena gracilis contains the 
pentafunctional AROM polypeptide with an Mr of 249,000 [Berlyn et al., 1970; Patel 
& Giles, 1979].
Strauss [1979] dissected the AROM-encoding aro3 gene of Saccharopolyspora pombe
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into five complementation groups, ordering them by recombination frequencies, and 
concluded that this aro3 gene is the functional homologue of the arom cluster of 
N.crassa. The aro3 gene has been cloned and found to complement all tested aro 
mutants of E.coli [Nakanishi & Yamamoto, 1984]. Subclones of aro3 have been 
isolated which complement both an aroD mutation and an aroD/aroE double mutation in 
E.coli.
The aromA locus of A.nidulans has been placed under the control of the powerful 
E.coli trc promoter, and expressed in E.coli [Hawkins & Smith, 1991]. The aromA 
gene complements mutations in the aroA, -B, and-D genes, but fails to complement 
mutations in the aroE gene. Hawkins & Smith subcloned the single domains of the 
aromA locus of A.nidulans into vectors, allowing separate expression of each of the 
individual domains of the AROM polypeptide, and showed that the DHQ synthase 
domain can function independently or as part of a bifunctional protein with EPSP 
synthase. However, the EPSP synthase domain is only active catalytically when fused 
to the C-terminus of the DHQ synthase domain, and not when these two polypeptides 
are merely supplied in trans, suggesting that the presence of a DHQ synthase domain 
covalently attached to its N-terminus is necessary to fold the EPSP synthase domain 
into an active formation [Moore & Hawkins, 1993]. The dehydroquinase domain 
functions independently, or as part of a bifunctional polypeptide with either shikimate 
dehydrogenase or shikimate kinase. It has been suggested that the AROM monomer 
consists of two distinct domains which can fold and function independently of each 
other; one consists of the dehydroquinate synthase/EPSP synthase activities, the other 
of the shikimate kinase/dehydroquinase/shikimate dehydrogenase activities. There is 
no expression of shikimate kinase from the whole AROM polypeptide or any part of it 
in E.coli. When the biosynthetic dehydroquinase is placed under the control of the 
qutE promoter/terminator, it complements an A.nidulans qutE mutation, showing that 
biosynthetic dehydroquinases are capable of functioning in the quinate pathway.
Integration of twelve copies of the aromA gene of A.nidulans into an arom mutant 
causes overexpression of the AROM polypeptide [Lamb et al., 1991]. Such 
overexpressors cannot grow on quinate as sole carbon source or quinate+glycerol, as 
DHS and DHQ are being fluxed at increased levels into the shikimate pathway, causing 
the build up of a shikimate pathway intermediate which is toxic at elevated levels. 
However, when these cells are grown on quinate+glucose, the presence of glucose 
causes carbon catabolite repression, which reduces the activity of the quinate pathway 
and allows growth to occur. Elevated levels of quinate prevent full carbon catabolite 
repression, allowing expression of the quinate pathway and preventing growth. If such 
overexpressing strains lose many of their copies of the aromA gene, effectively
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reverting to wild type-levels of AROM, they are again able to grow on quinate as sole 
carbon source. These authors have also shown that five-fold overexpression of AROM 
allows a qutRc/qutE  mutant to grow on quinate (qutRc denotes a mutation in QutR 
which leads to constitutive expression of the quinate utilisation genes), suggesting that 
the AROM protein is leaking DHQ and DHS, which may then be metabolised by the 
quinate pathway.
The aromA gene of A.nidulans has been placed under the control of the qutE promoter 
in an aromA/qutB double mutant (which is unable to grow in the absence of aromatic 
amino acids or to grow on quinate as sole carbon source), causing overexpression of 
the AROM enzyme complex [Moore et al., 1992]. These overexpressing strains 
showed a significantly reduced growth rate on quinate+glycerol as expected. They 
produce a quinate-inducible protein of 175 kDa (presumably the AROM protein) whose 
expression is correlated with the impaired growth on quinate+glycerol.
The A.nidulans AROM protein has been fused to the N-terminus of the glutathione S- 
transferase (GST)-encoding gene under control of the Ptac promoter, and has 
subsequently been overexpressed in E.coli [Hawkins et al., 1993]. It has been purified 
to greater than 98% homogeneity by a single-step affinity purification, and digested 
with thrombin to remove the GST N-terminus. The dehydroquinase activity is stable in 
enzyme assays, and the purified AROM polypeptide has a native Mr which suggests 
that it functions as a monomer in E.coli, although it typically functions as a dimer in 
A.nidulans. The dehydroquinase domain of AROM is reduced by borohydride only in 
the presence of DHQ, confirming its dehydroquinase as a type I enzyme. The Km of 
dehydroquinase for DHQ, when the AROM protein is purified from E.coli, is -200 pM 
(the type I enzyme from E.coli has a Km of 18 pm [Chaudhuri et al., 1986]), 
suggesting that the dehydroquinase activity of the monomeric AROM protein is 
inefficient, presumably due to it functioning as a monomer.
The arol gene of Saccharomyces cerevisiae encodes a 150 kDa AROM polypeptide 
which complements missense and nonsense alleles of S.cerevisiae and also the E.coli 
aroA, aroB, aroD and aroE mutations [Larimer et al., 1983]. The arol gene has been 
sequenced [Duncan et al., 1987] and shows the same composition and order as the 
AROM enzymes of S.pombe [Nakanishi & Yamamoto, 1984], A.nidulans [Hawkins,
1987] and N.crassa [Charles et al., 1986]. The AROM polypeptide has also been 
compared with the corresponding enzymes of E.coli, showing that the five 
monofunctional enzymes of E.coli are clearly homologous to separate regions of the 
multifunctional eukaryotic enzymes. The E.coli DHQ synthase, dehydroquinase and 
EPSP synthase enzymes show extensive similarity to the AROM polypeptide from
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A.nidulans, suggesting that the shikimate pathway enzymes have evolved from a 
common ancestor, and that their genes have fused in eukaryotes to produce a mosaic 
polypeptide, rather than having become dispersed in bacteria [Hawkins, 1987]. It has 
also been shown that fragments of this arom locus can complement aroA and aroD 
mutations of E.coli.
The aroA function of another fungus, Pneumocystis carinii, has been cloned [Banerji et 
al., 1993] and itself used to clone the complete arom locus of this fungus. The deduced 
protein sequence shows good similarity to the AROM proteins from other fungi and the 
corresponding shikimate enzymes of E.coli.
1.8 Organisation of the shikimate pathway in bacteria and plants
Berlyn & Giles [1969] showed that the enzymes of the shikimate pathway are not 
aggregated in bacteria (Escherichia coli, Salmonella typhimurium, Klebsiella 
pneumoniae, Bacillus subtilis, Pseudomonas aeruginosa and Streptomyces coelicolor), 
reporting Mr's for the dehydroquinase enzymes as low as 40,000 (E .co li, 
S.typhimurium  and B.subtilis), with others in excess of 130,000 (S.coelicolor and 
P.aeruginosa.). This organisation of separable activities was also identified in 
K.pneumoniae [Berlyn & Giles, 1973].
In plants, there appears to be two copies of the shikimate pathway; one in the plastids 
(chloroplasts) and the other in the cytosol. Evidence for such a theory has been 
provided by purification of separate bifunctional dehydroquinase/shikimate 
dehydrogenase isozymes from P.sativum  (pea) [Mousdale et al., 1987], EPSP 
synthase isozymes from P.hybrida (petunia) and L.esculentum (tomato) [Gasser et al., 
1988], and DAHP synthase isozymes from N.silvestris [Ganson & Jensen, 1988] and 
V.radiata (mung bean) [Rubin et al., 1982].
In plants, five of the shikimate enzymes exist as separate proteins, but the 
dehydroquinase and shikimate dehydrogenase activities appear, in all plants studied, to 
occur in a bifunctional protein, which is active as a monomer with an Mr of -59,000. 
The species in which this bifunctional protein has been identified include mosses 
(Physcomitrella patens [Polley, 1978] and Phaseolus mungo [Koshiba, 1978]), 
spinach (Spinacia oleracea) and pea (Pisum sativum [Mousdale et al., 1987]). This 
bifunctional activity also appears to exist in certain blue-green algae, including 
Chlamydamonas reinhardi [Berlyn et al., 1970]. It is equivalent to the two E.coli 
enzymes (29 kDa and 32 kDa) and to a proteolytic fragment of the AROM protein
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containing only these two activities (63 kDa), and is likely to have evolved by gene 
fusion.
In the bifunctional enzyme from Pisum sativum, the dehydroquinase activity occurs in 
the N-terminal part of the protein, with the shikimate dehydrogenase domain lying in 
the C-terminus [Deka et al., 1994]. Thus, this bifunctional enzyme is homologous to, 
and shows the same organisation as, the smaller of the two polypeptides produced by 
limited proteolysis of the AROM polypeptide of A.nidulans [Smith & Coggins, 1983]. 
The bifunctional protein may provide some form of channelling, limiting the flux of 
DHS into the quinate pathway, which is constitutive in plants.
1.9 The enzymes of the shikimate pathway
1.9.1 DAHP svnthase
3-deoxy-D-arabino-heptulosonate 7-phosphate synthase [EC 4.1.2.15] (phospho-2- 
dehydro-3-deoxyheptonate aldolase) is the first enzyme of the shikimate pathway, and 
as such is suggested to be a likely target for pathway regulation. It catalyses the 
condensation of D-erythrose-4-phosphate (E4P) and phosphoenolpyruvate (PEP) to 
form 3-deoxy-D-arabino-heptulosonate 7-phosphate (DAHP).
The actinomycete Nocardia mediterranei uses an early intermediate of the shikimate 
pathway as a precursor for the synthesis of the antibiotic rifamycin. Its DAHP 
synthase is inhibited by E4P, which acts as a competitive inhibitor with PEP for the 
active site [Gygax et al., 1982]. The enzyme, however, shows little or no feedback 
inhibition by the aromatic amino acids. In the Streptomyces species 3022a, DAHP 
synthase activity is not regulated by any intermediates or end-products of the shikimate 
pathway, but is inhibited partially by p-hydroxybenzoate [Lowe & Westlake, 1971]. It 
is also inhibited by E4P, but this inhibition is removed by the addition of PEP.
The single form of DAHP synthase from Streptomyces rimosus has been purified to 
97% homogeneity in this laboratory [Stuart & Hunter, 1993]. It has a subunit Mr of 
59,000 and native Mr of 120,000, suggesting that it functions as a dimer. Its activity is 
apparently inhibited only by tryptophan, which shows cooperative binding to the 
enzyme. The amino acid sequence of the N-terminus of the DAHP synthase enzyme 
from S.rimosus has been obtained [Walker et al., in press]. An oligonucleotide primer 
has been designed against this sequence, and the gene encoding this enzyme is 
currently being cloned and sequenced in this laboratory.
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E.coli contains three separate isozymes of DAHP synthase, expression of each being 
inhibited by one of the aromatic amino acids which acts as an effector for the relevant 
repressor. The DAHP synthase(tyr) isozyme, encoded by aroF, is repressed by TyrR, 
the tyrosine repressor, which requires either tyrosine or high concentrations (mMolar) 
of phenylalanine for activity [Brown & Somerville, 1971]. The DAHP synthase(phe) 
isozyme, encoded by aroG, is also repressed by TyrR, but requires both phenylalanine 
and tyrosine for regulation. The DAHP synthase(trp) isozyme, encoded by aroH, is 
repressed at equivalent levels by the tryptophan repressor, TrpR, which uses 
tryptophan as its effector [Ogino et al., 1982], and by the tyrosine repressor. The 
region responsible for regulation of the aroH gene contains both a Tyr box (at which 
TyrR binds), lying 38 bp upstream of the binding site for the Trp repressor, suggesting 
that the two repressors jointly regulate the expression of this isozyme [Muday et al.,
1991]. Therefore, regulation of the DAHP synthase isozymes is by feedback 
inhibition, with the end-products repressing expression of these isozymes and also 
inhibiting their activity. Expression of these three isozymes is implicated in controlling 
the flux through the shikimate pathway.
The plant Nicotiana silvestris contains two isozymes of DAHP synthase: one is 
functional in the cytosol, uses cobalt (Co) as its cofactor, and is inhibited by 
glyphosate; the other is located in plastids (including the chloroplast), uses manganese 
(Mn) as its cofactor, and is insensitive to inhibition by glyphosate [Ganson & Jensen,
1988], Mung bean (Vigna radiata) seedlings also contain two DAHP synthase 
isozymes: the glyphosate-inhibitable Co-dependent enzyme, and the glyphosate- 
resistant Mn-dependent isozyme [Rubin et al., 1982]. In the presence of glyphosate, 
the Mn-dependent isozyme is able to synthesise DAHP from E4P and PEP, and this 
DAHP is then fed into the cytosolic shikimate pathway as well as the plastid-located 
one. However, as both pathways contain a glyphosate-sensitive EPSP synthase, the 
shikimate pathway is still blocked, causing the accumulation of shikimate.
DAHP synthase has been purified from B. subtilis, and occurs as part of a bifunctional 
polypeptide which also contains the chorismate mutase activity [Huang et al., 1975]. 
This polypeptide is found to be associated with a small (approx. 10 kDa) polypeptide 
conferring shikimate kinase activity. The shikimate kinase enzyme only has activity 
when it forms part of this trifunctional enzyme complex, and its presence in the 
complex increases the activity of the other two enzymes by up to 50%.
1.9.2 Dehvdroquinate svnthase
Dehydroquinate synthase [EC 4.6.1.3] (7-phospho-3-deoxy-D-arabino-heptulosonate
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phosphate lyase) catalyses the conversion of DAHP to dehydroquinate (DHQ), and is 
the first catalysis performed by the AROM pentafunctional polypeptide. In E.coli, 
DHQ synthase is encoded by the gene aroB, which has been cloned [Duncan & 
Coggins, 1984] and sequenced, and is predicted to encode a protein of Mr 39,000 
[Millar & Coggins, 1986].
The DHQ synthase domain of the AROM polypeptide from A.nidulans has been 
overexpressed in E.coli, complementing an aroB mutation [van den Hombergh et al.,
1992] providing further evidence that the enzyme activities of AROM are functionally 
homologous to those of the separable enzymes of bacteria.
DHQ synthase from B. subtilis has been purified, and its activity found to be associated 
with those of the chorismate synthase and flavin reductase enzymes [Hasan & Nester, 
1978]. DHQ synthase activity is dependent on the presence of chorismate synthase, 
but not on the presence of the flavin reductase.
1.9.3 3-D ehvdroquinase
Dehydroquinase [EC 4.2.1.10] (3-dehydroquinate dehydratase) catalyses the 
conversion of dehydroquinate to dehydroshikimate. There are two distinct enzyme 
forms, type I and type II, which have different mechanisms of action [White et al., 
1990]: type I is a biosynthetic enzyme which is active as a dimer, and has a low Km; 
type II is a catabolic, degradative enzyme which is active as a dodecamer, and has a 
considerably higher Km (650 |iM for S.coelicolor). The type I enzyme is active in the 
shikimate pathway of bacteria, plants and lower eukaryotes; the type II enzyme was 
originally identified as being active in the quinate pathway of lower eukaryotes, 
although it has also been recently found in the shikimate pathway of certain Gram- 
positive bacteria and one Gram-negative bacterium (see below).
Polarity mutants of N.crassa which were auxotrophic for the aromatic amino acids lack 
the AROM polypeptide (arom-2 mutants), and were found to exhibit a high level of 
dehydroquinase activity when grown on quinate [Giles et al., 1967]. Unlike the 
constitutive biosynthetic activity which was already known to be associated with the 
AROM polypeptide, this activity was found to be stable when heated to 71°C, and was 
induced by the presence of quinate.
When A.nidulans is grown on media which do not induce its quinate pathway (and 
therefore do not induce its type II dehydroquinase), dehydroquinase activity can still be 
detected. This activity is heat-labile and does not cross-react with antibodies raised
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against the N .crassa  type II enzyme, suggesting that A .n idu lans  has both 
dehydroquinase enzymes [Kinghom & Hawkins, 1982]. The type II dehydroquinase 
gene, qutE , is transcribed only when grown on quinate, as it is transcriptionally 
regulated [Da Silva et al., 1986]. These authors suggested that the levels of the qutA 
gene product are rate-limiting for induction of the quinate pathway.
The sequence encoding the dehydroquinase domain of the arom locus of A.nidulans 
was cloned by virtue of its ability to complement an aroD mutation in E.coli [Kinghom 
& Hawkins, 1982]. It has been sequenced [Charles et al., 1985] and its product shows 
no similarity to that of the qutE gene, which encodes the type II enzyme from the same 
species, suggesting that the two genes evolved separately by convergent evolution, and 
have not undergone divergent evolution from a common ancestral gene. The 
dehydroquinase domain has been overexpressed in E.coli, and complements an aroD 
mutation [van den Hombergh et al., 1992].
Chaudhuri et al. [1986] purified dehydroquinase from E.coli to a single band on SDS- 
PAGE. It had a native Mr of 52,000-58,000 and subunit Mr of 29,000, suggesting 
that the enzyme functions as a dimer. Its activity is inhibited by NaBH^ The gene 
encoding this protein, aroD, was cloned due to its ability to complement a 
dehydroquinase mutant [Kinghorn et al., 1981] and found to encode a heat-labile 
protein. Both the N-terminus of the protein and its gene were sequenced [Duncan et 
al., 1986; Chaudhuri et al., 1991] and found to have no significant sequence identity to 
the qa-2 gene product from N.crassa [Berson et al., 1991] which encodes the catabolic 
dehydroquinase.
The aroD gene of S.typhimurium was cloned by complementation of an E.coli aroD 
mutation, sequenced, and found to show a high level of sequence similarity to the 
E.coli gene at the DNA level (69%), and at the amino acid level (70%) with the gene 
product [Servos et al., 1991]. It encodes a protein of estimated subunit size 28 kDa, 
and codon usage analysis suggests that the aroD genes from both S. typhimurium and 
E.coli are poorly expressed.
The activity of a type I dehydroquinase is known to be inhibited by chloride anions. As 
the dehydroquinase activity of the bifunctional protein containing the dehydroquinase 
and shikimate dehydrogenase domains from pea seedlings {P. sativum) is also inhibited 
by chloride ions, this dehydroquinase activity was identified as a type I enzyme 
[Mousdale et al., 1987]. However, this bifunctional protein functions as a monomer, 
unlike typical type I enzymes. It has been purified recently, and has a low Km for its 
dehydroquinase activity, which is inactivated by NaBH4  [Deka et al., 1994]. Both of
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these results are also indicative of the dehydroquinase portion of this bifunctional 
protein acting as a type I enzyme. This was confirmed by protein sequencing of the N- 
terminus and two internal peptides, all of which showed similarity to the type I 
dehydroquinase enzymes. It also placed the dehydroquinase domain in the N-terminal 
portion of the protein. The gene encoding the dehydroquinase activity has also been 
cloned by PCR, and encodes the amino acid sequence anticipated from protein 
sequencing. Sequencing also confirms that the two residues implicated in the active site 
of the protein, and conserved among all type I dehydroquinases (Lys-170 and His- 
143), are also present in this dehydroquinase domain.
Dehydroquinase has been purified to greater than 75% homogeneity from S.coelicolor, 
giving a single band with an estimated Mr of 16,000 on SDS-PAGE [White et al, 
1990]. The native Mr is approximately 209,000, so is presumably active as a 
dodecamer. It is stable at 70°C, has a Km of 650 (iM, and its activity is not inhibited 
by Cl- anions. The amino acid sequence of the N-terminus of the protein showed 
approximately 50% identity to the N-termini of the inducible catabolic dehydroquinases 
from N.crassa and A.nidulans. This was the first reported dehydroquinase from the 
shikimate pathway which resembles the eukaryotic catabolic enzymes, rather than the 
biosynthetic enzymes. The gene encoding it, aroQ, has subsequently been cloned and 
sequenced in this laboratory [P. White, unpublished results]. S.coelicolor was also 
tested for the presence of the quinate pathway, but is unable to grow on minimal 
medium with quinate as sole carbon source, and shows no detectable quinate 
dehydrogenase activity. It will grow on p-hydroxybenzoate, which is able to induce the 
quinate pathway in K.pneumoniae, but shows no quinate dehydrogenase activity or 
elevation of its dehydroquinase activity, suggesting that such growth is due to the 
presence in S.coelicolor of a functional 6-oxoadipate pathway, and not of a quinate 
pathway. These authors therefore suggested the classification of type I for the 
biosynthetic enzymes (which occur only in the shikimate pathway), and type II for the 
catabolic dehydroquinases (found in both the shikimate and quinate pathways).
Garbe et al. [1991] cloned the aroQ gene from Mycobacterium tuberculosis by 
complementation of an E.coli aroD mutation and, due to the similarity of its deduced 
amino acid sequence to those of the fungal quinate pathway dehydroquinases, classified 
it as encoding a type II enzyme. They also identified the DHQ synthase gene aroB 
which lies upstream of aroQ and overlaps it by 4 bp, suggesting that the two genes are 
translationally-coupled. Again, this sequence complements its respective E.coli 
mutation. Like S.coelicolor, M.tuberculosis is unable to grow on quinate as sole 
carbon source, so its type II dehydroquinase is likely to function only in the shikimate 
pathway. When placed under the control of the groE  promoter, it partially
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complements an A.nidulans aroD mutation (poor complementation possibly being due 
to the lack of a functional terminator in Aspergillus, or the mutant producing a non­
functional protein which could form an inactive heterodimer with the aroQ product) 
[Moore etal., 1992],
The shikimate pathway has also been studied in another actinomycete, Amycalotopsis 
methanolica, which is able to grow on quinate but not shikimate as sole carbon source, 
although it can metabolise shikimate when grown on either glucose or quinate. This 
suggests that A.methanolica has a functional shikimate pathway, but that it is not 
induced by shikimate [Euverink et al., 1992]. Apparently only a single dehydroquinase 
enzyme is present, which is heat-stable and therefore likely to be a type II enzyme, 
although its activity is not induced by quinate. The dehydroquinase appears to be 
associated with dehydroquinate synthase, as no single dehydroquinase mutants could 
be isolated. However, single DHQ synthase mutants do occur, and are able to grow on 
quinate in the absence of supplementary aromatic amino acids, suggesting that the 
dehydroquinase enzyme is effective in both biosynthesis of the aromatic amino acids 
and catabolism of quinate. The dehydroquinase was purified to a single band by SDS- 
PAGE, and has a subunit Mr of 12,000 and native Mr of 135,000, suggesting that it 
exists as a dodecamer in its active state. Its activity was not inhibited by NaBH* and it 
had a higher Km than is typical for type I dehydroquinases, supporting its identification 
as a type II enzyme. Its first 20 N-terminal amino acids have been sequenced and show 
45% similarity to the type II enzymes from N.crassa, A.nidulans and S.coelicolor, and 
75% to that of M. tuberculosis.
Another gene entitled aroQ, and encoding a type II dehydroquinase, has recently been 
identified in a Gram-negative bacterium, Actinobacillus pleuropneumoniae [Lalonde et 
al., 1994], due to its ability to complement an aroD mutation in E.coli. Its deduced 
amino acid sequence shows similarity to the type II enzymes of N.crassa, A.nidulans 
and M.tuberculosis (44-62%), and not to that of E.coli. A.pleuropneumoniae is able to 
grow in the absence of tryptophan, suggesting the presence of a pathway leading to the 
synthesis of chorismate, but is unable to grow on quinate, implying that this type II 
dehydroquinase also functions solely in the shikimate pathway.
The qutE gene of A.nidulans weakly complements an E.coli aroD mutation [Hawkins 
et al., 1985], but fully complements such E.coli mutations when placed under the 
control of the E.coli trc promoter, showing that a fungal catabolic dehydroquinase is 
capable of functioning as part of the shikimate pathway [Hawkins & Smith, 1991]. 
The N.crassa qa-2 gene, encoding its type II dehydroquinase, has been subcloned 
under the control of the Ptac promoter and expressed in E.coli’, it complements an aroD
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mutation, supporting the theory that type II dehydroquinases can function in the 
shikimate pathway [Hawkins et al., 1993c],
The predicted protein sequences of the type I dehydroquinases from E.coli and 
A.nidulans, and of the type II enzymes from A.nidulans and N.crassa, show conserved 
sequence motifs which may be involved in the active site or its stabilisation with the 
substrate/product [Hawkins, 1987],
Kleanthous et al. [1992] compared the type I (from E.coli) and type II (from 
A.nidulans) enzymes. The type I enzyme consists of -50% a-helix and 25% 6-sheet; 
type II is -75% a-helix. The type II enzyme shows four-fold greater resistance to 
denaturation by guanidine hydrochloride, and denatures at between 82°C and 95°C, 
whereas the type I enzyme denatures at 57°C. The type II enzyme has a lower activity 
at physiological conditions (relatively low flux rates) and has a Km an order of 
magnitude higher than that of the type I enzyme. The pH dependence of Vmax is 
consistent with the type I having a single ionising group, whereas the complex profile 
of the type II enzyme suggests that it has several ionising groups. Both enzymes are 
inactivated by DEPC (diethyl pyrocarbonate) which modifies histidine residues, and 
both are protected from it by incubation in a substrate/product mixture, implying that 
the DEPC modifies residues implicated in the active site. Unlike type I, type II is not 
inactivated by NaBH4 , and has no conserved lysine, implying that the type II 
dehydroquinases do not function via a Schiff s base intermediate. The type I enzymes 
produce the first double bond in the aromatic ring by syn elimination of water, whereas 
type II enzymes abstract water in trans [Harris et al., 1993].
Iodoacetate binds to dehydroquinase, inhibiting the enzyme activity. Radioactively- 
labelled iodoacetate labels two methionine residues in the E.coli dehydroquinase 
enzyme; one at the N-terminus, the other at the C-terminus [Kleanthous et al., 1990a]. 
The label is incorporated equally at both sites. The C-terminal methionine (Met-205) is 
conserved in the type I dehydroquinase enzymes of both S.cerevisiae and A.nidulans. 
The N-terminal methionine is not conserved, but residues surrounding it are conserved 
in both type I and type II dehydroquinases and DHQ synthase enzymes, suggesting that 
the N-terminal methionine residue (Met-23) is involved in the binding site for DHQ and 
not the catalytically-active site of the enzyme. The alkylation of the methionine residues 
by iodoacetate is reversed by incubation with mercaptoethanol, resulting in a 50% 
reduction in labelling and an increase in enzyme activity from 12% to 50% [Kleanthous 
et al., 1990b]. The label is only lost from the C-terminal methionine residue, the 
differential reversibility of alkylation being due presumably to the residues occurring in 
differing microenvironments.
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Incubation of type I dehydroquinase with diethyl pyrocarbonate (DEPC) causes 
carbethoxylation of six histidine residues, and therefore a loss of enzyme activity, 
although modification of a single histidine residue appears to be responsible for 
inactivation [Deka et al., 1992]. Preincubation of the enzyme with DHQ protects 
against inactivation, suggesting that DEPC affects the active site of the enzyme. 
Treatment of DEPC-inactivated dehydroquinase with hydroxylamine reverses the 
carbethoxylation. A modified seven-residue peptide of the E.coli dehydroquinase 
containing two histidines has been isolated, although only one of these residues (His- 
143) is conserved in type I dehydroquinases.
When a type I enzyme interacts with its substrate (3-DHQ), an imidazole side chain of a 
histidine residue facilitates abstraction of the pro-R proton (hydrogen) from C-2 of the 
aromatic ring. The essential histidine residue His-143 appears to be a good candidate 
for this step of the reaction mechanism [Deka et al., 1992]. The hydroxyl group at C-l 
is eliminated, producing a carbonium intermediate and allowing the N6-amino group of 
a conserved lysine side chain to form a Schiff s base (imine) intermediate with the keto 
group of dehydroquinate [Kleanthous et al., 1992].
NaBH4  reduces the active-site imine to a stable secondary amine, inactivating the 
enzyme by trapping dehydroquinate at the active site. This allows labelling of the active 
site with NaB3H4 , followed by CNBr cleavage and purification of the radioactively- 
labelled band. A lysine residue was found to be labelled in both the AROM polypeptide 
of N.crassa and the dehydroquinase of E.coli [Chaudhuri et al., 1991]. However, no 
lysine residue was identified in an appropriate position in the type II enzyme from 
S.coelicolor [P.White, unpublished results]. The imine intermediate has been shown to 
occur during this reaction using electrospray mass spectrometry [Shneier et al., 1991].
DHQ has been labelled with deuterium at both its C-2 pro-R and pro-S hydrogens 
(producing [2-2H]DHQ). Labelled product of the dehydroquinase reaction (DHS) was 
reduced in situ to the more stable intermediate shikimate, with its deuteration being 
measured by *H NMR spectroscopy. Type I dehydroquinase removes the pro-R  
hydrogen in a syn elimination as has been previously been suggested. However, the 
type II enzyme eliminates the pro-S hydrogen in trans [Shneier et al., 1993; Harris et 
al., 1993]. Thus, the two dehydroquinase isozymes proceed with opposite 
stereochemistries to achieve the same reaction, evidence of them being distinct proteins 
which have undergone convergent evolution to produce the same catalytic activity.
Aquaspirillum magnetotacticum, a Gram-negative freshwater bacterium, contains a 
gene which complements aroD mutations in both E.coli and S.typhimurium. However,
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this gene appears not to be homologous to the E.coli aroD gene or to the qa-2 gene 
which encodes the type II dehydroquinase in N.crassa [Berson et al., 1991]. It is 
therefore possible that this sequence encodes a novel type of dehydroquinase enzyme.
1.9.4 Shikimate dehydrogenase
Shikimate dehydrogenase [EC 1.1.1.25] (shikimate oxidoreductase) converts DHS to 
shikimate. The enzyme utilised in the shikimate pathway is an NADP+-dependent 
enzyme, so differs from the quinate/shikimate dehydrogenase enzyme involved in the 
quinate pathway, which is an NAD+- or PQQ-dependent enzyme.
In E.coli, this enzyme is encoded by the aroE gene, which has been subcloned from a 
lambda bacteriophage library [Anton & Coggins, 1984]. This gene has been 
sequenced, and placed under the control of the IPTG-inducible Ptac promoter [de Boer 
et al., 1983] for overexpression and purification in E.coli [Anton & Coggins, 1988]. It 
produces a single protein band whose 60 N-terminal amino acids have been sequenced 
and agree with the amino acid sequence deduced from the nucleotide sequence of the 
gene. The predicted protein sequence shows similarity to the shikimate dehydrogenase 
domains from the AROM polypeptides from A.nidulans and S.cerevisiae, and also to 
the quinate/shikimate dehydrogenase enzyme from the quinate pathway in N.crassa.
Like dehydroquinases, the activity of the shikimate dehydrogenase domain (the C- 
terminal domain of the dehydroquinase:shikimate dehydrogenase bifunctional protein) 
from Pisum sativum is inactivated by treatment with DEPC [Deka et al., 1994], 
implying that a histidine residue lies at, or near to, the active site.
1.9.5 Shikimate kinase
Shikimate kinase [EC 2.7.1.71] (ATP:shikimate 3-phosphotransferase) phosphorylates 
shikimate to produce shikimate 3-phosphate. E.coli contains two functional shikimate 
kinase enzymes, with shikimate kinase II having a Km two orders of magnitude lower 
than that of shikimate kinase I. Shikimate kinase II, which functions as a monomer and 
has an Mr of 17,500, is encoded by aroL, which lies upstream of and forms an operon 
with aroM, whose function is unknown [de Feyter et al., 1986]. aroL mutants are not 
auxotrophic, presumably due to the presence of the shikimate kinase I enzyme, but the 
presence of a functional shikimate kinase II enzyme does result in an increased growth 
rate in aroF/aroG mutants, which facilitated cloning of aroL by complementation of 
aroF/aroG/aroL triple mutations [de Feyter & Pittard, 1986].
26
Chapter 1
Like the aroF and aroG genes (which encode two of the DAHP synthase isozymes of 
E.coli), this operon appears to be regulated by the TyrR repressor, its promoter 
containing three operator sites [Heatwole & Somerville, 1992], Tryptophan and 
tyrosine inhibit the activity of shikimate kinase, but not in a TyrR' background, 
suggesting that the TyrR repressor must interact with either tyrosine or tryptophan to 
regulate the expression of shikimate kinase. The TyrR repressor has been shown to 
bind tyrosine in vivo.
TrpR, the repressor regulated by tryptophan, binds to a 24 bp palindromic sequence, 
interfering with the ability of RNA polymerase to mediate transcription from promoters 
which contain this palindrome. TrpR, which regulates transcription of aroH  (which 
encodes the third DAHP synthase isozyme), and whose binding sites have also been 
identified in the aroL promoter, has been shown to bind to P aroL in a tryptophan- 
dependent manner. However, the repression of aroL mediated by TrpR only occurs in 
the presence of TyrR. Repression due to TyrR is increased by the action of TrpR, 
indicating that the two repressors exhibit a form of synergism. It has been proposed 
that TrpR is able to bind to its "strong" box, but can only bind to its "weak" box when 
TyrR is already bound to the promoter. TrpR bound at the weak box is best positioned 
to inhibit binding of RNA polymerase to the promoter. It is also possible that, if P aroL 
is a strong promoter, repression by TyrR is required for any repression due to TrpR to 
be effective.
Shikimate kinase I is encoded by aroK, and lies upstream of aroB in an operon 
[L0bner-Olesen & Marinus, 1992]. Its predicted protein sequence shows similarity to a 
region of shikimate kinase II which includes the ATP-binding site. aroK was confirmed 
as encoding a shikimate kinase by its ability to complement an aroK/aroL mutant, 
producing growth in the presence of shikimate and the absence of the aromatic amino 
acids. Although the transcription of aroL is increased by a knock-out mutation in 
TyrR, such a mutation has only a minimal effect on transcription of aroK, confirming 
that it is not regulated by TyrR.
1.9.6 EPSP svnthase
5-enolpyruvylshikimate 3-phosphate synthase [EC 2.5.1.19] (3-phosphoshikimate 1- 
carboxyvinyltransferase or 5-0-{1-carboxyvinyl} transferase) catalyses the addition of 
the enolpyruvyl moiety of phosphoenolpyruvate (PEP) to shikimate 3-phosphate 
(S3P), producing EPSP. This is the final activity included in the pentafunctional 
AROM polypeptide.
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The broad-spectrum, post-emergence herbicide glyphosate (N-phosphonomethyl- 
glycine; its monoisopropylamine salt is sold commercially as "Roundup") is known to 
inhibit the shikimate pathway in plants and bacteria. Although it may inhibit certain 
DAHP synthase and DHQ synthase activities (for example in the yeast Candida albicans 
[Bode et al., 1984]), glyphosate mainly inhibits the activity of EPSP synthase, and also 
at much lower concentrations than required to inhibit DAHP synthase or DHQ 
synthase. Therefore, EPSP synthase has been suggested as the target for glyphosate.
Glyphosate causes accumulation of shikimate, and prevents the conversion of shikimate 
3-phosphate to anthranilate in Klebsiella pneumoniae [Steinrticken & Amrhein, 1980]. 
When K.pneumoniae was grown in a glyphosate-containing medium, tolerance to 
glyphosate was correlated with an increase in the specific activity of the EPSP synthase 
(up to ten-fold increase), although shikimate and S3P were still excreted, suggesting 
that resistance was achieved by overexpression of the enzyme [Amrhein et al., 1983]. 
Inhibition of EPSP synthase by glyphosate in K.pneumoniae was reversed by addition 
of the aromatic amino acids. Growth of cultured plant cells from Corydalis 
sempervirens in a glyphosate-containing medium produced a thirty-fold increase in 
EPSP synthase in glyphosate-tolerant cells which still showed a build-up of shikimate. 
It has been proposed that shikimate 3-phosphate, which is expected to build up in cells 
inhibited by glyphosate, is then dephosphorylated to shikimate, which does 
accumulate.
Glyphosate has been shown to be a competitive inhibitor for the PEP binding site of the 
EPSP synthase domain of the AROM polypeptide from N.crassa, and binds to an 
EPSP synthase:S3P complex [Boocock & Coggins, 1983]. Glyphosate is a non­
competitive inhibitor of EPSP synthase for S3P.
The E.coli enzyme has been purified to homogeneity [Lewendon & Coggins, 1983]. It 
has a subunit Mr of 49,000, and functions as a monomer. The gene encoding EPSP 
synthase, aroA, has been isolated by complementation of an E.coli aroA mutation 
[Duncan & Coggins, 1984]. The protein has been overexpressed and purified, with 
overexpressing cells found to exhibit resistance to glyphosate at up to seventeen times 
the level which kills non-overexpressing bacteria [Duncan et al., 1984a]. It appears 
that overexpression titrates out the glyphosate. The aroA gene has also been 
sequenced, and found to encode a protein with an estimated Mr of 46,112. The N- 
terminal sequence of the protein shows identity to the predicted protein sequence 
[Duncan et al., 1984b].
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gene, which encodes the enzyme 3-phosphoserine aminotransferase, part of the serine 
biosynthetic pathway [Duncan & Coggins, 1986]. Serine and chorismate are required 
in equimolar concentrations for the synthesis of enterochelin, an ionophore which is 
required for uptake of iron from the environment. Thus, it is possible that having a 
gene from the serine and chorismate biosynthetic pathways in the same operon allows 
coordinate expression of these two pathways, and regulation of enterochelin 
biosynthesis during iron starvation. This operon has also been shown to be under the 
positive control of cyclic AMP [Lim et al., 1994].
The same two-gene operon has been found in S. typhimurium [Hoiseth & Stocker, 
1985], Yersinia enterocolitica [O'Gaora et al., 1989], Salmonella gallinarum (cause of 
fowl typhoid) [Griffin & Griffin, 1991] and Klebsiella pneumoniae [Sost & Amrhein, 
1990] with serC lying upstream of aroA in each operon. The operons in S. gallinarum 
and E.coli both contain putative Rho-independent terminators in the intergenic region 
between serC and aroA, although their functions are unknown. The operon in 
Y. enterocolitica does not contain such an identifiable terminator sequence. Although 
this organisation of the operon has not been shown to exist in S.typhi, its aroA gene 
has been cloned and sequenced, and its predicted protein sequence shows 97-7% 
similarity to that of S. typhimurium [Chatfield et al., 1990].
The aroA gene of M.tuberculosis has been cloned by complementation of an E.coli 
aroA mutation, and encodes a 53 kDa protein as shown by Western blots [Garbe et al.,
1990]. The M.tuberculosis aroA also hybridises to aroA from B.pertussis, which has 
been cloned [Maskell et al., 1988], produces a protein of deduced Mr of 46,688, and 
shows good similarity to the deduced E.coli EPSP synthase sequence. The EPSP 
synthase domain of the gene encoding the AROM polypeptide from P.carinii has also 
been cloned [Banerji et al., 1993]. EPSP synthase has also been purified from 
seedlings of Pisum sativum (pea), has a Km comparable to that of the E.coli enzyme 
(50 kDa) [Mousdale & Coggins, 1984], and is also inhibited by glyphosate.
The aroA gene from Petunia hybrida has been cloned from a cDNA library and 
sequenced, and this clone has been used to isolate the aroA gene of Lycopersicon 
esculentum (tomato) from a cDNA library [Gasser et al., 1988]. The aroA cDNA of 
Lesculentum has been expressed in E.coli, and produces an active protein. Petunia and 
tomato are both members of the Solanaceae family and their EPSP synthases show 
93% identity at the amino acid level. Both species also have a second putative EPSP 
synthase-encoding sequence which hybridises weakly to their isolated cDNA. These 
sequences have been cloned but may be pseudogenes, or genes from the cytoplasmic 
shikimate pathway which have diverged from the chloroplast genes.
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Unusually, the EPSP synthases of certain bacteria from the genus Pseudomonas are not 
sensitive to inhibition by glyphosate, and such strains do not excrete either shikimate or 
shikimate-3-phosphate in the presence of glyphosate [Schulz et al., 1985]. EPSP 
synthase from the cyanobacterium Anabaena variabilis also shows reduced inhibition 
by glyphosate [Powell et al., 1992]. However, the purified enzyme has only a slightly 
elevated Km for PEP, unlike the mutant EPSP synthases which have greatly elevated 
Km's for PEP. Therefore, the A.variabilis enzyme is likely to be more useful than the 
mutant bacterial enzymes for the production of glyphosate-insensitive transgenic plants, 
particularly as cyanobacteria are believed to share a common ancestry with chloroplasts 
from higher plants.
A glycine to alanine substitution (G96A) appears to have no significant effect on the 
activity of EPSP synthase from a variety of species (Petunia, Soyabean, Maize, 
Arabidopsis, E.coli) but confers a five hundred-fold increase in the tolerance to 
glyphosate, suggesting that the mutation interferes with binding of glyphosate [Padgette 
et al., 1991]. This mutation also interferes with binding of PEP to the enzyme, but has 
no effect on the binding of S3P or EPSP. The naturally-occurring mutant aroA gene 
from K.pneumoniae also contains this substitution, and encodes a glyphosate-resistant 
EPSP synthase [Sost & Amrhein, 1990]. These authors suggest that a glycine at this 
position is likely to produce a 6-tum in the protein, but an alanine is likely to favour a 
continuation of the a-helix. Therefore, the substitution may alter the local protein 
configuration, and prevent glyphosate binding. The proline to serine substitution 
(P101S) also reduces binding of glyphosate in Petunia. Introducing the G96A 
mutation into a P101S mutant causes a further decrease in binding of PEP and 
glyphosate, and by an amount equivalent to that caused by the introduction of this 
mutation into a wild-type enzyme, suggesting that the two mutations affect different 
interactions between glyphosate/PEP and EPSP synthase.
A mutant aroA gene from S. typhimurium, encoding an EPSP synthase containing a 
proline to serine substitution (P101S), causes resistance to glyphosate, but has no 
effect on the enzyme kinetics [Stalker et al., 1985]. The mutation lies within a region 
which is highly conserved between the aroA genes of S.typhimurium and E.coli. The 
mutant protein is still able to complement an E.coli aroA mutation, and also confers 
resistance to glyphosate in E.coli [Stallings et al., 1991]. Expression of this gene from 
a Ti-based vector in Agrobacterium tumefaciens, and its subsequent infection in tobacco 
plants, confers considerable resistance to glyphosate in the plant, with levels of 
tolerance to glyphosate which correlate closely with expression levels [Comai et al., 
1985].
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Treatment of E.coli EPSP synthase with DEPC reduces enzyme activity to around 1%, 
although the enzyme may be protected by preincubation with S3P, PEP or EPSP, 
particularly when the two substrates (S3P and PEP) are added together [Huynh, 1987], 
Inactivation by DEPC is reversible by hydroxylamine, so inactivation must be due to 
modification of a histidine residue. Four of the eight His residues in EPSP synthase 
must be modified for complete inactivation, although only one is essential for activity. 
The modification does not affect binding of substrate or glyphosate. It has been 
proposed that the essential histidine is located very close to or within the active site and 
may be involved in catalysis.
l-ethyl-3-(3-dimethylamino-propyl)carbodiimine (EDC) amidates carboxyl groups and 
modifies four carboxyl groups in EPSP synthase of E.coli causing inactivation, 
although only one is essential for activity [Huynh, 1988]. Modification reduces 
binding of glyphosate, and may be prevented by preincubation of the enzyme with S3P 
and glyphosate. It has been shown that the modified residue is Glu-418, which is 
conserved amongst several EPSP synthases, and possibly lies in the glyphosate- 
binding site. The negatively-charged carboxyl group of Glu-418 has been proposed as 
interacting with the positively-charged imino group of glyphosate. This glutamate 
residue may be involved directly in catalysis or may interact with the essential His-385 
residue.
Pyridoxal 5'-phosphate (PALP) modifies lysine residues, and inactivates the EPSP 
synthase from E.coli, with the enzyme being protected from modification by 
preincubation with S3P, EPSP or S3P+glyphosate [Huynh et al., 1988a]. The 
modified residue is Lys-22, which may undergo conservative substitution by arginine 
(which has the same cationic group as lysine) to retain enzyme activity, but replacement 
with alanine or glycine inactivates the enzyme. The positively-charged amino group of 
Lys-22 is proposed to be critical in binding of the substrate. The cationic group of Lys- 
23 of EPSP synthase from Petunia hybrida (which is equivalent to Lys-22 from the 
E.coli enzyme) has been shown to be required for binding of the substrate [Huynh et 
al., 1988b]. These authors propose that this residue is involved in the binding of S3P.
EPSP synthase from P.hybrida is inactivated by phenylglyoxal (PGO) and p- 
hydroxy(PGO) which modify three arginine residues, including Arg-28 and Arg-131 
[Padgette et al., 1988b]. Incubation with S3P + glyphosate protects the enzyme against 
inactivation. In K.pneumoniae, glyphosate alone appears to protect against inactivation 
by PGO (although it is possible that either the glyphosate or enzyme used was 
contaminated with S3P) [Steinriicken & Amrhein, 1984].
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DTNB (5,5'-dithiobis-{2-nitrobenzoic acid}) modifies cysteine residues, but only 
reacts with two of the six cysteines in the EPSP synthase isolated from E.coli. In the 
presence of S3P and glyphosate, only one of these cysteines, Cys-408, is modified, 
suggesting that this residue lies in or near to the active site of the enzyme [Padgette et 
al., 1988a]. However, such modification does not inactivate the enzyme, implying that 
this cysteine is not required for substrate binding or catalysis, and presumably lies close 
to the ligand binding-site.
It has been shown that, initially, S3P binds to EPSP synthase, forming a complex to 
which PEP subsequently binds [Anderson et a l,  1988], confirming earlier results 
[Boocock & Coggins, 1983]. PEP does not bind to EPSP synthase in the absence of 
S3P. The negative charges of both the carboxylate and phosphate moieties of PEP are 
required for its binding to the enzyme, EPSP synthase showing a high degree of ionic 
and structural specificity for both PEP and glyphosate [Walker et al., 1991]. It has 
been proposed that the 5' hydroxyl group of S3P is responsible for a nucleophilic 
attack on the C-2 of PEP to form a tetrahedral intermediate. This addition-elimination 
reaction proceeds with the phosphate group of the tetrahedral intermediate becoming 
protonated, resulting in the production of inorganic phosphate and EPSP. The 
inorganic phosphate is released from the enzyme first, followed by EPSP.
Anderson et al. [1988] have proposed that the binding of glyphosate+S3P at the active 
site may mimic the binding of the tetrahedral intermediate to the enzyme. However, 
these authors could find no evidence to support the existence of an enolpyruvyl-EPSP 
synthase intermediate as proposed by Anton et al. [1983]. The existence of the 
tetrahedral intermediate has been proven by its isolation [Anderson & Sikorski, 1988]; 
it was shown to contain the shikimate ring from S3P and both the phosphate and 
enolpyruvyl groups donated by PEP.
An alternative hypothesis was proposed by Anton et al. [1983], who showed that 
purified EPSP synthase of K.pneumoniae is able to bind PEP in the absence of S3P, 
forming an enzyme-enolpyruvyl intermediate. These authors postulated that, in the 
presence of S3P, a proton is incorporated into the 8-carbon of PEP, allowing release 
from the enzyme-substrate intermediate of inorganic phosphate, with the protonation of 
PEP being inhibited by glyphosate. They also proposed that a negatively-charged 
group from the active site stabilises the carbonium anion of the protonated intermediate, 
which releases phosphate.
The EPSP synthase from E.coli has been crystallised at 3A resolution [Stallings et al.,
1991] and shown to consist of two globular, hemispherical domains with both termini
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occurring in the lower domain. Each domain has a three-fold axis of symmetry, 
producing three subdomains.
As the shikimate pathway is known not to occur in mammals, it has been suggested that 
the shikimate pathway enzymes may be targets for anti-infective agents. Attenuated 
mutants of such infectious organisms, caused by mutations in the shikimate pathway 
enzymes, could also be used as non-virulent live vaccines since, to grow, they would 
require external p-aminobenzoate and dihydroxybenzoate which are not readily 
available in vertebrate tissue [Griffin & Griffin, 1991]. The aroA gene of a virulent 
S.typhimurium strain has been disrupted by Tn 10 transposon mutagenesis, producing 
auxotrophy [Hoiseth & Stocker, 1981]. Non-revertible mutants, caused by deletion or 
deletion-inversion events in the transposon, have been isolated and injected into mice, 
and were found to be non-virulent. Such mice were also found to be resistant to 
subsequent infection by virulent S.typhimurium, suggesting that this aroA mutant does 
function as a live vaccine.
1.9.7 Chorismate synthase
Chorismate synthase (EPSP phosphorylase) [EC 4.6.1.4] is the final enzyme of the 
shikimate pathway, and does not occur as part of the AROM polypeptide. In E.coli, it 
is encoded by the gene aroC, which has been sequenced, overexpressed and purified 
[White et al., 1988]. It produces a protein of predicted subunit Mr of 40,000, although 
the native Mr is estimated at 144,000, suggesting that it functions as a tetramer. In 
N.crassa, the subunit Mr of chorismate synthase is predicted to be 50,000, with the 
native Mr approximately 198,000, so it is also likely to function as a tetramer. 
Sequences of peptides of the N.crassa chorismate synthase show similarity to the 
predicted amino acid sequence of the E.coli enzyme. Both enzymes also require a 
reduced flavin cofactor for enzyme activity, although the N.crassa enzyme needs only 
flavin, as it also carries a diaphorase activity which allows it to reduce flavin itself. The 
aroC gene of S.typhi has also been cloned, and complements an E.coli aroC mutation 
[Charles et al., 1990]. The predicted amino acid sequence shows approximately 95% 
similarity to that of E.coli.
The aroC gene has also been cloned from the cyanobacterium Synechocystis PCC 6803 
and its predicted amino acid sequence shows good similarity to the enzymes from 
E.coli, S.cerevisiae and the higher plant Corydalis sempervirens [Schmidt et al., 1993]. 
It has been expressed in E.coli, and produces a protein which, in Western blots, cross- 
reacts with antibodies raised against the chorismate synthase protein from 
C.sempervirens, but not with those raised against the enzyme from E.coli.
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1.10 The Ouinate Pathway
Quinate is present in decaying leaves, comprising approximately 10% by weight of 
decaying leaf litter, and so acts as a natural nutrient source of fungi and other lower 
eukaryotes. The quinate pathway catalyses the breakdown of quinate to 
protocatechuate, which may then enter the 6-ketoadipate pathway, leading to cleavage 
of the aromatic ring, and subsequently to the production of succinate and acetyl-CoA 
(Figure 1.4). Thus, the quinate pathway is a degradative pathway. Two of the 
intermediates of this pathway, dehydroquinate (DHQ) and dehydroshikimate (DHS), 
are also involved in the shikimate pathway, and both pathways have a dehydroquinase 
enzyme which catalyses the conversion of DHQ to DHS. Although the dehydroquinase 
enzyme involved in the shikimate pathway may be either a type I or type II enzyme, 
only the type II enzyme has been found in the quinate pathway.
In A.nidulans, which plays a role in the woodland decay cycle, the three structural 
enzymes in the quinate pathway, quinate dehydrogenase, dehydroquinase and DHS 
dehydratase, are induced by quinate, with similar induction kinetics [Hawkins et al., 
1982]. The dehydroquinase has been purified, its Km calculated at 500 pM, has a 
subunit Mr of 18-20,000, and is thermostable at 71°C, typical of a type II enzyme. It is 
immunoprecipitated by antibodies raised against the N.crassa type II dehydroquinase.
Using the N.crassa qa-2, qa-3 and qa-4 genes as probes, the three structural genes of 
the quinate pathway in A.nidulans (qutB, qutC, qutE) have been isolated [Hawkins et 
al., 1985]. The qutE gene, encoding the type II dehydroquinase, complements E.coli 
aroD mutations weakly. The N.crassa type II dehydroquinase-encoding gene, qa-2, 
also complements such E.coli mutations.
A clone has been isolated which was shown to contain the qutA, qutB, qutD, qutE and 
qutG genes [Hawkins et al., 1988]. The predicted amino acid sequence of the qutD 
gene, encoding a quinate-specific permease [Whittington et al., 1987], shows similarity 
to that of the Qa-Y protein from N.crassa, for which no function had previously been 
assigned. The QutB protein appears to be analogous to the shikimate dehydrogenase 
domain of the A.nidulans AROM polypeptide and the N.crassa Qa-3 protein, and the 
QutG protein appears to be analogous to the Qa-X protein of N.crassa.
When DNA from A.nidulans was probed with the qa-ls and qa-4 genes of N.crassa, 
each probe identified two hybridising sequences; a strongly hybridising band and a 
weakly hybridising one (possibly a pseudogene) [Lamb et al., 1990]. The strongly 
hybridising sequences complemented their respective N.crassa mutations (which the
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weakly hybridising sequences did not do), showing that these sequences contain the 
true functional genes. The predicted protein sequence of QutG shows similarity to 
myo-inositol monophosphatase from bovine brain, suggesting that QutG may 
dephosphorylate the activator, QutA, allowing induction of the quinate pathway. These 
authors produced a physical map for the quinate cluster which is in good agreement 
with the genetic evidence (Figure 1.5).
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Figure 1.4 The quinate pathway, taken from Geever et al.. 1989
N.B. QA denotes quinate DHQ denotes dehydroquinate
SA denotes shikimate DHS denotes dehydroshikimate
PCA denotes protocatechuate
The qutB gene has been overexpressed in E.coli and complements an aroE mutation 
[van den Hombergh et al., 1992], suggesting that the quinate/shikimate dehydrogenase 
enzyme of the quinate pathway can replace shikimate dehydrogenase from the shikimate 
pathway, although no quinate/shikimate dehydrogenase activity could be detected in 
E.coli.
The qutC gene has been sequenced and shown to be highly similar to the qa-4 gene of 
N.crassa, which encodes the DHS dehydratase [Lamb et al., 1992a]. Northern blotting 
has shown that the QutC protein is induced by quinate, and also identified a novel 
quinate-inducible gene, qutH , encoding a 1.45 kb mRNA transcript which is 
transcribed divergently from qutC and lies between the qutC and qutD genes.
A group of regulatory motifs has been found upstream of each of the structural genes 
and the permease gene in the quinate pathway, comprising a 2 2  nt—9 nt—16 nt pattern
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qutH qutB qutE qutR
qut C qutD qut G qut A
Figure 1.5 Organisation of the quinate pathway of A.nidulans
lying between each pair of divergently-transcribed genes, with the qutA gene containing 
a 16 nt variation of the 22 nt motif [Hawkins et al., 1988]. The 22 nt motif has been 
proposed as a possible target for the DNA-binding finger of the QutA activator protein, 
and the 16 nt motif is also implicated in the binding of QutA. The 9 nt motif is possibly 
involved in binding of RNA polymerase II.
qutH  lacks the 22 nt--9 nt--16 nt sequence motif organisation which occurs in the 
upstream sequences of the other qut gene pairs. The QutH protein is predicted to have 
features characteristic of the positively-acting DNA regulatory proteins in eukaryotes, 
including a "zinc-cluster" DNA binding motif [Vallee et al., 1991]. It shows some 
similarity to the DNA polymerase from the hepatitis B virus. QutH has been proposed 
to be a DNA-binding protein involved in controlling the transcription of genes which 
may be implicated in the metabolism of protocatechuate.
The quinate pathway of A.nidulans is regulated by two genes encoding a repressor and 
an activator, which were identified by mutations [Hawkins et al., 1984]. It has been 
proposed that the repressor, QutR, is expressed constitutively, and inhibits 
transcription of the activator-encoding gene, qutA, while quinate induces the pathway 
by inhibiting the activity of the repressor. qutA has been cloned and sequenced [Beri et 
a l, 1987] and shows predicted similarity to the Qa-IF regulatory protein of N.crassa, 
which contains a "zinc cluster" as its DNA binding domain [Vallee et al., 1991], and to 
other eukaryotic regulatory proteins at their putative DNA binding sites. The QutA 
protein contains a putative helix-tum-helix motif for binding of DNA.
Overexpression of the QutA, -E and -G proteins causes an elevation in the levels of the 
type II dehydroquinase, but not of any of the other structural proteins of the quinate 
pathway. The dehydroquinase appears to be regulated normally by the activator when 
induced by quinate [Beri et al., 1990]. Deleting the qutG gene from the overexpressed 
fragment has no effect on the levels of the structural enzymes, and overexpression of
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QutA alone has no effect on their levels, suggesting that the concentration of activator is 
not the sole limiting factor in expression of the qut cluster, possibly due to the cluster 
containing a limited number of QutA binding sites which may be totally occupied in the 
wild-type cell.
The current regulatory hypothesis states that the constitutively-expressed QutR 
repressor of A.nidulans phosphorylates the activator, QutA, inactivating it and therefore 
causing repression of the pathway. In the presence of quinate, DHS or DHQ, the 
repressor itself is inhibited, preventing its inactivation of QutA. The phosphorylated 
activator is dephosphorylated by the QutG protein, allowing induction of the quinate 
pathway. In the absence of any of the inducers of the pathway, the QutR protein has 
greater activity than the QutG protein, so that the QutA activator protein is 
phosphorylated, and so is unable to activate the quinate pathway.
The complete quinate (qa) cluster of N.crassa has been sequenced, and shows 
considerable similarity to the qut cluster of A.nidulans [Geever et al., 1989]. The qa 
cluster consists of divergently-transcribed pairs of genes, with the regulatory genes 
existing as a pair, although the gene order differs from that of the qut cluster. In the qa 
cluster, the unpaired qa-y gene lies between the regulatory pair of genes and the 
structural gene pairs. The qa cluster appears to contain only seven quinate-inducible 
genes, one less than the qut cluster, and contains no homologue for the qutH  gene, 
which is believed to be involved in the regulation of metabolism of protocatechuate.
1.11 Relationship between the shikimate and quinate pathways
The shikimate pathway and quinate pathway are both primary metabolic pathways, and 
share two intermediates (DHS and DHQ) and the enzyme which interconverts them (3- 
dehydroquinase). The AROM polypeptide in the shikimate pathway of N.crassa was 
initially proposed as having a channelling function [Hautala et al., 1975] which would 
prevent the intermediates from the shikimate pathway from being fluxed into the quinate 
pathway. This may be expected from the relative Km's of the dehydroquinases from 
the shikimate pathway and the quinate pathway (the type II dehydroquinases have a 
considerably higher Km than their type I homologues [White et al.x 1990]), and may 
provide a function for the fusing of the single enzymes (which occur in the bacteria, 
where there is no quinate pathway to compete for DHQ and DHS) to produce the 
pentafunctional AROM polypeptide.
It has, however, been shown that DHS and DHQ leak from the AROM polypeptide of
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A.nidulans at a rate comparable to the rate of flux catalysed by the AROM protein, 
suggesting that, if any channelling occurs, it will only be at a very low level and would 
be significant only under conditions of very poor availability of nutrients [Lamb et al., 
1991]. However, growth under these conditions is quite plausible in the natural 
environment. A.nidulans does not express the quinate pathway enzymes constitutively, 
indicating that the steady-state levels of DHS and DHQ which leak from the AROM 
polypeptide are not sufficient for the induction of the enzymes of the quinate pathway.
Supplementation of A.nidulans with the aromatic amino acids has no effect on the 
levels of the type I dehydroquinase or shikimate dehydrogenase activities (i.e. has no 
effect on the level of the AROM protein) [Lamb et al., 1992b]. Overexpression of 
QutC (the DHS dehydratase from the quinate pathway) causes an increase in flux 
through the quinate pathway, and so a drain on the levels of DHS and DHQ available 
for the shikimate pathway. This produces an increase in the level of shikimate 
dehydrogenase when grown on MM+glycerol with respect to its level on MM+glycerol 
supplemented with the aromatic amino acids. This increase is believed to be a response 
to the limitations imposed on the shikimate pathway. The level of overexpression of 
DHS dehydratase is correlated with an increase in shikimate dehydrogenase activity 
(and thus of the other activities performed by the AROM polypeptide). However, if the 
DHS dehydratase is overexpressed to too high a level, the drain on the resources 
available to the shikimate pathway is too great, and these cells show extremely poor 
growth in the absence of aromatic amino acid supplements.
aroB mutants of A.nidulans grown on MM+glycerol in the absence of the aromatic 
amino acids show a two-fold increase in AROM enzyme levels relative to their levels in 
the presence of these supplements, supporting the hypothesis that a decrease in 
aromatic amino acid concentrations leads to a starvation response and a subsequent 
increase in the level of the AROM protein. It is believed that the pentafunctional AROM 
protein allows only a low-level channelling function which has no effect under steady- 
state growth conditions, but is significant under physiological conditions of nutrient 
limitation, ensuring an essential minimal flux through the shikimate pathway.
The Qa-lS repressor from the quinate pathway of N.crassa shows similarity to the 
three C-terminal domains of the AROM polypeptide (dehydroquinase, shikimate 
dehydrogenase and shikimate kinase activities) and to these enzymes from E.coli 
[Anton et al., 1987], These authors proposed that the Qa-lS protein has evolved by 
gene duplication and adaptation from part of the AROM protein, and that the shikimate 
kinase domain may have evolved into a novel protein kinase domain in the Qa-lS 
repressor, which catalyses phosphorylation of the Qa-IF activator protein.
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A 20-amino acid region of the shikimate kinase enzymes shows approximately 50% 
similarity to the dehydroquinase and DHS synthase enzymes, and also shows 
significant similarity to the Qa-lS enzyme of N.crassa, with this similarity being 
conserved across several species [Bugg et al., 1991], This suggests that this region is 
involved in substrate binding, possibly binding of the C-4 hydroxyl group which is 
found in all of the metabolites utilised by these enzymes.
The qutR gene of A.nidulans has been sequenced, and its predicted protein sequence 
also shows significant similarity to the three C-terminal domains of the AROM 
polypeptide of A.nidulans (as expected, as it is analogous to the Qa-lS of N.crassa) 
[Hawkins et al., 1992]. The regions round the active sites of the type I dehydroquinase 
enzymes of E.coli, S.cerevisiae, A.nidulans and N.crassa show similarity to the 
repressor proteins, QutR and Qa-lS, of A.nidulans and N.crassa, although the 
repressor proteins lack the conserved lysines which, in the dehydroquinase enzymes, 
have been implicated in catalysis [Chaudhuri et al., 1991]. This suggests that the 
repressor proteins are able to bind the substrate of the dehydroquinase enzymes (DHQ) 
but are unable to undertake catalysis on it. The repressor proteins both have the 
consensus motif for purine nucleotide binding and have kinase activity, supplying 
further evidence for their ability to phosphorylate the activator proteins.
There is, however, an alternative hypothesis to phosphorylation for the method of 
action of the QutR repressor. The QutA and Qa-IF activators from A.nidulans and 
N.crassa show similarity throughout most of their length to the two N-terminal 
domains of the AROM polypeptides (DHQ synthase and the N-terminal 80% of EPSP 
synthase) [Hawkins et al., 1993b], although the activators contain a putative zinc- 
cluster DNA-binding domain [Vallee et al., 1991] which is absent from the AROM 
polypeptides. These two domains are able to fold and produce a stable protein, 
independently of the C-terminal domains of the AROM protein [Moore & Hawkins, 
1993]. The QutR and Qa-lS repressors are similar to the remainder of the AROM 
protein. It has been shown that the AROM protein functions as a dimer, with the 
monomers contacting each other between the N-terminal (DHQ synthase) and C- 
terminal (shikimate dehydrogenase) domains [Case & Giles, 1971]. Therefore, it has 
been proposed that the shikimate dehydrogenase-like domain of QutR lies in close 
proximity to the DHQ synthase-like domain of QutA. The dehydroquinase-like and/or 
shikimate kinase-like domain of QutR then occlude(s) residues of QutA which are 
required for activation, and thus the QutR protein is able to effect repression on the 
quinate pathway of A.nidulans by preventing binding of the activator to the qut cluster 
[Hawkins et al., 1993a].
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As has been reported, the activators of the quinate pathway (QutA and Qa-IF) are 
similar to the N-terminus of the AROM protein, and the repressors of the quinate 
pathway (QutR and Qa-lS) are similar to the C-terminal domains of the AROM 
proteins. The AROM proteins of A.nidulans, N .crassa  and S.cerevisiae  are 
homologous to each other, and are extremely likely to have evolved from a common 
ancestor. However, as S.cerevisiae does not possess a quinate pathway, it appears that 
the activators and repressors of the quinate pathway have evolved by splitting the arom 
locus into two portions, and fusion of the activator and repressor genes to produce the 
arom locus is extremely unlikely to have occurred [Hawkins et al., 1993b] (Figure 
1 .4 ).
1.12 Metabolic Control Analysis
Metabolic Control Analysis (MCA) is a method of studying the flux through intact 
metabolic systems or pathways, and the concentrations of metabolites within such 
systems [Kacser & Porteous, 1987]. It is usually performed on systems in a steady 
state, and can be approached using two methods: studying the individual enzyme 
reactions in isolation (as typified by enzymology), or studying the whole system in 
vivo.
MCA involves the measurement of three coefficients: the elasticity, concentration 
control and flux control coefficients.
1.12.1 The elasticity coefficient
This is a measure of the response of an enzyme rate to a change in concentration of a 
metabolite, and is calculated as the change in reaction velocity relative to the change in 
metabolite concentration. An enzyme has as many elasticity coefficients as metabolites 
(substrates, products and effectors) associated with it.
1.12.2 Concentration control coefficient
This is a measure of the response of the concentration of a metabolite to a small change 
in enzyme concentration. Each metabolite has a concentration control coefficient for 
each enzyme in the system. The sum of all concentration control coefficients for any 
metabolite is zero.
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1.12.3 Flux control coefficient
This is the response of flux through any one part of the system to a small change in any 
one enzyme concentration. It is a measure of the importance of an enzyme to the flux 
through a system; the higher the flux control coefficient, the more control an enzyme 
exerts on the flux. Branch points in a pathway introduce negative flux control 
coefficients into a system. The flux summation theorem states that sum of all of the 
flux control coefficients in a system is unity. The connectivity property states that the 
ratios of the flux control coefficients of adjacent steps is equal to the ratios of the two 
elasticity coefficients with respect to the shared substrate.
1.12.4 Application of MCA
Naturally, any external changes in effector or substrate concentrations will affect 
metabolite (and possibly enzyme) concentrations, and subsequently alter all of the 
elasticity coefficients to reflect the new steady state of the system, thus producing a new 
set of flux control and concentration control coefficients, and causing a redistribution of 
control throughout the system.
In theory, altering the rate of any one reaction in the system will affect the 
concentrations of metabolites of that particular reaction, the rate of flanking reactions, 
and ultimately the whole system. Therefore, the fluxes through the various steps are 
interdependent. However, in a particularly complex system, it is possible that no 
alteration at any single stage will have a significant effect on the flux through the 
system; modification of multiple stages, or even all of the stages, in a pathway may be 
required.
The tryptophan biosynthetic system of S.cerevisiae has been studied using MCA 
[Niederberger et al., 1992]. The five genes of the tryptophan biosynthetic pathway 
were down-modulated by reducing their copy number from four to zero; the activities 
of extracted enzymes were copy number-dependent as anticipated, but the effects on 
tryptophan flux and growth rate were very low. Up-modulation of these five genes by 
overexpression of any one (10- to 50-fold) also produced only very small (up to 30%) 
increases in total relative flux. However, overexpression of all five genes in tandem 
produced an almost nine-fold increase in flux. Addition of the increases produced by 
singly-overexpressing the enzymes would produce an expected two-fold increase.
Mutation of the gcd2 gene of S.cerevisiae causes constitutive derepression of the genes 
under general amino acid control, including the shikimate pathway. Mutation of trp4
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under general amino acid control, including the shikimate pathway. Mutation of trp4 
blocks the tryptophan pathway after anthranilate. Therefore, comparison of the levels 
of chorismate and anthranilate in gcd2 and gcd2/trp4 mutants allows analysis of the flux 
through the shikimate pathway. Up-modulation of the shikimate pathway caused by 
the gcd2 mutation produced a 1-7-fold increase in flux.
1.13 Other amino acid biosynthetic pathways in Streptomxces
The biosynthesis of a few other amino acids (arginine, histidine, proline and 
tryptophan) is also under investigation in Streptomyces coelicolor. There is some 
clustering of the genes involved in the biosynthesis of arginine, with the argC, argj and 
argB genes being clustered (although not necessarily coupled transcriptionally) and 
lying close to argH\ however, complete clustering does not appear to occur as the argG 
gene is apparently located elsewhere on the chromosome [Hindle et al., 1994]. Similar 
organisation appears to exist with the genes involved in proline biosynthesis, where the 
proA, proC  and proB  genes are clustered but not coupled transcriptionally; those 
involved in the biosynthesis of tryptophan, with the genes occurring in the “early” 
(putatively/rpD and trpF) and “late” (trpCBA) clusters [Hood et al., 1992]; and those 
implicated in the biosynthesis of histidine (hisD, hisC, hisBd, hisH  and hisA) being 
clustered [Limauro et al., 1990]. Therefore, it may be anticipated that there will be 
some clustering of the genes involved in the shikimate pathway in S.coelicolor. 
Sequencing around the aroQ gene is currently being performed to investigate this.
The putative promoter sequence identified immediately upstream of argC contains a 
region showing good similarity to the ArgR repressor binding site, as do sequences in 
both E.coli and B.subtilis [Hindle et al., 1994], implying that transcriptional regulation 
of argC (and possibly argj and argB) may involve feedback inhibition. Tryptophan 
biosynthesis is transcriptionally regulated according to growth rate and growth phase in 
S.coelicolor but shows no apparent feedback regulation, and the genes involved in 
proline biosynthesis are transcribed constitutively [Hood et al., 1992]. These results 
suggest that feedback regulation is unlikely to be a general method of control for the 
amino acid biosynthetic pathways in Streptomyces.
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1.14 Experimental aims
Many of the products and/or intermediates of the primary metabolic pathways of 
Streptomyces are used as precursors for the biosynthesis of secondary metabolites. 
Therefore, it is of interest to investigate whether an increase in production of these 
precursors, achieved via up-regulation of the relevant primary metabolic pathways, 
will lead to an increase in the synthesis of secondary metabolites.
The experiments reported in this thesis have been undertaken as part of an 
investigation into the effects of up-regulation of the shikimate pathway in 
Streptomyces coelicolor. In order to measure the flux control coefficients of the 
enzymes in the shikimate pathway, the pathway must be blocked to allow analysis of 
the build-up of pathway intermediates. Therefore, inactivation of the type II 
dehydroquinase enzyme (the third enzyme of this pathway, which is encoded by the 
aroQ gene) was attempted by gene disruption.
Gene disruption also allows functional replacement of an enzyme to be effected. 
Therefore, in anticipation of the successful disruption of aroQ , the aroD  gene 
encoding the type I dehydroquinase from E.coli was expressed in S.coelicolor. Even 
in non-disruptants, expression of an additional enzyme may improve the efficiency of 
this step of the pathway. Overexpression of the indigenous dehydroquinase enzyme 
was also attempted, by the introduction of this gene on a multicopy plasmid vector, in 
order to improve the efficiency of this step.
To allow analysis of the downstream enzymes of the pathway, it is desirable to 
disrupt the aroA gene, which encodes the sixth enzyme in the pathway, EPSP 
synthase. As the first stage of such a disruption, the cloning of the aroA gene was 
attempted using a variety of methodologies.
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2.1 Introduction
This chapter contains the general procedures used in the experiments which were the 
basis of this thesis. The chapter is divided into four main sections for convenience: 
bacterial strains, vectors and chemicals; microbiological techniques and standard media; 
general DNA methods; and general protein methods.
2.2 Bacterial strains, vectors and chemicals
2.2.1 Bacterial strains
The bacterial stains used are listed below:
STRAIN GENOTYPE REFERENCE/SOURCE
Escherichia coli strains
DS941
TG-1
S17-1
MB5386
CB51
AB2848
recF 143, proAl, str3\, thrl,
leu6, tsx33, rat/2, his4, argE3,
lacY+, lacZAMl5, lacIQ, galK2,
ara 14, supE44, xyl5.
supE, hsdA5, thi, A(lac-proAB),
F [traD36, proAB+, lacN ,
/acZAM15].
recA, pro, hsdR, hsdM+, 
with integrated RP4.
TnlO: :recA, Tn9v.dam, dcm
dam
aroD
D. J. Sherratt
Gibson (1984)
Mazodier et al. (1989)
MacNeil (1988)
C. Boyd 
J. R. Coggins
S trep tom yces lividans strains  
TK24 str6
TK64 pro2, str6
Hopwood et al. (1985) 
Hopwood et al. (1985)
Streptom yces coelicolor strains 
209 SCP1 NF, SCP2-
1147 SCP1+, SCP2+
G216 SCP1+, SCP2+
Table 2.1 Bacterial strains
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2.2.2 Plasmid and bacteriophage vectors
The plasmid pUC18 was obtained from Pharmacia Biotech Ltd. (St. Albans, UK). 
Plasmid pIBI24/25 was kindly donated by Dr. M. Anderson, Department of 
Biochemistry, University of Glasgow.
Plasmid pBluescript™II (KS+) was obtained from Stratagene (La Jolla, Ca., USA). 
Plasmid pMTL23 was kindly donated by Dr. M. Stark, Department of Genetics, 
University of Glasgow.
pT7Blue vector was obtained from AMS Biotechnology UK Ltd. (Oxford, UK). 
Plasmid pGEM7zf(+) was obtained from Promega Corporation (Madison, USA). 
M13mpl8 and M13mpl9 are bacteriophage cloning vectors from which single-stranded 
DNA may be isolated for DNA sequencing. They were obtained from Pharmacia 
Biotech Ltd.
The Streptomyces coelicolor genomic library [Taylor, 1992] was constructed using the 
AGEM-11 replacement vector supplied as "BamH I arms" by Promega Corporation. 
pKDlOl is a pGEM5zf(+)-based vector which has been altered to aid cloning of PCR 
products (Kovalic et al., 1991).
pIJ486/7 is a general streptomycete cloning vector (plJlOl-based) [Ward et al., 1986]. 
pUGTl is a pIJ486-based vector which contains the ermE resistance marker, and the 
tip A promoter [Ingham et al., 1995].
All E.coli plasmids described above contain a ColEl replicon.
2.2.3 Chemicals and biochemicals
Ampicillin and ethidium bromide were obtained from Sigma Chemical Co. (Poole, 
UK).
Bactotryptone, yeast extract and Bactotryptone (agar) were obtained from Difco 
(Detroit, USA).
ATP, DTT, TEMED (N,N,N',N'- tetramethylethylene diamine), and Tris buffer were 
obtained from Boehringer Mannheim (Lewes, UK).
DMSO, phenylalanine, polyethylene glycol 8000, and tryptophan were obtained from 
BDH Chemicals (Poole, UK).
Agarose, IPTG (isopropyl-p-thiogalactoside), phenol (ultrapure), and X-gal (5-bromo- 
4-chloro-3-indolyl-B-galactoside) were obtained from BRL (Gibco Ltd., Paisley, UK). 
Acrylamide, bisacrylamide and SDS were obtained from FSA Laboratory Supplies 
(Loughborough, UK).
Oligonucleotides were synthesised on an Applied Biosystems Model 280A DNA 
synthesiser at the Institute of Genetics, University of Glasgow, using reagents from 
Cruachem (Science Park, Glasgow).
4 5
Chapter 2
All other chemicals were of analytical reagent grade and were obtained from one of the 
following suppliers: BDH Ltd.; Formachem Ltd. (Strathaven, UK); FSA Laboratory 
Supplies; Koch-Light Ltd. (Haverhill, UK); Sigma Chemical Co.
2.2.4 Enzymes, proteins and kits
A kit for molecular weight determination of proteins was obtained from Sigma 
Chemical Co.
All restriction enzymes, T4 DNA ligase, and T4 Polynucleotide kinase were obtained 
from BRL and Promega Corporation.
Sequencing kit used was the Sequenase™ sequencing kit (USB Biochemicals, La 
Jolla, Ca., USA) supplemented with T7 DNA polymerase (Pharmacia Biotech Ltd.).
2.3 Standard media and microbiological techniques
2 .3 .1  Media used for growth of S.coelicolor
All growth media were sterilised by heating to 120°C for 15 mins in an autoclave. 
Supplements and buffer solutions were heated to 108°C and CaCl2 to 114°C for 10 
mins. Heat-labile solutions, such as antibiotics, were sterilised by filtration through 
Nalgene 0-22 pm pore membranes (Nalge Co., New York, USA).
2.3.1.1 Complex media
a) Soya Mannitol Agar (SM)
This was used as a general plating medium for Streptom yces , particularly for 
production of spores. It consists of 2% (w/v) mannitol, 2% (w/v) soya bean flour, and 
1 *6 % (w/v) agar, made up in tap water.
b) Yeast extract-Malt extract fYEME)
This was the only liquid medium used for growth of Streptomyces. It consists of 0-3% 
(w/v) Difco yeast extract, 0-5% (w/v) Difco bacto peptone, 0-3% (w/v) Oxoid malt 
extract, 1% (w/v) glucose, 34% (w/v) sucrose, made up in distilled water. To prevent 
pelleting, and produce a well-dispersed growth, MgCl2 was added to a final 
concentration of 5 mM, and glycine to a final concentration of 0-5% (w/v).
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2.3.1.2 Regeneration medium
The regeneration medium used for plating out of transformed protoplasts of 
S.coelicolor was R2 medium. This consists of R2 agar and R2 broth added in a 1:1 
ratio.
a) R2 agar
This consists of 0-05% (w/v) K2 S 0 4, 2-02% (w/v) MgCl2 .6H2 0 , 0-59% (w/v) 
CaCl2 .2H2 0 , 2% (w/v) glucose, 0-6% (w/v) proline, 0-02% (w/v) Casamino acids, 
0-4% (v/v) Trace Elements solution, 4-4% (w/v) agar, made up in distilled water.
bl R2 broth
It consists of 1-15% (w/v) MOPS buffer pH7-4, 1% (w/v) Yeast extract, 20-3% (w/v) 
sucrose, made up in distilled water.
cl Trace Elements solution
This was made up of 0-004% (w/v) ZnCl2, 0-02% (w/v) FeCl3 .6 H2 0 , 0-001% (w/v) 
CuC12 .2H2 0 , 0-001% (w/v) MnCl2 .4H2 0 , 0-001% (w/v) Na2B4 O7 .10H2 O, 0-001% 
(w/v) (NH4 )6Mo7 0 2 4 .4 H2 0  in distilled water.
These three solutions were autoclaved for 15 mins at 121°C. 100 ml R2 agar was 
melted in a steamer, and added to 100 ml pre-warmed R2 broth. 1 ml of 1% (w/v) 
KH2P 0 4  was added immediately before pouring the plates.
2.3.2 Media for propagation of E.coli
Chemicals of good quality were used in the preparation of the growth media and 
solutions (AnalaR grade when available). The sources of many of the chemicals varied 
during the course of this work. The most common suppliers were BDH Chemicals 
Ltd.; Difco Laboratories (Detroit, Michigan, USA) and Sigma Chemical Co. Ltd. 
al L-broth
1% (w/v) tryptone, 0-5% (w/v) yeast extract, 0-5% (w/v) NaCl, 0-1% (w/v) glucose,
0-002% (w/v) thymine, made up in distilled water and adjusted to pH 7-0 with NaOH. 
bl L-agar
As L-broth, but without glucose and with the addition of 1-5% (w/v) bacto-agar. 
cl 2xYT medium
1-6% (w/v) bacto-tryptone, 1% (w/v) bacto-yeast extract, 0-5% (w/v) NaCl, made up 
in distilled water and adjusted to pH 7-0 with NaOH.
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d) Top agar
As L-agar, but with only 1% (w/v) bactoagar. 
el Top agarose
As L-Agar, but with 0-65% agarose. 
f) Minimal agar
Agar was made to 1-75% with water. To 75 ml of this, 25 ml of D+M salts were added 
and glucose and thiamine were added to final concentrations of 2  mg/ml and 2 0  pg/ml, 
respectively. Other supplements were added if necessary. 
gl Davis and Mingoli fD+Ml Salts (x4)
2-8% (w/v) K2 H P 0 4, 0-8% (w/v) KH2 P 0 4, 0-4% (w/v) (NH4 )2 S 0 4, 0-1% (w/v) 
trisodium citrate, MgS04 .7H20 , made up in distilled water.
2.3.3 Growth of Streptomyces  mvcelia in liquid media
Cultures were typically grown in 500 ml conical flasks containing 100 ml of medium at 
30°C on an orbital shaker at 200 rpm.
Growth experiments employed YEME complex medium which produced reproducible 
and rapid growth. Spores from frozen suspensions or suspensions that were freshly- 
prepared from a frozen slope were used to inoculate the medium. Cells grown on 
YEME could be harvested after 48-72 hours and stored indefinitely as a cell pellet at 
-20°C.
2.3.4 Harvesting of mvcelia
After growth, mycelia were diluted in an equal volume of distilled dH2 0 , recovered 
from the media by centrifugation ( 1 0  mins, 1 0 0 0 0  g) and resuspended in dH^O.
2.3 .5  Growth of E.coli
Liquid cultures of E. coli strains from which plasmids were to be isolated were grown 
in L broth with the appropriate antibiotic selection (typically ampicillin at 100 fig/ml). 
The volume of broth inoculated depended on the quantity of plasmid required. 
Routinely, 1-5 ml and 100 ml cultures were used for small and large scale plasmid 
preparations, respectively (sections 2.4.2.3 and 2.4.2.2 respectively). For the 
preparation of competent cells, liquid cultures of E. coli DS941 were grown in L broth 
while E. coli TG-1 was grown in 2xYT (section 2.3.2). To maximise aeration of the 
culture, the volume of the Erlenmeyer flask used was at least five times that of the 
broth. All cultures were incubated at 37°C in an orbital shaker at ca. 250 rpm.
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2.3.6 Production of S.coelicolor  spores
2.3.6.1 Preparation and storage of suspensions
Concentrated spore suspensions were required for inoculating liquid cultures of S. 
coelicolor or S.lividans. The protocol described by Hopwood et al. (1985) was 
followed with minor modifications:
A boiling tube containing a slant of SM agar (produced by pouring ca. 20 ml of molten 
agar into the tube and allowing it to solidify with the tube held at +5° from the 
horizontal) was inoculated with 150 pi of a spore or mycelial fragment suspension and 
incubated at 30°C. After 5-10 days the surface of the culture was covered in a dark 
grey mass of spores.
The slant was then sealed using parafilm and frozen at -20°C. Spores could be 
harvested immediately or stored indefinitely at -20°C. The spores were harvested by 
adding 5 ml of dH2 0  to the frozen slant and rubbing the surface of the slant with a 10 
ml glass syringe. Contaminating agar or mycelial fragments were removed by a single 
passage through a cotton wool filter, as described in Hopwood et a l (1985). The 
filtered spore suspension was then either used fresh to inoculate YEME media or frozen 
at -20°C.
2.3.6.2 Spore counts
Colony forming units were determined by plating suitably diluted spore samples on 
Soya plates. Counts of the number of colonies were made after incubation at 30°C for 
5 days.
2.3.7 Preservation of E.coli strains
E.coli strains were stored in glycerol. An 800 pi aliquot of an overnight culture was 
mixed with an equal volume of 40% (v/v) glycerol, 2% peptone (w/v) and frozen at 
-70°C. The strains were revived by scraping the surface of the frozen suspension with 
a toothpick and either inoculating liquid broth or streaking onto agar to isolate a single 
colony.
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2.3.8 Introduction of plasmid DNA into E.coli
2.3.8.1 Preparation of competent cells
a) CaClo method
An overnight culture of the recipient strain was diluted 1 in 100 into 30 ml L-broth and 
incubated for 90-120 mins to a density of approximately 1 0 8/ml cells (OD60o 0-4- 
0-6). The cells were harvested using a centrifuge (12000 g, 4°C for 5 mins) and 
resuspended in 10 ml of ice-cold 50 mM CaC^. The cells were pelleted again, 
resuspended in 1 ml of ice-cold 50 mM CaCl2 and either kept on ice for at least 15 min 
before use, or stored in 1 0 0  pi aliquots following the addition of 2 0 0  pi 1 0 0 % glycerol.
bl Hanahan method
For cells with high transformation efficiencies, the following steps were carried out 
(Hanahan, 1983). Cells were prepared and harvested as above but were then 
resuspended in 2.5 ml of ice cold TFB (10 mM MES/KOH pH 6-3, 100 mM RbCl, 45 
mM MnCl2 , 10 mM C0 CI2 , 3 mM hexaminecobaltic chloride) and incubated on ice for 
15 mins. 100 pi of DMSO was then added and the cells incubated on ice for 5 minutes, 
followed by the addition of 100 pi of 2*25 M DTT, 40 mM potassium acetate (pH 6  0) 
and the cells incubated on ice for a further 10 minutes. Finally, 100 pi of DMSO was 
added, and the cells were stored on ice and used on the day of preparation.
2.3.8.2 Transformation procedure
Transformations were carried out in sterile 1-5 ml microfuge tubes. An aliquot 
(maximum 10 pi) of ligation mix or plasmid DNA was added to 100 pi aliquots of 
competent cells and the mixture was incubated on ice for at least 30 minutes. The 
DNA/cell mix was heat shocked at 42°C for 2 minutes before being placed back on ice. 
The cells were then plated onto L broth plates containing the appropriate 
antibiotic/chromogenic substances and incubated overnight at 37°C.
2.3.8.3 Transformation with bacteriophage M13
This procedure is as above, except that, after heat-shock, the transformed cells and 100 
pi exponentially-growing (plating) cells were added to 3 ml 0-6% soft agar containing 
10 pi IPTG (stock 24 mg/ml) and 50 pi X-gal (stock 20 mg/ml). The mixture was 
plated onto L-agar plates, which were incubated at 37°C overnight.
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2.3.8.4 Selection of pUC-derived recombinant clones
a) Ampicillin
Stock solutions (20 mg/ml made up in water) were added to molten agar (cooled to 
55°C) to a final concentration of 50 |ig/ml.
b) X-gal f5-bromo-4-chloro-3-indolvl-B-galactosidaseI
This was used in conjunction with IPTG to identify E. coli strains containing pUC- 
based or M13mpl8/19 vectors with inserts in their multiple cloning sites. 
Recombinants containing inserts are generally white while those lacking inserts are 
blue. X-gal was stored at a concentration of 20 mg/ml in dimethylformamide (DMF) at 
-20°C while IPTG was stored at a concentration of 24 mg/ml in df^O  at -20°C. X-gal 
and IPTG were added to L-agar plates to a final concentration of 20 pg/ml and 50 
|Lig/ml, respectively.
2.3.9 Introduction of plasmid DNA into Streptomyces
Plasmids were introduced into protoplasts of Streptomyces spp. by genetic 
transformation using the polyethylene-glycol-mediated protocol described by Hunter 
(1985).
Reagents
Medium P: 5-73 g N-tris[Hydroxymethyl]methyl-2-aminoethanesulfonic acid (TES), 
103 g sucrose, 2-93 g MgCl2 -7 H2 0 , 0-5 g K2 SO4 , 3-68 g CaCl2 .2 H2 0 , 2 ml trace 
element solution; adjusted to pH 7-4 with NaOH and made up to 1 litre in distilled 
water.
Lvsozvme solution: 10% (w/v) sucrose, 25 mM TES buffer (pH 7-2), 2-5 mM 
K2S 04, 2 ml trace elements (Hopwood et al., 1985), 2-5 mM MgCl2, 2*5 mM CaCl2. 
KH2PO4 (0-005% [w/v]) and lysozyme (0-3 mg/ml) were added immediately prior to 
use.
PEG solution: 1 g of polyethylene glycol 1540 (supplied by BDH) was melted in a 
microwave (600 W) for 10 secs on the reheat setting and then mixed with 3 ml of 
medium P.
2.3.9.1 Preparation of protoplasts
30 ml cultures were grown in the appropriate medium at 30°C. The optimal time to 
harvest the mycelium in order to recover the most competent protoplasts was species- 
dependent (i.e. S.lividans mycelia were harvested after 65 hrs and S.coelicolor after 48
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hrs, respectively). The mycelium was pelleted at 12000 g for 10 minutes and washed 
twice in 10-3% (w/v) sucrose. The pellet was then resuspended in 4 ml of lysozyme 
solution and incubated at 37°C for 15-30 min. The formation of protoplasts was 
monitored using a microscope, and the reaction terminated by adding 5 ml of P 
medium.
The protoplasts were then filtered through cotton wool (Hopwood et al., 1985), 
pelleted using a centrifuge (12000 g for 10 minutes) and washed twice in P medium. 
Finally, they were resuspended in 2 ml of medium P, dispensed into 100 pi aliquots 
and frozen at -70°C.
2.3.9.2 Transformation of protoplasts
The protoplasts were thawed on ice. DNA was added in a volume of less than 10 pi 
and the mixture incubated on ice for 30 secs. 400 pi PEG solution was added, the 
solution incubated on ice for a further 1 min and, finally, 800 pi medium P was added. 
Dilutions of the transformation mix were then made in medium P and plated onto 
regeneration medium.
2.3.9.3 Regeneration of transformed protoplasts
Selection of transformants, due to plasmid-borne resistance markers, was performed by 
overlaying the regeneration plates with 1 ml of a 10-3% (w/v) sucrose solution 
containing a suitable antibiotic after 16-20 hrs of non-selective growth at 30°C. 
Antibiotics used in this work for plasmid selection in Streptomyces were thiostrepton 
(obtained from E.R. Squibb, New Jersey, USA), gentamicin (Sigma), erythromycin 
(Sigma), lincomycin (Sigma) and viomycin sulphate (Pfizer). Thiostrepton was 
dissolved in DMSO to make a 1% (w/v) stock solution. Erythromycin was dissolved 
in absolute ethanol to produce a 1% (w/v) stock solution. Gentamicin sulphate was 
dissolved in dH2 0  to produce a 1% (w/v) stock solution. Lincomycin was dissolved in 
dH2 0  to produce a 4% (w/v) stock solution. Viomycin was dissolved in dH2 0  to 
produce a 5% (w/v) stock solution. All five of these antibiotic stock solutions were 
stored at 4°C.
Transformed protoplasts were selected by overlaying with 220 pg thiostrepton, 1-25 
mg gentamicin, 4 mg erythromycin, 2 mg lincomycin or 2-5 mg viomycin per plate.
S.lividans and S.coelicolor protoplasts were regenerated on R2 agar plates at 30°C.
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2.3.10 Conjugation between E.coli and Streptomyces
A plasmid capable of being maintained in E.coli and containing an oriT  was first 
transformed into E.coli S17-1 [Mazodier et al., 1989]. A transformant was obtained 
and a 5 ml culture grown in 2xYT.
A slope of Streptomyces spores was resuspended in 5 ml of dH2 0 . The spores were 
heat shocked at 50°C for 10 mins before being cooled under a cold tap, followed by the 
addition of 5 ml pre-germination medium containing 0-01 M CaCl2 (Mazodier et al., 
1989). This was then placed at 37°C with shaking for 2-3 hrs. The germinating spores 
were spun down at 1 2 0 0 0  g for 1 0  min and resuspended in 1 ml of dH2 0 .
1 ml of the overnight S I7-1 culture was spun down at 12000 g for 30 secs and 
resuspended in 1 ml of fresh 2xYT.
100 pi of germinating spores and 100 pi of S I7-1 were plated and spread onto an L- 
agar plate and left at 30°C for 12 hrs. The plates were washed with L-broth, scraped 
with a pasteur pipette, and excess liquid taken off with the pasteur pipette before the 
plates were left to dry. They were then overlaid with the selective drug and nalidixic 
acid (to kill the S17-1 cells). Transformants grew up in 3-4 days.
2.4 General DNA methods
2.4.1 Commonly used buffers
a) TE buffer (10x1
100 mM Tris-HCl pH 8-0, 10 mM EDTA. Sterilised using an autoclave and stored at 
room temperature. It was used as a lx solution for most applications.
b) Phage buffer (lxl
20 mM Tris-HCl pH7-4, 100 mM NaCl, 10 mM MgS04.
c) TAE Buffer (10x1
4-84% (w/v) Tris, 1-64% (w/v) Na acetate, 0-36% (w/v) Na2EDTA.2 H2 0 , made up in 
distilled water, pH adjusted to 8-2 with glacial acetic acid.
d) TBE buffer HOx') pH8-3
10-9% (w/v) Tris, 5-5% (w/v) boric acid, 0-93% (w/v) Na2EDTA.2H20  made up in 
distilled water.
e) Agarose gel loading buffer (TOx^ ) pH 7-4
0*5% (w/v) bromophenol blue, 0-05% (w/v) xylene cyanol, 50% (w/v) Ficoll, 1%
5 3
Chapter 2
(w/v) SDS, 100 mM EDTA. 
f) X/Hind III DNA markers
X cI857 SI  DNA was obtained from BRL. This DNA was cleaved with the restriction 
enzyme Hind III and resulting DNA fragments diluted to a final concentration of 27 
ng/pl in TE (final concentration lx) with loading buffer added to lx concentration. 
Typically, 10 j l l I  was used on agarose gels as markers for comparing the size and 
concentration of bands in samples.
Sizes of fragments produced: 23,130 bp; 9,416 bp; 6,557 bp; 4,361 bp; 2,322 bp; 
2,027 bp and 564 bp.
2.4.2 Preparation of plasmid DNA
2.4.2.1 Reagents for isolation of plasmid DNA
Protocols based on the alkaline lysis method (Bimboim and Doly, 1979) were used for 
the isolation of plasmid from small (5 ml) or large (50-200 ml) cultures of E. coli. This 
method, or an alternative alkaline lysis developed by Kieser, was used for isolation of 
plasmid DNA from Streptomyces.
a) Bimboim Dolv I IB DP
50 mM glucose, 25 mM Tris-HCl pH 8-0, 10 mM EDTA. If streptomycete plasmids 
were being isolated, lysozyme was added immediately before use to a final 
concentration of 5 mg/ml.
b) Bimboim Dolv II (BDID
0*2 M NaOH, 1% (w/v) SDS which was stored in a plastic container.
c) Bimboim Dolv III fBDIID
5 M KOAc pH 4-8; prepared by mixing equal volumes of 3 M CH3COOK and 2 M 
CH3COOH.
d) DNase-free RNase
Pancreatic RNase (RNase A) was dissolved at a concentration of 10 mg/ml in d ^ O , 
heated to 100°C for 15 mins and allowed to cool slowly to room temperature. The 
RNase was then aliquoted and stored at -20°C.
e) TES buffer
25 mM Tris-Cl pH 8-0, 25 mM EDTA, 10% sucrose.
f) Acid phenol/chloroform
50 g phenol was dissolved in 50 ml chloroform and 10 ml dH2 0 . Hydroxy quinoline
was added to colour the solution.
g! Alkaline SDS
0-3 M NaOH, 2% (w/v) SDS.
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2A.2.2 Large-scale plasmid preparation from E.coli
a) Caesium chloride gradient
100 ml cultures of stationary phase cells were harvested using a centrifuge (12000 g, 5 
min at 4°C). The pellet was resuspended in 8  ml of Birnboim-Doly I solution and 
incubated at room temperature for 5 mins. 16 ml of Birnboim-Doly II solution were 
added and the solution left on ice for 5-10 mins, before 12 ml of cold Birnboim-Doly 
III solution were added. The suspension was mixed gently and left on ice for 15-30 
mins. The cell debris and most of the chromosomal DNA were removed by 
centrifugation (32000 g, 5 mins at 4°C). The remaining nucleic acid was precipitated 
by the addition of 0 - 6  volumes of isopropanol and then harvested by centrifugation 
(39200 g, 15 mins).
The nucleic acid pellet was washed with 70% (v/v) ethanol. The plasmid DNA was 
further purified by equilibrium density centrifugation on a caesium chloride/ethidium 
bromide (CsCl/EtBr) gradient. The nucleic acid pellet was redissolved in 1 ml of dH20  
and 4-5 g of CsCl dissolved in 3-5 ml of dH2 0 . The DNA and CsCl solutions were 
combined with 250 pi of EtBr (10 mg/ml), creating a solution with a density of 1-58 
g/ml. The nucleic acid-CsCl solution was spun in a Beckman Ti70 angled rotor at 
289,000 g for 16 hours at 20°C. Two bands were visible in the gradients after 
centrifugation, a lower supercoiled plasmid band and an upper chromosomal and 
relaxed plasmid DNA band.
The lower band was removed using a 1 ml syringe and the EtBr removed by repeated 
extractions with water-saturated butanol. After dilution with 3 volumes of dH2 0 , 9 
volumes of absolute ethanol were added. The precipitate was pelleted by centrifugation 
(27000 g, 4°C for 30 mins). The resulting plasmid pellet was washed twice with 70% 
(v/v) ethanol and dried in vacuo before being redissolved in 1 ml dH2 0 . This 
procedure yielded very large amounts of pure plasmid DNA (up to 1 mg from E. coli 
cultures) suitable for all in vitro manipulations.
bl PEG precipitation
The protocol was the same as that for a), up to the resuspension of the DNA, in dH2 0  
and CsCl. Instead the DNA was resuspended in 3 ml of dH2 0 . 3 ml of ice-cold 5 M 
LiCl was added and mixed. The precipitated DNA was removed by centrifugation 
(12000 g, 4°C for 20 mins). The pellet was resuspended in 500 jil lx TE buffer 
(containing 10 mg RNase), and incubated at room temperature for 30 mins. 500 jil of
1-6 M NaCl containing 13% PEG-8000 was added, the solution mixed, and 
centrifuged (12000 g, 4°C for 5 mins). The pellet was washed with 70% EtOH, before
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being dried under vacuum and redissolved in dH2 0 .
2.4.2.3 Small-scale plasmid preparation from E.coli
Routinely, plasmids were isolated from 1*5 ml of E. coli cultures. The cells were 
pelleted by centrifugation in a 1-5 ml microfuge tube (12000 g for 30 secs) and 
resuspended in 100 pi of BDI, containing lysozyme at a concentration of 1 mg/ml, 
using a vortex mixer. This was followed by the addition of 200 pi of BDII and 
repeated inversion of the microfuge tube to thoroughly mix the suspension. 
Immediately afterwards, 150 pi of pre-chilled BDIH was added to the viscous bacterial 
lysate, mixed gently on the vortex mixer and placed on ice for 5-10 mins. The cell 
debris and most of the chromosomal material were harvested by centrifugation ( 1 2 0 0 0  
g, 4°C for 10 min) in a microfuge. The supernatant was transferred to a fresh tube and 
extracted with half volumes of phenol/chloroform and chloroform. The nucleic acid 
was then precipitated by the addition of 2  volumes of ethanol and allowed to stand at 
room temperature for 5 mins. The precipitate was harvested by centrifugation in a 
microfuge (12000 g, 4°C for at least 15 mins). The resulting pellet was rinsed twice 
with 70% (v/v) ethanol before it was allowed to dry by leaving the tube open on the 
bench. The nucleic acid was then resuspended in 50 pi d t^O  containing DNase-free 
RNase (20 pg/ml).
If further purification of the DNA was required (for example for double-stranded 
sequencing reactions), the pellet was resuspended in 16 pi of lx TE, to which 4 pi of 4 
M NaCl and 20 pi of 13% PEG were added, followed by incubation on ice for 20 
mins. Centrifugation for 15 mins at 4°C produced a pellet, which was washed in 70% 
ethanol, and resuspended in lx TE.
2.4.2.4 Large-scale plasmid preparation from Streptomyces
100 ml Streptomyces culture was diluted 1:1 with dH2 0  and pelleted by centrifugation 
(12000 g, 10 mins at room temperature). The pellet was resuspended in 4 ml BDI 
containing 25 mg/ml lysozyme, and incubated at 37°C for 30 mins. 8  ml BDII was 
added, followed by 15 mins incubation on ice, and 6  ml BDIII added, followed by 5 
mins incubation on ice. Cell debris and most chromosomal DNA was isolated by 
centrifugation (20000 g, 4°C for 30 mins).
The plasmid DNA contained in the supernatant was precipitated with 0.6 volumes of 
isopropanol and 15 mins incubation at room temperature. The DNA was pelleted by 
centrifugation (20000 g for 10 min at room temperature), washed with 70% ethanol,
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centrifugation (20000 g for 10 min at room temperature), washed with 70% ethanol, 
and resuspended in lx TE buffer.
2.4.2.5 Preparation of plasmid DNA by the "Kieser" method (Hopwood 
etal., 1985)
Upto 1 ml of Streptomyces culture was diluted 1:1 with dH2 0  and pelleted by 
centrifugation. The pellet was washed in TES buffer, resuspended in 500 |il TES 
buffer (containing 2 mg/ml lysozyme), and incubated at 37°C for up to 30 mins. 250 
Jill of alkaline SDS was added, the solution homogenised immediately, and incubated at 
70°C for 15 mins. After cooling to room temperature, the solution was mixed with 80 
pi of acid phenol/chloroform, centrifuged, and the supernatant isolated. This step was 
repeated using 80 pi of chloroform, and the supernatant added to 60 pi 3 M sodium 
acetate and 600 pi isopropanol. The solution was mixed and left at room temperature 
for 10 mins, followed by centrifugation. The pellet was washed in 70% ethanol, and 
resuspended in lx TE.
2.4.3 Preparation of "total" DNA from S.coelicolor
20 ml Streptomyces culture was diluted 1:1 with dH2 0  and pelleted by centrifugation 
(12000g, 4°C for 10 mins), resuspended in 5 ml lysozyme solution [Hopwood et al., 
1985] (containing 4 mg/ml lysozyme) and incubated at 37°C for 30 mins, followed by 
the addition of 2-5 ml 2% SDS and mixing by vortex. Cell debris was removed by 
extraction with phenol/chloroform and centrifugation (12000g, 4°C for 15 mins). Such 
extraction was repeated until no interface remained (a minimum of three extractions). 
DNA was then precipitated by the addition of 0-1 vol. of 3 M Na acetate and 1 vol. 
isopropanol, with 5 mins incubation at room temperature followed by centrifugation 
(12000 g, 4°C for 10 mins). The DNA was resuspended in lx TE buffer (often 
requiring incubation at 50°C to resuspend the DNA).
2.4.4 Organic solvent extraction
Protein was removed from DNA solutions by phenol/chloroform extraction. An equal 
volume of TE-saturated phenol was added to samples which were then mixed by 
vortexing and centrifuged in a microfuge for 1-5 mins. The upper aqueous phase was 
removed to a fresh microfuge tube and the process repeated this time using 
phenol/chloroform (1:1 v/v). Finally, traces of phenol were removed by extraction 
with an equal volume of chloroform in an identical manner. Precipitation with ethanol 
or isopropanol removed any remaining solvent.
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2.4.5 Precipitation of DNA using ethanol or isopropanol
DNA solutions were precipitated by the addition of 1/10 volume of 5 M NaCl and 2 
volumes of cold ethanol or an equal volume of isopropanol. After mixing, the DNA 
was pelleted by centrifugation (27000 g, 4°C, 30 mins for volumes of 7-5-20 ml, or 
12000 g, 4°C, 15 mins for small volumes in microfuge tubes). The pellet was washed 
in 70% (v/v) ethanol and dried briefly in a vacuum desiccator, or in an open tube on the 
bench.
2.4.6 Spectrophotometric measurement of nucleic acid
Nucleic acid concentrations were determined spectrophotometrically at 260 nm. In a 1 
cm path length an absorbency value of 1-0 corresponds to 50 pg/ml for double­
stranded DNA , 33 pg/ml for single-stranded DNA and 20 pg/ml for oligonucleotides.
2.4.7 Digestion of DNA with restriction enzvmes
Restriction digests were carried out using the BRL restriction enzymes and REact 
buffers which were provided with each batch of enzyme. There are ten different REact 
buffers with a range of salt concentrations, each one suitable for a range of enzymes. 
Alternatively, digests were performed using Promega restriction enzymes and the 
accompanying restriction buffers. Analytical digests were carried out in a volume of 20 
pi at 37°C. Preparative digests were carried out in larger volumes. When DNA was 
digested with two restriction enzymes, the endonuclease requiring the lower salt buffer 
was used first. After the recommended duration of digestion, the salt concentration 
was adjusted and the second enzyme added.
2.4.8 Ligation of DNA fragments
The ligation of DNA fragments was carried out usually at a DNA concentration of 6  
mg/ml. The molar ratio of insert fragment to vector was 3:1, when the vector could 
not ligate to itself (for example when using a vector that has been dephosphorylated or 
has been cut with two non-complementary enzymes). A molar ratio of 10:1 was used 
when the ends of the vector could ligate to each other. Ligations were performed 
usually in 10 pi of lx ligation buffer provided by BRL, containing 1 U of T4 ligase per 
pg of DNA. The reactions were incubated for 4 hours at room temperature or 
overnight at 16°C.
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2.4.9 T-tailing of linearised, blunt-ended vectors
After the linearised, blunt-ended vector DNA had been purified from an agarose gel, it 
was denatured by heating to 90°C for 5 mins, followed by three-fold dilution of the 
solution in lx Taq-buffer. dTTP was added to 2 mM, followed by the addition of 2U 
of Taq polymerase and 2 hours incubation at 70°C. The T-tailed vector was again run 
on an agarose gel and purified, to remove the enzyme and any unincorporated dTTP.
2.4.10 Removal of the 5' phosphate from linearised DNA
lOx CIP Buffer: 200 mM Tris-HCl pH 8  0, 10 mM MgCl2 , 10 mM ZnCl2  and 0-5 
mg/ml Bovine Serum Albumin.
Procedure: Calf Intestinal Alkaline phosphatase (CIP) was used to remove the 5' 
phosphate from DNA. Around 5 pmoles of 5'-terminal phosphorylated DNA with 5' 
protruding ends (approximately 7 pg of a 5 kb molecule) were incubated in lx CIP 
buffer, containing 01 U of CIP at 37°C for 30 mins. The reaction was terminated by 
heating to 65°C in lx  gel loading buffer for 10 mins. The 5'-terminal 
dephosphorylated DNA was recovered from an agarose gel after electrophoresis.
2.4.11 Agarose gel electrophoresis
DNA was visualised on horizontal neutral agarose gels. Although 0-8% (w/v) gels 
were most commonly used, 1-2 % (w/v) gels were occasionally used to separate 
fragments of <1-5 kb. Gels were routinely prepared and run in TBE buffer. However, 
TAE buffer was used when DNA fragments were to be isolated from the gels (see 
section 2.4.13), ^-Hind III markers were used on all gels as size markers and for 
quantification of the amount of DNA by comparing the intensity of bands to those of 
the samples (2.4.If).
a) Mini gels
BRL model H6  gel kits were used for the rapid analysis of DNA after digestion with 
restriction enzymes or precipitation steps. 016  g agarose was added to 2 0  ml of lx 
TBE (or TAE), boiled, and then cooled to 60°C. EtBr was added to 200 ng/ml and the 
molten agarose poured into a 7*6 cm x 51 cm gel caster with an 8  well slot former (4-1 
x 0-8 mm wells). After the gel had set, the slot former was removed and the gel placed 
in the tank with 500 ml of lx TBE (or TAE).
5 9
Chapter 2
separated by electrophoresis for 30-60 mins with an applied voltage of 2-10 V/cm. 
1/10 volume loading buffer (2.4.1e) was added to the DNA samples before they were 
loaded onto the gel. The separated DNA molecules were visualised on a 302 nm UV 
transilluminator.
b) Large gels
200 ml gels were also used to ensure good separation of DNA fragments for accurate 
sizing and/or Southern analysis. They were made by pouring 200 ml of molten agar, 
containing 200 pg EtBr, into a 16*5 x 23 cm gel former with a 14 space slot former. 
The gels were run overnight at 20 V in lx TAE or TBE buffer. DNA samples were 
mixed with 1/10 volume of lOx loading buffer (2.4.le) before loading onto the gel.
2.4.12 Photography of agarose gels
Gels stained with ethidium bromide were viewed on a 302 nm UV transilluminator and 
photographed using Polaroid type 67 land film or using a Pentax 35 mm SLR loaded 
with Ilford HP5 film. Both cameras were fitted with Kodak Wratten filters (No. 23A). 
Alternatively, pictures were obtained using a Mitsubishi video copy processor attached 
to a UVP video camera.
2.4.13 Recovery of DNA from agarose
al using SPIN-X tubes
SPIN-X tubes were obtained from Costar UK Ltd. These tubes contain a cellulose 
acetate membrane, which allows the passage of buffer and DNA, but stops agarose 
from passing through.
The DNA band was excised from the gel and placed in the upper chamber of the SPIN- 
X tube. This was then placed at -70°C for 5 minutes, thawed by placing at 37°C for 5 
minutes, and spun in a centrifuge at 12000 rpm for 5 mins. The filtrate contained the 
DNA in a state which could be used immediately.
b) using Oiaex-suspension
A Qiaex gel extraction kit was obtained from Qiagen, Germany. The gel slice 
containing the excised DNA fragment was mixed with 3 vols. QX1 solubilisation 
buffer and Qiaex-suspension (10 pi per 5 jig DNA). The gel slice was incubated at 
50°C for 10 mins with frequent mixing to solubilise the gel and allow the DNA to 
absorb to the Qiaex-suspension. The suspension was pelleted, washed twice with 500 
pi QX2 wash buffer, and twice with 500 pi QX3 wash buffer. The suspension was
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pelleted and air-dried for 10-15 mins, followed by resuspension in lx TE buffer, 5 
mins incubation at room temperature and pelleted again. The DNA was contained in the 
supernatant, in a condition ready for any subsequent manipulations.
2.4.14 Techniques with E.coli bacteriophage X
2.4.14.1 Preparation of plating bacteria for infection with 
bacteriophage X
50 ml of L-broth supplemented with 0-2% (w/v) maltose, 20 mM-MgS0 4  was 
inoculated with a single colony of the appropriate E.coli strain (e.g. NM621), and 
grown overnight at 37°C on an orbital shaker. The cells were pelleted by centrifugation 
(12000 g, 4°C, 5 mins) and resuspended in 0-5 volumes of sterile, ice cold 10 mM 
MgSC>4 . The cell suspension was diluted if the OD^oo was greater than 2 (1*6 x 109 
cells/ml). The cells were stored at 4°C and remained viable for at least 3 weeks.
2.4.14.2 Infection of bacteriophage X, plating and titre
Serial 10-fold dilutions of X phage stock (or packaged X DNA) were prepared in phage 
buffer (2.4.1b). Bacteriophage X infection was achieved by adding 100 pi aliquots of 
each dilution to 100 pi (1.5 x 108 cells) of a suspension of plating bacteria. The samples 
were incubated at 37°C for 20 minutes. 3 ml of top agarose at a temperature of 45°C 
was added and the mixture was poured onto plates containing bottom agar. The plates 
were left to stand for 5 minutes at room temperature to allow the top agarose to harden 
and then incubated at 37°C overnight. The plaques were counted and the titre 
determined for each dilution assayed.
2.4.14.3 Isolation of bacteriophage particles from a plaque
The plaque of interest was stabbed out of the plate using the narrow end of a sterile 
glass Pasteur pipette to form a plug of agar. The plug was left in 1 ml of phage buffer 
containing 70 pi of DMSO (to kill any cells) for two hours at room temperature (or 
overnight at 4°C) to allow bacteriophage particles to diffuse out of the agar. An average 
plaque yielded 1 0 6 - 1 0 7 infectious bacteriophage particles, which could be stored 
indefinitely at -70°C in phage buffer/DMSO without loss of viability.
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2.4.15 Techniques for handling E.coli bacteriophage M13
2.4.15.1 Transfection and plating of M13
Cloning in M13 vectors is essentially the same as cloning in plasmids. M13 produces a 
double stranded, replicative form (RF) which is isolated and treated just like an 
ordinary plasmid such as pUC18/19. After introduction of foreign DNA into such 
vectors by ligation, they can be introduced into a suitable E.coli host which produces 
pili, such as TG-1.
E.coli TG-1 was made competent by one of the methods above (2.3.8.1) and the 
transformation protocol followed up to and including the heat-shock stage. After this 
step, 200 pi of a fresh exponential TG-1 culture were added to the transfected cells, 
followed by 10 pi of IPTG (24 mg/ml) and 50 pi of X-gal (20 mg/ml). The cells were 
then mixed and added to 2-5 ml of molten water-agar (0-6% w/v, pre-cooled to 45°C), 
which were poured onto dried L-agar plates. Plaques containing recombinant phage 
appeared white on the agar, whereas non-recombinant phage appeared blue.
2.4.15.2 Preparation of single-stranded DNA from M13
The single-stranded M l3 templates were prepared as described in the "M l3 
Cloning/Dideoxy sequencing Instruction Manual" published by Bethesda Research 
Laboratories.
a) Minipreparations
A single M13 plaque was used to infect 1*5 ml of 2xYT broth containing 15 pi of an 
overnight culture of E.coli TG-1. This culture was grown at 37°C for 5-6 hrs with 
vigorous shaking, then transferred to a microfuge tube and harvested by centrifugation 
at room temperature for 5 mins. The supernatant, containing the phage particles, was 
recovered and respun. The remaining supernatant was mixed with 200 pi of a solution 
of 20% (w/v) PEG (8000), 2-5 M NaCl and left to stand at room temperature for 15 
mins to precipitate the phage particles. These were recovered by centrifugation at room 
temperature in a microfuge for 15 mins.
The supernatant was discarded, the pellet respun and all traces of supernatant removed. 
The pellet was then resuspended in 100 pi d t^ O  and extracted twice with 
phenol/chloroform and twice with chloroform. The DNA was then precipitated from 
the aqueous phase with sodium acetate and ethanol, and recovered by centrifugation in 
a microfuge. The ssDNA was then washed with 70% (v/v) ethanol, dried in vacuo
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b) Maxipreparations
The same overall procedure was followed as for the "minipreparations", except that all 
the volumes were scaled up 20-fold. The cells from a 30 ml culture were spun out 
(14000 g for 2 mins), the supernatant recovered and respun as before. The 
supernatant (20 ml) that remained was then precipitated with 5 ml of 20% (w/v) PEG, 
2-5 M NaCl for 10 mins at room temperature and the phage harvested by centrifugation 
(14000 g at 20°C for 15 mins). The phage pellet was resuspended in 1 ml of dH20 , 
then reprecipitated and processed as for the minipreparations with the volumes scaled 
up accordingly.
2.4.16 Labelling of DNA with y-32P or Digoxvgenin
2.4.16.1 Labelling of the 5' termini of oligonucleotides with y-32P 
using bacteriophage T4 polynucleotide kinase
Bacteriophage T4 polynucleotide kinase catalyses the transfer of the y-phosphate group 
from ATP to a free hydroxyl group on the 5' terminus of DNA. In a total reaction 
volume of 1 0  j l l I  the mixture contained:
8  pmoles of purified oligonucleotide, kinase buffer (50 mM Tris-HCl pH 8  0, 10 mM 
MgCl2, 5 mM DTT, 1 mM spermidine), 8  pmoles (y-3 2 P) ATP and 10 units of T4 
polynucleotide kinase. The reaction was carried out at 37°C for 30 minutes by which 
time it had gone to completion. Unincorporated label was removed by gel filtration (see 
below) .
2.4.16.2 Removal of unincorporated radionucleotide
Unincorporated label from end-labelling reactions was removed by gel filtration 
chromatography on a 20x1 cm Sephadex G-50 column. Sephadex G-50 was hydrated 
in lx TE and poured columns equilibrated in lx TE. The reaction mixture was mixed 
with an equal volume of Blue Dextran dye in lx TE and loaded directly on top of the 
column. The radioactivity was monitored as it passed down the column and as it 
approached the bottom, fractions were collected manually. Labelled oligonucleotide 
was co-eluted first with the Blue Dextran dye, followed by a trough of radioactivity, 
and then a second peak corresponding to the unincorporated label. The fractions 
containing the largest number of incorporated counts were pooled.
2.4.16.3 Labelling of DNA using the "random priming" technique
The method of "random primed" DNA labelling is based on the hybridisation of a
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mixture of all possible hexanucleotides to the DNA to be labelled. The complementary 
strand is synthesised from the 3'-hydroxyl termini of the random hexanucleotide 
primer, with Klenow enzyme (DNA polymerase I). A random priming kit from 
Boehringer Mannheim, UK. was used for this purpose. Protocols were followed as 
per the manufacturer's instructions.
2.4.16.4 Labelling of DNA with digoxygenin-dUTP (DIG-dUTP) 
using the "random priming" technique
The method of "random primed" DIG DNA is essentially the same as for labelling with 
32P (2.4.16.3), except that the labelling reaction was carried out overnight. A 
random priming kit from Boehringer Mannheim, UK., was used for this purpose. 
Protocols were followed as per the manufacturer's instructions.
2.4.17 Southern blotting
After electrophoresis and photography, the resolved DNA fragments were transferred 
under alkali conditions to nylon membrane (adapted from Southern, 1975), as 
described in "Blotting and hybridisation protocols for Hybond-N™ membranes" 
(published by Amersham International pic), or by a modification of this protocol, "dry 
blotting".
2.4.17.1 Reagents
a) Denaturing solution 
1-5 M NaCl, 0-5 M NaOH. 
bl Alkali transfer buffer
1-5 M NaCl, 0-25 M NaOH.
c) 20x SSC
3 M NaCl, 0*3 M tri-sodium citrate, pH 7-0.
2.4.17.2 Procedure
The gel was rinsed in distilled water, placed in enough denaturing solution to immerse 
it completely and left for 30 mins to chemically denature the DNA contained within the 
agarose. The gel was then equilibrated for 10-15 mins in alkaline transfer buffer. The 
DNA was transferred to the nylon membrane in transfer buffer, by capillary action 
(disposable nappies proved a particularly useful absorbent material for driving the 
transfer process).
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After blotting for a least 4 hours (but usually overnight), the membrane was washed 
briefly in 2x SSC to remove any adhering agarose. The DNA was fixed to the 
membrane either by UV crosslinking using a Statagene "Stratalinker", or by baking at 
80°C for 2  hours.
2.4.17.3 Dry blotting
The procedure was similar to that above, except that the gel was first washed twice in
0-25 M HC1 for 15 mins to depurinate the DNA, and was washed briefly in dH^O 
before denaturation as above. No equilibration in alkali transfer buffer was performed, 
although the 3MM Whatman paper placed on top of the membrane was soaked in 
transfer buffer. Transfer took only 1-2 hrs, followed by fixing as above.
2.4.18 Hybridisation of oligonucleotides to filter-bound nucleic acid
2.4.18.1 Prehybridisation
Nylon filters were not pre-wetted, but were placed directly into a hybridisation tube 
containing prehybridisation solution (6 x SSC, 0 05% (w/v) sodium pyrophosphate, 
200 pg/ml heparin, 0*05% (w/v) SDS); 200 pis of the prehybridisation solution was 
used per cm2 of filter surface area. The tube was placed in a hybridisation oven and the 
filter prehybridised for at least 4 hours at 50-68°C, depending on individual 
prehybridisations.
Alternatively, filters were prehybridised in QuickHyb solution (Stratagene), containing 
sonicated Salmon sperm DNA as blocking reagent, for 1 hr at 50-68°C.
2.4.18.2 Hybridisation and washing
After prehybridisation, the prehybridisation solution was replaced by hybridisation 
solution. The hybridisation solution was the same as the prehybridisation solution, 
except that it contained 0-5% (w/v) SDS and the salt concentration was varied 
according to the conditions required (see results of individual hybridisations).
50 pis of the solution was used per cm2 of filter surface area. 10 pmoles of labelled 
oligonucleotide (2.4.16) was added to the bag before it was sealed. Hybridisation 
conditions were as described for each individual hybridisation.
Hybridised filters were washed twice in large volumes of buffer at ionic strengths
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appropriate to the experimental conditions. The temperature of this buffer was also 
varied experimentally. After washing, the filters were left damp, wrapped in Saran 
wrap and exposed to Fuji RX film using intensifying screens at either -70°C (for 
radiolabelled probes) or room temperature (for DIG-labelled probes). Films were 
developed by a Kodak X-OMAT processor.
2.4.19 Screening of plasmid clones bv colony hybridisation
Recombinant pIBI-based clones were screened using a modification of the method 
described in the Hybond-N protocol manual. Nylon filters were placed on duplicate 
agar plates containing the selective antibiotic. Bacterial colonies were crossed onto a 
master plate (containing antibiotic) and then onto the nylon filters (onto which 
alignment marks had been made). The plates were inverted and grown overnight at 
37°C. The filters were removed and placed colony side up on a pad of absorbent filter 
paper soaked in denaturation solution (1-5 M NaCl, 0-5 M NaOH) and left for 7 mins.
The filters were then transferred, colony side up, to a pad of filter paper soaked in 
neutralising solution (1-5 M NaCl, 0-5 M Tris-HCl pH 7-2, 1 mM EDTA), and left for 
3 mins. This step was repeated with a fresh pad soaked in the same solution. The 
filters were then washed briefly in 2x SSC, transferred to dry filter paper and allowed 
to dry in air, colony side up. Finally, the filters were baked at 80°C for 2 hrs, or UV- 
crosslinked. The filter was then hybridised with a nucleic acid probe (2.4.18).
2.4.20 Screening of a bacteriophage X library
2.4.20.1 Primary screening
Cells from a prepared bacterial suspension were infected (2.4.14.1) with phage from 
the bacteriophage X library at a multiplicity of 1 0 4  pfu/1 0 8 cells. 2 x l0 3 pfu were plated 
onto 10x10 cm petri dishes using 8  ml of 0-6% (w/v) top agarose in L broth. The 
plates were incubated overnight at 37°C.
Up to six impressions could be taken from one plate onto nylon membranes, provided 
that sufficient time was allowed for fresh phage to diffuse to the top agarose surface 
(Sambrook et al., 1989). Alignment marks were made on the plate and on the filter 
using a syringe needle. Filters were removed and treated as described for colony filters 
(2 .4 .19 ).
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2.4.20.2 Secondary screening
Single plaques were isolated as described in 2.4.14.3. A lawn of bacteria (108 cells) 
were plated onto a 9 mm circular petri dish along with a suitable dilution of phage 
particles removed from the agar plug. The plates were then grown up overnight at 
37°C. An impression was taken of the plate onto duplicate nylon filters which were 
treated as in (2.4.19a).
2.4.21 Hybridisation, and detection of DIG-labelled DNA hybrids
Prehybridisation and hybridisation of filters with DIG-labelled random primed DNA 
was carried out as described in the Digoxygenin protocols manual from Boehringer 
Mannheim, UK.
DIG-bound DNA was detected using AMPPD as a chemiluminescent substrate for 
alkaline phosphatase. Again, all protocols were followed as per the manufacturer's 
instructions.
2.4.22 Stripping filters
Filters were boiled for approximately 30 mins in 01%  (w/v) SDS solution, and the 
efficiency of stripping detected by autoradiography overnight. If the autoradiogram 
was clear when developed, the filter was suitable for reprobing.
2.4.23 DNA sequencing techniques
2.4.23.1 Single-stranded sequencing
Dideoxy sequencing (Sanger et al., 1977) was carried out on single-stranded M13 
templates using either a Sequenase™ kit (supplied by United States Biochemical 
Corporation) or a T7 sequencing kit (supplied by Promega). All sequencing strategies 
used deoxy-7-deazaguanosine triphosphate (dc7 GTP) as a replacement for dGTP, to 
reduce sequence compressions [Mizosawa et al., 1986]. Extension and labelling 
reactions were performed as suggested by the manufacturers. However, termination 
was carried out at 42°C instead of the normal 37°C. 35S-dATP was used for labelling.
2.4.23.2 Double-stranded sequencing
Plasmid DNA prepared by alkaline lysis of 1*5 ml E.coli culture, followed by
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precipitation with PEG (2.4.23), was resuspended in 5 pi TE, to which 1 pmol of 
sequencing primer and 1 jil of 1 M NaOH were added, followed by 30 mins incubation 
at 37°C. 1 pi of 1 M HC1 and 2 pi of 5x sequencing buffer were then added, followed 
by a further 10 mins incubation at 37°C. A further 1 pi of 100 mM DTT, 2 pi of lx 
labelling mix, 0*5 pi of 3 5S-dATP and 2 pi of diluted T7 polymerase (1-5 U/pl) were 
added, and the labelling mixture incubated at room temperature for 5 mins.
To each of four tubes, 2-5 pi of one of the four ddNTP's was added. The tubes were 
pre-warmed for 2 mins at 37°C, followed by the addition of 3-5 pi of the labelling 
mixture. The reactions were incubated at 37°C for a further 5 mins, followed by the 
addition of 4 pi of stop solution. The reactions were heated at 70°C for 3 mins before
2-5 pi of each was loaded onto a sequencing gel.
2.4.23.3 Autoradiography of DNA sequencing gels
Autoradiography was performed in metal cassettes (medical chest X-ray type) using 
Kodak X-ray film. All autoradiography of sequencing gels was performed at room 
temperature, as autoradiography at -70°C produces bands that are diffuse and therefore 
more difficult to read. The X-ray films were developed using a Kodak X-OMAT 
automatic processor, Model ME-I.
2.4.24 Denaturing polyacrylamide gel electrophoresis for DNA
A BRL sequencing unit (Model S2) was used for high voltage polyacrylamide gel 
electrophoresis.
2.4.24.1 Preparation of polyacrylamide gels
6 % (w/v) denaturing polyacrylamide gels were used for sequencing. The gels were 
prepared from the following stock solutions:
40% (w/v) acrylamide stock 9 ml 
urea 30 g
The urea was dissolved by heating the mix to 37°C and then cooled to room
sequencing
lOx TBE 
dH2Q
6  ml 
2 1 ml
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temperature. The sequencing gel solution could be stored at 4°C for several weeks 
without loss of resolution. Before pouring the gel, 300 pi of freshly prepared 10% 
(w/v) ammonium persulphate and 50 pi of TEMED were added to 50 ml of the stock 
solution.
2.4.24.2 Preparation of glass plates, and pouring of the gel
The plates (40 cm x 33 cm) were cleaned thoroughly with water and alcohol, and 
assembled using spacers (0.4 mm thick) along the vertical sides and 3MM Whatman 
paper along the bottom of the gel. The entire assembly was held in place by clamps. 
The gel solution was poured from a beaker down one edge of the plates while tilting the 
plates at an angle of approximately 30°. The plates were then laid at an angle of 5° and 
the sharks tooth combs inserted in an inverted fashion. The gel polymerised usually 
within 30 mins at room temperature.
2.4.24.3 Electrophoresis of sequencing gels
The gel was pre-electrophoresed for 30 mins at a constant power of 60 W. Prior to 
loading, the samples containing sequencing loading buffer were heated to 95°C for 5 
mins, placed on ice and loaded onto the gel. If two cycles were performed, the first set 
of samples was run until the darker blue dye front reached the bottom of the gel, when 
the second set of samples was loaded. When the dark blue dye front had run 
approximately half-way down the gel, 61-52 g sodium acetate was added to the 500 ml 
of lx TBE in the lower buffer tank, and electrophoresis continued until the darker blue 
dye front reached the bottom of the gel. This allowed upto 400 nucleotides to be read.
2.4.25 The polymerase chain reaction
DNA was amplified from a number of sources, but all following the same general 
procedure, detailed below:
Reaction cocktail: Unamplified DNA (-100 ng genomic DNA, -5 ng plasmid)
PCR buffer, containing MgCh at concentrations of 0-5-3 mM) 
DMSO (10% v/v) 
dNTPs (1-25 mM)
Primers (100 pmol each)
Protocol: Denature DNA (94°C for 5 mins)
+ 1U Taq polymerase
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Denature DNA (94°C for 1 min)
Anneal primers (45-65°C, depending on the annealing
temperature of the primers used; typically for 30 secs) 
Extension of the DNA (72“C for 30 secs to 2 mins, depending 
on the length of DNA being amplified)
Repeat above procedure 20-30 times
Denature DNA (95°C for 4 mins)
Anneal primers (as above, except lengthen this step to typically
1 -2  mins)
Extension of the DNA (72°C for 4 mins)
Typically, a tenth of the PCR reaction was run on a 1% agarose gel to determine if 
amplification of the DNA had occurred. DNA could be extracted and purified as 
described in section 2.4.13.
2.5 General protein methods
2.5.1 Preparation of crude protein extracts
Cell pellets were resuspended in ice-cold extraction buffer (100 mM potassium 
phosphate buffer pH70 [6-15 ml 1M K2HPO4 , 3-85 ml 1M KH2 PO4  in 100 ml], 5 
mM EDTA, 1 mM benzamidine, 0-4 mM DTT; benzamidine and DTT added 
immediately before lysis) and lysed by passage through an automatic French Pressure 
cell, under 750 psi pressure. The suspension was centrifuged at 10,000 g for 15 mins 
at 4°C, and the supernatant isolated.
2.5.2 Assay for activity of 3-dehvdroquinase
The activity of the dehydroquinase enzymes in the lysed cells was assayed by 
measuring the change in OD234 caused by the addition of DHQ to the cell supernatant 
(DHQ and DHS absorb at a wavelength of 234 nm).
The assay solution consisted of: 50 mM Tris-HCl, pH 8-0
0-5 mM DHQ [White et a l, 1990] 
supernatant from the cell lysate (typically 1-5 jil)
The supernatant was added to the solution of Tris-HCl in dH2 0  in a 1 ml glass cuvette, 
which was inverted approximately three times to mix the contents, and the absorbency
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at 234 nm set at zero. The substrate (dehydroquinate) was added, the cuvette inverted 
again, and the absorbency measured on a spectrophotometer at 234 nm for 30 secs. 
The rate of change in the absorbency was measured at least three times per sample, and 
an average calculated.
Since the type I dehydroquinase enzyme is thermolabile, whilst the type II enzyme is 
thermostable, supernatants were heated at 70°C for 5 mins to denature the typel 
enzyme. E.coli supernatants were centrifuged (12,000 g for 15 mins) to remove 
denatured protein from the supernatant.
To analyse the inhibitory effect of chloride anions on the activity of the 
dehydroquinases, 100 mM potassium phosphate (pH 7-0) [Chaudhuri et al., 1986] was 
used as the assay buffer in the absence or presence of various concentrations of KC1. 
The absorbency was again set to zero prior to the addition of substrate to the cuvette, 
and the reaction measured at 234 nm.
2.5.3 Estimation of protein concentration
This was determined by the method of Bradford (1976) using bovine serum albumin 
(BSA) as a standard. 950 pi Bradford's reagent was added to the BSA, and the 
volume made up to 1 ml by the addition of dH2 0 , and the OD5 9 5  measured 
approximately 30 mins after the reaction was set up. A standard curve of OD595  versus 
pg BSA was plotted, and protein concentrations of the cell lysates estimated from this 
curve.
2.5.4 Denaturing polyacrylamide gel electrophoresis of proteins
Electrophoresis of the supernatant from the cell lysate was performed in the presence of 
0-1% (w/v) SDS by the method of Laemmli (1970) in a 5% (w/v) stacking gel and a 
12% (w/v) running gel. A ratio of 30 : 0-8 acrylamide : bis-acrylamide was used in the 
gel, and polymerisation was induced by the addition of 0 -1% (w/v) fresh ammonium 
persulphate and 0-1% (v/v) TEMED.
1 0 0  pi 2 x protein loading buffer was added to an equal volume of cell lysate, and the 
mixture boiled for 10 mins, followed by centrifugation (12000 g for 5 mins at 4°C). 
Extracted supernatant was loaded onto the gel, and the gel electrophoresed at a constant 
current of 20 mA. A molecular weight ladder, supplied by Sigma Chemical Co., was 
also run on the gel to allow estimation of subunit Mr.
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The gel was stained after electrophoresis with Coomassie blue (0-1% (w/v) Coomassie 
brilliant blue G250 in dH2 0 ) for 10 mins, and was destained in 10% (v/v) acetic acid, 
1 0 % (v/v) methanol.
2.5.5 Analysing levels of pathway intermediates
Approximately 100 pg of protein from a crude extract, or 20 pi of a cell culture 
supernatant diluted 1:1 with dH2 0 , were run down an Aminex HPX-87H Organic 
Acids Analysis column (300 x 7-8 mm I.D.; 9 pm particle diameter) on an HPLC in 5 
mM H2 SO4 at a flow rate of 1 ml per minute for 45 mins to measure the levels of five 
of the intermediates (DHQ, DHS, shikimate, S3P and EPSP) and the product 
(chorismate) from the shikimate pathway. The absorbency of the column eluate was 
measured at 215 nm on a spectrophotometer. The retention times for these six 
compounds had already been estimated under identical conditions [Mousdale & 
Coggins, 1985]. 100 pmoles of DHQ and shikimate were run separately on the column 
to allow correlation of the reported times with the estimated times derived from the 
chromatograms. The concentrations of intermediates and product were measured in 
mAbs units.
7 2
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Attempted disruption of the aroO  gene of S.coelicolor
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3.1 Introduction
One of the ultimate aims of the shikimate project in this laboratory is to increase the rate 
of flux through the shikimate pathway, in order to provide higher levels of the 
intermediates and products of this pathway, which may then be utilised in the synthesis 
of primary and secondary metabolites. In order to do this, we wished to study the 
metabolic flux through this pathway, to allow identification of the enzymes with the 
greatest flux control coefficients, and therefore the enzymes which exert the greatest 
level of control over the rate of flux through the whole pathway (see section 1.12). 
These enzymes provide the most obvious targets for upregulation, in an attempt to 
ultimately increase the flux through the pathway.
Dehydroquinase, which converts dehydroquinate to dehydroshikimate, catalyses the 
third step of the shikimate pathway. In S.coelicolor, the dehydroquinase enzyme is a 
type II enzyme, which has a high Km (650 fiM), is thermostable, and functions as a 
dodecamer [White et al., 1990]. The aroQ gene, which encodes this type II enzyme in 
S.coelicolor, has previously been cloned and sequenced in this laboratory [P. White, 
unpublished results].
The high Km of the S.coelicolor dehydroquinase identifies it as being relatively poor at 
sequestering its substrate (DHQ), which may produce an increase in the pool size of 
DHQ in the cell, and suggesting that it may have a high flux control coefficient. 
Therefore, under conditions of upregulation of the pathway, which may occur 
immediately prior to, or even during, differentiation and secondary metabolism, the 
dehydroquinase enzyme may impose a limitation on the rate of flux through the 
pathway.
One of the aims of this project was to replace the dehydroquinase gene with the aroQ 
gene of E.coli [Kinghom et al., 1981], which encodes a type I dehydroquinase enzyme 
[Chaudhuri et al., 1986] whose Km is approximately one twentieth that of the enzyme 
from Streptomyces [White et al., 1990], Thus, the type I enzyme is much more 
effective at sequestering its substrate than the type II enzyme, and may therefore have a 
lower flux control coefficient. Therefore, functional replacement of the indigenous type 
II dehydroquinase with the type I enzyme of E.coli may produce an increase in flux 
through the shikimate pathway.
3.1.1 Transformation of S.coelicolor  with DNA derived from E.coli
Numerous replicative vectors carrying a variety of different antibiotic resistance
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markers, multiple cloning sites and expression systems have been created for use in 
streptomycetes. However, it is still desirable to perform certain subcloning 
manipulations in E.coli, and to then transform the constructs into a particular 
Streptomyces strain. Transfer of plasmids from E.coli to Streptomyces also allows the 
use of both bifunctional and suicide (integrative) vectors, which have numerous 
applications in streptomycete research. However, many prokaryotes have developed 
methods for distinguishing their own DNA from foreign DNA, particularly through the 
use of chemical modification of the host DNA. They have also developed defence 
mechanisms which cause the degradation of DNA which has been recognised as 
foreign, preventing its replication and the expression of foreign genes. The 
streptomycetes in particular have effective modification and defence systems.
The E.coli dam gene encodes a Dam methylase which modifies the sequence GATC, 
converting the adenine base to N6-methyladenine. Dam methylation is involved in the 
repair of DNA mismatches, and also in the modulation of gene expression and DNA 
replication [Palmer & Marinus, 1994]. The dcm  gene of E.coli encodes a Dcm 
methylase which modifies the sequence CC(A/T)GG, converting the internal cytosine 
residue to 5-methylcytosine.
A number of Streptomyces strains contain methyl-dependent restriction systems: 
S.coelicolor has been found to contain a restriction system sensitive to Dam methylation 
[MacNeil, 1988] and digests any DNA containing such a methylation; S.rimosus 
restricts Dcm-methylated DNA; S.avermitilis restricts DNA modified by either Dam or 
Dcm methylases. Therefore, S.coelicolor, S.rimosus and S.avermitilis cannot be 
transformed with DNA from the majority of E.coli strains. S.lividans, however, does 
not methylate its DNA in such a way, so that its DNA may be used to transform 
protoplasts of other Streptomyces species. Also, S.lividans does not restrict DNA 
which has been modified by either Dam or Dcm methylases, and may therefore be 
transformed with DNA from all E.coli strains.
During the experiments presented in this thesis, two E.coli strains, MB5386 and CB51, 
were used to provide DNA which was not Dam-methylated for transformation into 
S.coelicolor. MB5386 contains a transposon, Tn9, disrupting the dam gene, and a 
mutant copy of the dcm  gene, preventing expression of either the Dam or Dcm 
methylases (MacNeill, 1988). The Tn9 transposon may be selected for by growth on 
chloramphenicol-containing medium, as the transposon contains the cat gene, which 
encodes a chloramphenicol acetyl transferase enzyme, and therefore mediates resistance 
to chloramphenicol. CB51 contains a mutant dam gene, so does not methylate the 
adenine residue in the GATC sequence. Therefore, DNA isolated from either of these
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strains is able to avoid the restriction barrier of S.coelicolor.
In order to perform a functional replacement of the host dehydroquinase enzyme, it was 
necessary to first disrupt the aroQ gene of S.coelicolor, which encodes the host's type 
II dehydroquinase enzyme. Gene disruption would also allow analysis of the first two 
steps of the pathway, catalysed by DAHP synthase and DHQ synthase, in isolation, 
and enable analysis of whether either of these genes is a suitable target for replacement, 
or whether any of the other upregulation methodologies, such as overexpression, may 
be advantageous in increasing the flux through the pathway.
3.1.2 Gene disruption in S.coelicolor
Two different gene disruption strategies were available; integration of an internal 
fragment of the gene, and functional replacement with a mutant gene copy. Both of 
these methods are discussed below:
3.1.2.1 Disruption via integration of an internal fragment
In this method, an internal fragment of a cloned gene is inserted into a non-replicative 
(suicide) vector, the plasmid is transformed into the strain targeted for disruption, and 
the internal fragment integrates by Campbell-type homologous recombination between 
the cloned insert and its chromosomally-located parental gene copy; otherwise the 
plasmid is lost as it is unable to replicate in the chosen host. This recombination event 
produces two gene copies; one with an N-terminal deletion, the other with a C-terminal 
deletion. The vector sequence lies between these two terminally-deleted gene copies. 
If the cloned internal fragment has either sufficiently large deletions, or deletions of 
essential fragments, at each end of the gene, then neither terminally-deleted copy of the 
gene will encode a functional protein, and disruption will have been effected 
successfully. The existence on the vector of an antibiotic-resistance marker which is 
functional in the transformed strain enables selection for such a disruption event, as the 
vector is unable to replicate stably in the host, so resistant transformants must contain a 
copy of the plasmid integrated into the chromosome. Legitimate recombination should 
only occur between the chromosomally-located parental gene copy and the internal gene 
fragment on the plasmid, as no other regions of the suicide vector are likely to bear any 
significant homology to the genome of the host.
Suitable vectors for the above disruption strategy include ColEl-based vectors, 
naturally-occurring temperature-sensitive host vectors, and atfP-deleted 0C31 vectors:
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ColEl-based vectors, including the E.coli pUC-based vectors, are unable to replicate in 
streptomycetes, and so can only survive in a Streptomyces host by integration into the 
chromosome. Such vectors are suitable for use as suicide vectors in Streptomyces. It 
has been demonstrated that suicide vectors are able to transform into protoplasts of 
S.coelicolor and to integrate into the chromosome, but at a much lower frequency (circa
2-5X104 reduction)than replicative double-stranded plasmid DNA [Smith, 1992].
Temperature-sensitive vectors will replicate stably in their host cells at permissive 
temperatures. However, they are unable to replicate at elevated, non-permissive 
temperatures. Therefore, under such conditions, they are only able to survive in the 
host by integration into the chromosome. Thus, temperature-sensitive plasmids are 
suitable for use as both expression and suicide vectors. This strategy was utilised for 
disruption of the pat gene, encoding resistance to phosphinothricyl-alanyl-alanine 
(PTT), of S.viridochromogenes using the naturally-occurring temperature-sensitive 
plasmid pSG5 from S.ghanaensis [Muth et al., 1989]. However, no naturally- 
occurring temperature-sensitive plasmids have been isolated from S.coelicolor.
0C31 is a temperate Streptomyces bacteriophage which can undergo a lytic or lysogenic 
infection of its host. During a lytic infection it does not integrate into the chromosome, 
remaining as an extra-chromosomal DNA molecule, and lyses its host to release 
progeny phage. However, when 0C31 enters its lysogenic life-cycle, it usually 
integrates site-specifically into the chromosome at the attB site due to homologous 
recombination between the attB site and the attP site of the phage, with the two sites 
exhibiting almost complete identity. Deletion of the attP site from the phage prevents 
this site-specific recombination event from occurring, so that lysogens are only 
produced through homologous recombination between the insert and its 
chromosomally-located parental gene copy. Disruption using this strategy has already 
been used successfully in S.coelicolor, for example in the disruption of the hrd genes, 
which encode putative sigma factors [Buttner et al., 1990].
Disruption via integration of an internal gene fragment requires as little as 620 bp of 
homologous DNA for the integration event to occur, as shown by the disruption of 
hrdD using a 0C31 lysogen [Buttner eta l., 1990]. Unfortunately, the coding sequence 
of the aroQ gene of S.coelicolor is only 639 bp in length. In order to produce non­
functional, terminally-deleted proteins by this method, sufficient sequence from each 
end of the gene must be deleted. This would considerably reduce the size of the coding 
region in the S.coelicolor aroQ gene, possibly to a size which is unable to undergo 
recombination with the chromosomal copy. Also, integration of 0C31 is performed by 
an integrase protein which it encodes, and which increases the frequency of
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recombination.
It is also possible that, in S.coelicolor , aroQ  forms part of a bifunctional or 
multifunctional operon. Disruption by this method produces a gene deleted at its 3' 
end, with the integrated 0C31 or plasmid sequence and the 5'-deleted gene lying 
downstream of it. Such an integration event is likely to prevent transcription through 
the 5'-deleted aroQ gene copy, due to the length of the intervening sequence, and 
therefore is also likely to prevent transcription into any downstream gene which may be 
contained within this operon. It is also possible that the 5'-deleted aroQ gene copy and 
any downstream genes will be brought under the control of 0C31- or plasmid-encoded 
regulatory sequences, causing abnormal expression of any gene(s) downstream of 
aroQ. Disruption via gene replacement is less likely to suffer from either of these 
problems. For these reasons, this strategy for disruption of the aroQ  gene of 
S.coelicolor was not attempted. The sequences upstream and downstream of aroQ are 
currently being sequenced in this laboratory, possibly followed by transcriptional 
analysis.
3.1.2.2 Disruption via gene replacement
Through this method, the functional chromosomally-located gene is replaced by a 
mutant plasmid-borne gene copy. The plasmid used is often a non-replicating suicide 
vector, or may be an unstable host vector. The mutation may be due to an internal 
deletion, a substitution (often performed by PCR mutagenesis), or an insertion [for 
example, Buttner & Lewis, 1992]. This strategy requires two recombination events to 
occur between the two gene copies, one on either side of the mutation. It allows the 
mutation to be effectively exchanged from the gene copy carried on the plasmid into the 
chromosomal copy, with the functional gene copy being moved onto the plasmid 
(Figure 3.1). The first recombination event causes integration of the plasmid into the 
chromosome; the second event liberates the plasmid, carrying either the mutant copy 
(therefore regenerating the original, non-mutated host) or the functional gene copy 
(therefore causing the production of a disrupted mutant).
If a suicide vector is used to carry the mutated gene copy, the plasmid will be lost from 
the cells after the second recombination event due to its inability to replicate in the host. 
If an unstable vector is used, it may survive in the cells for a few generations, but is 
likely to be lost quickly from the population if grown under non-selective conditions.
Cells into which the plasmid has integrated by a single recombination event are likely to 
eventually lose the plasmid via a second homologous recombination event when grown
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under conditions which do not select for maintenance of the integrated copy. However, 
it is also possible to promote the secondary recombination event in certain Streptomyces 
strains through protoplasting (which ensures that only a single copy of the genome is 
present in each cell, and therefore increases the ease of identification of the desired cell) 
and regeneration on non-selective media (which releases the selection pressure, and 
allows a secondary recombination event to occur). It has been demonstrated that the 
required secondary recombination event occurs in approximately 3 to 4% of colonies 
after a single round of sporulation on non-selective solid media in S.coelicolor [Smith, 
1992]. This strategy was used for disruption of the gene encoding the fifth step of the 
bialaphos biosynthetic pathway in S.hygroscopicus [Anzai et al., 1988].
Insertion mutagenesis is performed by the stable insertion of a transposon, or by the 
subcloning of an antibiotic-resistance gene, into the coding region of the plasmid-borne 
gene which has been targeted for disruption. The resistance gene should be subcloned 
into a restriction site as close as possible to the centre of the insert fragment carried on 
the vector, in order to allow as much of the coding sequence on either side of the 
resistance marker to function as a template for homologous recombination. This 
method also carries the disadvantage that it is likely to interfere with the transcription of 
any genes lying downstream of, and transcriptionally coupled to, the disrupted gene.
3.1.3 Transformation of S.coelicolor
There are currently four methods available for transformation of Streptomyces:
3.1.3.1 Transformation of protoplasts with double-stranded plasmid 
DNA
This basically follows the PEG-mediated method of Hopwood et al. [1985]. Non- 
methylated plasmid DNA is transformed into protoplasts, which are plated onto R2 
regeneration medium and incubated at 30°C. Selection is achieved by overlaying the 
plates after 16-20 hrs with 1 ml of 10-3% sucrose solution containing the relevant 
antibiotic. Transformants typically appear after around 5 days, and sporulate after 7 to 
10 days. S.lividans protoplasts are able to be transformed with DNA isolated from 
either E.coli or other Streptomyces strains. S.coelicolor protoplasts can be transformed 
with plasmid DNA derived from S.lividans, but may only be transformed with DNA 
from E.coli which has not been Dam-methylated. Transformation of protoplasts was 
the method most used during the work reported in this thesis.
Although it is possible to transform linearised plasmids into certain bacterial species
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[for example in E.coli', Winans et al., 1985] which may promote insertion of this 
plasmid DNA into the chromosome via homologous recombination, many species 
contain exonuclease enzymes which degrade such unprotected linear DNA (but not the 
giant linear plasmids which occur naturally in streptomycetes and whose ends are 
capped with protein, protecting them from such degradation [Chen et al., 1993]). This 
transformation methodology, however, often requires mutations in the host genes 
encoding these exonucleases (recB and recC genes in E.coli) in the recipient strain to 
prevent degradation of the linear DNA. Unfortunately, such mutations are not available 
in Streptomyces strains.
An alternative way of preventing degradation of linear DNA molecules to mutations in 
exonuclease genes is the capping of the ends of the linear DNA, using one of two 
possible strategies: either with oligonucleotides which are able to ligate to both strands 
of each end of the plasmid, forming a looped end (analogous to a hairpin structure); or 
to cap the ends of the linearised plasmid with proteins, as occurs with naturally- 
occurring linear plasmids and linear chromosomes. However, neither of these systems 
have been reported in Streptomyces species. Therefore, transformation of protoplasts 
with linearised plasmid DNA is not currently considered as a viable experimental 
procedure in Streptomyces.
3.1.3.2 Transformation of protoplasts with single-stranded plasmid 
DNA
Single-stranded plasmid DNA can be obtained from vectors containing a bacteriophage 
f 1 origin of replication by single-stranded rescue using a helper bacteriophage, for 
example M13K07, which has been mutated to promote an elevated level of single­
stranded plasmid DNA isolated relative to phage DNA. Hillemann et al. [1991] have 
developed a method for gene disruption in S.viridochromogenes by transformation 
with single-stranded suicide vectors. These authors showed that transformation by 
single-stranded DNA increased integration by approximately 10- to 100-fold relative to 
transformation with double-stranded DNA from the same plasmid, with both systems 
showing approximately equal transformation efficiencies. They were able to utilise 
homologous fragments as small as 2 0 0  bp in length.
Single-stranded DNA which is transformed into S.coelicolor will undergo replication to 
produce a double-stranded plasmid. The daughter strand will not be methylated as it is 
synthesised by the replication machinery of S.coelicolor. If the single-stranded DNA 
used for transformation is from an E.coli strain containing a Dam methylase, it will be 
methylated at the adenine residue of the sequence GATC. The plasmid, therefore, will
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be hemi-methylated. However, S.coelicolor has been shown to restrict hemi- 
methylated plasmid DNA [C. Smith, personal communication] as well as fully 
methylated DNA. Although single-stranded plasmid DNA derived from a methylating 
host will produce transformants of S.coelicolor, it does so at a greatly reduced 
frequency (circa 2 x l0 5 reduction) compared to replicating double-stranded plasmid 
DNA [Smith, 1992].
The S.coelicolor restriction-methylation barrier can be evaded by transformation with 
DNA isolated from a non-methylating E.coli strain (for example MB5386 or CB51). 
However, none of these non-methylating E.coli strains currently contain the F plasmid, 
which is required for isolation of single-stranded plasmid DNA. Therefore, all single­
stranded DNA transformed into S.coelicolor will form a hemi-methylated double­
stranded plasmid which will be restricted to produce a linear molecule, and will 
subsequently be degraded by exonucleases. Thus, although this method of 
transformation was briefly attempted as part of this project prior to the discovery that 
hemi-methylated DNA is degraded in S.coelicolor, a method for transformation of 
S.coelicolor by single-stranded DNA is currently unavailable.
3.1.3.3 Transconjugation of spores
Transconjugation of plasmids between various Streptomyces strains has long been 
known to occur [Hopwood et al., 1969]. However, transfer of plasmids by 
conjugation has also been shown to occur from E.coli to a variety of streptomycetes 
using a bifunctional plasmid [Mazodier et al., 1989]. This method of transfer requires 
the presence on the plasmid of a mob (mobilisation) region, which contains an oriT 
(origin of transfer), and a tra gene supplied in trans. The tra gene from the RP4 
plasmid (an IncP plasmid) is required for mobilisation of the plasmid, and is often 
integrated into the chromosome, whilst oriT is the region of the plasmid at which the 
initial incision is made to produce the linearised DNA molecule which is passed across 
the "conjugation tube".
Mazodier et al. isolated plasmid DNA from exconjugants of S.lividans when matings 
were performed on a solid medium, but conjugation did not appear to occur when the 
donor (E.coli) and recipient {S.lividans) were grown together in liquid medium. Also, 
no transfer to mycelia was observed, and the efficiency of transfer to spores was 
increased 5- to 10-fold by pregermination of the spores.
It has also been demonstrated that an IncQ plasmid (RSF1010) is able to transfer from 
E.coli to both S.lividans and Mycobacterium smegmatis (another Gram-positive
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bacterium which is very closely related to the streptomycetes), and to self-replicate 
stably in both species [Gormley & Davies, 1991]. IncQ plasmids appear to be 
relatively independent of the host bacterium's replication machinery, supplying the 
enzymes necessary for the initiation and propagation of their own replication. They 
require only DNA polymerase HI from an E.coli host, and are able to stably replicate in 
S.lividans. For mobilisation, they also require the tra gene to be supplied in trans in the 
donor strain. Again, S.lividans exconjugants contained plasmids which were restricted 
with Bel I, and therefore were not methylated.
3.1.3.4 Electroporation of mycelia
Streptomyces rimosus mycelia exhibiting well-dispersed growth in a complete liquid 
medium may be harvested, treated with lysozyme, and transformed with up to 2  jig of 
plasmid DNA if subjected to a brief, high-voltage electric discharge [Pigac & 
Schrempf, 1995]. The electrical pulse results in the formation of transient pores in the 
membrane, through which uptake of DNA can occur. Transformants are plated, after 
growth in non-selective liquid medium to allow expression, onto antibiotic-containing 
medium to select for transformants. These authors claim that this method has 
advantages relative to transformation of protoplasts, including a 1 0 -fold increase in 
transformation efficiency, increased reproducibility, easier preparation of transformable 
cells, and growth of transformants within 72 hours.
This transformation methodology is currently being applied to a range of Streptomyces 
strains. However, in this laboratory, suitably-dispersed growth of mycelia cannot 
currently be achieved with S.coelicolor, so that we are unable to obtain enough 
electrocompetent mycelia to achieve a sufficient transformation efficiency. Therefore, 
this method of transformation has not been utilised in the experiments presented in this 
thesis. Based on all of the knowledge described above, the strategy for gene disruption 
chosen in the work described below was insertion mutagenesis with a gene encoding 
antibiotic resistance, using an E.coli (suicide) plasmid as the transmission vector.
3.2 Results
3.2.1 Attempted disruption of aroO  with ermE
3.2.1.1 Disruption of a plasmid-borne aroQ  gene with ermE
The aroQ gene of S.coelicolor, which had previously been cloned in this laboratory [P.
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White, unpublished results], encodes a type II dehydroquinase enzyme. It is contained 
within an approximately 3 kb Hind Ill/Ssr I fragment, which was previously subcloned 
into the vector pLBI25 to generate pPW63. p i 13 is a pIBI24-based vector, created by 
replacement of the Ssp I fragment of the vector with the tsr gene [H. Hacker, personal 
communication].
The tsr gene, which was cloned from S.azureus, functions as a selectable marker in 
S.coelicolor by inducing resistance to thiostrepton by modification of ribosomes 
[Thompson et al., 1986]. It encodes a rRNA methylase which methylates an adenosine 
residue in the ribosomes, converting it to 2 '-0 -methyladenosine, and preventing the 
binding of thiostrepton to the ribosomes [Thompson et al., 1982c].
The ermE gene was originally cloned from Streptomyces erythraeus (subsequently 
reclassified as Saccharopolyspora erythraea) [Thompson et al., 1982a]. It encodes a 
rRNA methylase which modifies adenine residues in the ribosomes, converting them to 
N 6 ,N6-dimethyladenine [Thompson et al., 1982c], This modification confers 
resistance to both the macrolide antibiotic erythromycin, and to lincomycin.
The 3 kb Hind III/Sst I fragment from S.coelicolor, which contains the aroQ gene, was 
isolated from pPW63 and subcloned into pi 13, creating plasmid pPMl (Figure 3.2). 
The ermE gene of plasmid pIJ4026 was excised on a 1*8 kb Bgl II fragment. It was 
used to disrupt the aroQ gene of S.coelicolor by subcloning this fragment into the 
unique Bgl II site of pPMl, which occurs inside the coding region of aroQ, generating 
the plasmid pPM3.
pPM3 contains a unique Pst I site which lies in a region of the multiple cloning site 
transferred from pIJ4026 during the subcloning of ermE, and lies upstream of the ermE 
gene on the Bgl II fragment. To allow this plasmid to be transferred from E.coli strains 
containing a tra gene by conjugation, a plasmid mob region containing an oriT was 
subcloned into the unique Pst I site of pPM3, creating plasmid pPM4 (Figure 3.2).
The above subcloning events were performed in E.coli DS941. However, this strain 
fully methylates plasmid DNA contained within it, and so plasmid DNA derived from it 
cannot be used for transformation of protoplasts of S.coelicolor. Therefore, plasmid 
pPM3 was transformed into competent E.coli MB5386 cells, and selected for by 
growth on L agar supplemented with ampicillin. Ampicillin-resistant transformants of 
MB5386 were streaked onto L agar supplemented with chloramphenicol to ensure that 
these transformants were true dam~ cells. After the efficacy of this mutation had been 
ascertained, non-methylated pPM3 was isolated for transformation of protoplasts of
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S.coelicolor.
3.2.1.2 Selection for erm E
Spores of S.coelicolor 209 were streaked onto Soya agar plates supplemented with 
lincomycin at concentrations of 200, 400, 600, 800 (Xg/ml and 1 mg/ml. They were 
also streaked onto Soya plates supplemented with erythromycin at a concentration of 
200 fig/ml. Although no spores grew on the plates in the presence of erythromycin, 
they grew on all of the lincomycin-containing plates. Therefore, erythromycin was 
preferred for selection of the presence of ermE in Streptomyces during the experiments 
described below.
Spores of S.coelicolor 1147 were plated onto Soya agar plates supplemented with 
between 1 and 5 mg erythromycin per plate (40-200 fig/ml). Colonies grew on plates 
containing 1 mg and 2 mg erythromycin only. Therefore, transformed protoplasts of 
S.coelicolor were overlaid with 4 mg erythromycin per plate, or plated onto agar 
containing 200 JLig/ml (as suggested for S.lividans [Hopwood et al., 1985]).
3.2.1.3 Transformation of protoplasts of S.coelicolor  1147 with pPM3
pPM3 plasmid DNA was isolated from the non-methylating E.coli strain MB5386 
[MacNeil, 1988], and transformed into high-efficiency protoplasts of S.coelicolor 1147 
with or without digestion with Pst I endonuclease. Transformation with a linear DNA 
molecule is known as a “hit and run” transformation. The transformation mixtures 
were plated onto R2 regeneration plates, incubated at 30°C, and overlaid either with 
erythromycin to select for both single- and double-recombinants, or with thiostrepton to 
select for single-crossovers. No colonies grew up on the plates which were overlaid 
with thiostrepton. However, two colonies from each of the Pst I-restricted and 
unrestricted transformations grew on erythromycin plates. Transformants were 
streaked again onto erythromycin-containing and thiostrepton-containing Soya agar 
plates to test the efficacy of selection of protoplasts, and again no growth was observed 
on thiostrepton; three of the colonies (including only one of those transformed with 
digested plasmid) grew up on the erythromycin-containing plates. The resultant 
colonies were patched onto both erythromycin-containing and thiostrepton-containing 
Soya agar plates. Two colonies were isolated which were resistant to erythromycin, 
but not to thiostrepton, indicative of a double-crossover. To again test the efficacy of 
selection, these two isolates were re-streaked onto erythromycin- and thiostrepton- 
containing plates and, as anticipated, grew only on erythromycin-containing plates.
86
Chapter 3
To check for any auxotrophic requirements of such putative disruptants, the two 
erythromycin-resistant isolates and an untransformed 1147 colony were streaked onto 
minimal medium with and without a supplement of the aromatic amino acids. All three 
strains grew on the supplemented medium, but only 1147 grew on medium lacking the 
aromatic amino acids (phenylalanine, tryptophan and tyrosine). This suggested that 
S.coelicolor strains lacking a functional dehydroquinase enzyme require an exogenous 
supply of the aromatic amino acids for growth, as the shikimate pathway is unable to 
produce chorismate, thus preventing the synthesis of these amino acids which are 
required for growth.
Chromosomal DNA was prepared from the two putative dehydroquinase-disrupted 
strains and untransformed 1147, approximately 1-5 pg of each was digested with either 
Hind III or Sst I restriction endonucleases, and was run out on a 0*8% TBE agarose 
gel. This DNA was Southern-blotted onto nylon membrane, and the membrane was 
probed with a radiolabelled ermii-containing probe (the 1 -7 kb Kpn I fragment of 
pIJ4026). However, no DNA band on the membrane lit up, suggesting that the ermE 
probe did not hybridise to any bands on the membrane, and therefore that neither isolate 
contains ermE (and hence a disrupted dehydroquinase gene), or that the labelling ermE 
probe or the probing of the filter was not successful. Unfortunately, no positive 
control had been included on the filter to test the efficiency of the probing.
It was concluded from this result that the erythromycin-resistant isolates arose by 
spontaneous mutation to resistance. This theory is supported by the fact that no 
thiostrepton-resistant colonies were obtained at any point during this experiment. Also, 
although two erythromycin-resistant colonies were produced by the "hit and run" 
transformation, it has since been demonstrated that exonuclease enzymes of 
S.coelicolor digest linear DNA, and so it is extremely unlikely that the linearised 
plasmid DNA would have been able to integrate into the chromosome.
Following the dismissal of these two colonies as containing an aroQ disruption, they 
were not investigated further.
3.2.1.4 Transconjugation of spores of S.coelicolor  1147 with pPM4
Plasmid pPM4 was transformed into E.coli strain S17-1, which contains a 
chromosomally-located tra gene, and is therefore capable of mobilisation of plasmids 
(including pPM4) carrying a mob region, which contains the origin of transfer, oriT.
Approximately 108 S.coelicolor 1147 spores were plated onto Soya agar plates along
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with approximately 2xl08 S17-l/pPM4 cells, and incubated at 30°C. Plates were 
overlaid with erythromycin (which selects for transconjugants) and nalidixic acid 
(which kills E.coli, but to which Streptomyces are naturally insensitive). This 
produced an almost confluent lawn of putative transconjugants, which were replica- 
plated onto plates supplemented with either erythromycin or thiostrepton. Again, 
growth on erythromycin was nearly confluent, but considerably fewer colonies grew 
on thiostrepton-containing plates.
44 colonies from the thiostrepton-containing plates were streaked onto non-selective 
plates to allow a secondary recombination event to occur, and then streaked back onto 
plates containing either thiostrepton or erythromycin. All 44 colonies grew in the 
presence of both antibiotics. This round of non-selective growth followed by selective 
growth was repeated twice, to produce a single colony which was erythromycin- 
resistant, thiostrepton-sensitive (disruptant #1). After a further round of non-selective 
growth, another colony which had apparently undergone the required secondary 
recombination event was isolated (disruptant #2).
The two putative disruptants, a putative pPM4 integrant (erythromycin- and 
thiostrepton-resistant), and untransformed 1147 were grown up in YEME liquid 
medium supplemented with MgCl2 (to 5 mM), glycine (to 0-5% w/v) and, for the 
putative disruptants, erythromycin. Total DNA was isolated from all four strains.
Approximately 5 |ig total DNA from each of the four strains (untransformed 1147, 
putative single-crossover, and two putative mutants) was digested with either Pst I or 
Sst I, and electrophoresed on a 0-8% TAE agarose gel (Figure 3.4). The DNA was 
transferred to nylon membrane by Southern blotting, and the membrane probed 
successively with labelled aroQ (from S.coelicolor) and ermE genes.
When the filter was probed with the radiolabelled aroQ gene from S.coelicolor (the 3 kb 
Hind IQ/Sst I fragment of pPW63), it was anticipated that the gDNA isolated from an 
untransformed colony would exhibit a single band to which the probe would hybridise; 
the gDNA isolated from the putative single crossover isolate would contain two bands 
of unknown size (totalling approximately 21-5 kb) when digested with Pst I, and three 
bands (totalling approximately 14-5 kb) to which the aroQ probe would hybridise when 
digested with Sst I; and the genomic DNA (gDNA) isolated from the putative 
disruptants would show two bands (totalling approximately 13-7 kb; this probe would 
not hybridise to the oriT fragment, which has Pst I ends) when the DNA was digested 
with Pst I, and two bands (of approximately 1-3 kb and 6-1 kb) when cut with Sst I
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1 2 3 4 5 6 7 8 9  10
Figure 3.4 gDNA isolated from untransform ed 1147. two putative 
disruptants and a putative 1147/pPM4 transform ant
lanes 1 and 10: XIHind III markers
lanes 2 and 3: gDNA from 1147 digested with Pst I and Sst I respectively 
lanes 4 and 5: gDNA from disruptant #1 cut with Pst I and Sst I respectively 
lanes 6 and 7: gDNA from disruptant #2 cut with Pst I and Sst I respectively 
lanes 8 and 9: gDNA from 1147/pPM4 cut with Pst I and Sst I respectively
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Figure 3.5 Autoradiogram  of membrane carrying gDNA from 1147 
isolates probed with a fragm ent containing the aroQ  gene from 
S .co e lico lo r  
(lanes as in Figure 3.4)
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1 2 3 4 5 6 7 8 9 10 11 12
Figure 3.6 gDNA from two putative disruptants of 1147 and one 
single-crossover isolate
lanes 3 and 12: XJHind III markers
lanes 1 and 4: 10 ng and 2 ng (respectively) of the tsr gene
lanes 2 and 5: 10 ng and 2 ng (respectively) of the ermE  gene
lanes 6 and 7: gDNA from disruptant #1 cut with Bel I and Bgl II respectively
lanes 8 and 9: gDNA from disruptant #2 cut with Bel I and Bgl II respectively
lanes 10 and 11: gDNA from 1147/pPM4 cut with Bel I and Bgl II respectively
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Figure 3.7 Autoradiogram  of membrane carrying gDNA from 1147 
isolates probed with a fragm ent containing the tsr gene
(lanes as in Figure 3.6)
(the “blob” in lane 11 is believed to be an artefact)
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[see Figure 3.3]. However, all four isolates, when digested with either Pst I or Sst I, 
exhibited only the same single band on the autoradiogram (Figure 3.5).
Approximately 5 |ig of gDNA isolated from the two putative disruptants and the 
putative 1147/pPM4 transformant were digested with either Bel I or Bgl II, and run out 
on a 0-8% TAE gel. The Streptomycete genome is estimated at 6-9 megabases 
[Hopwood & Kieser, 1990]; the tsr gene is IT kb in length, and would constitute 
around 0 015% of the genome in an integrant. Therefore, around 1 ng of tsr DNA 
(0.015% of 5 jig) would represent a single copy of the tsr gene in the gDNA digests. 
Approximately 10 ng and 2 ng of the unlabelled tsr and ermE probes were also run on 
the gel as positive controls (Figure 3.6). The DNA was subsequently transferred by 
Southern blotting to a nylon membrane. When the membrane was probed with the 
labelled tsr gene, it was anticipated that the probe would hybridise to the tsr control and 
to the gDNA isolated from the putative single-crossover. However, the probe 
apparently only hybridised to the tsr control, even though the membrane was exposed 
to X-ray film for up to 24 hrs at -70°C (lanes 1 and 4 in Figure 3.7). When the filter 
was probed with the ermE probe, it was anticipated that it would hybridise to the ermE 
control, the gDNA isolated from the putative single-crossover isolate and the gDNA 
isolated from the two putative double-crossovers. However, only the ermE control lit 
up on the autoradiogram. These results suggest that the two putative disruptants and 
the putative single crossover are actually wild-type S.coelicolor 1147. These results 
provide further evidence that ermE is a poor resistance marker in S.coelicolor 1147.
3.2.1.5 Transform ation of protoplasts of S.coelicolor  G216 with pPM3
The S.coelicolor strain G216 has the same genotype as that of strain 1147, but 
protoplasts isolated from it have a higher efficiency of transformation. Therefore, it 
was chosen to substitute for 1147 for disruption of the aroQ gene.
Protoplasts of G216 were transformed with pPM3 isolated from the non-methylating 
E.coli strain MB5386, the transformation mixture plated on R2 supplemented with the 
aromatic amino acids, and overlaid with 2 mg lincomycin. The excessive number of 
transformants (approximately 500 per plate) suggested that lincomycin was not an 
effective selecting agent in G216. Growth of non-transformed G216 spores on 
medium containing lincomycin supports this theory.
102 of the colonies which had grown on R2 overlaid with lincomycin were streaked 
onto Soya plates without antibiotic supplements, or Soya plates supplemented with 
either erythromycin or thiostrepton. Only four colonies grew on the erythromycin-
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containing plates, and two colonies on the thiostrepton-containing plates.
The colonies from the non-selective plates were re-streaked onto plates containing either 
erythromycin or thiostrepton. Only 84 of these isolates showed any growth on 
erythromycin-containing plates, giving rise to 243 colonies, and just a single isolate 
growth on the plates containing thiostrepton. 207 erythromycin-resistant colonies were 
again patched onto plates containing either erythromycin or thiostrepton, with 162 
growing on the plates containing erythromycin and 10 on the thiostrepton-containing 
medium.
19 erythromycin-resistant, thiostrepton-sensitive colonies and one double-resistant 
colony (G216/pPM3) were grown in YEME liquid medium supplemented with MgCl2 , 
glycine and erythromycin. Untransformed G216 was grown under similar conditions, 
but without the medium being supplemented with antibiotic. Total DNA was isolated 
from all twenty-one of these isolates. 10 pg of gDNA from each isolate was digested 
with Sst I and run out on a 0-8% TAE gel, along with 5 ng of each of the ermE and tsr 
genes (Figure 3.8). The DNA was transferred to a nylon membrane by Southern 
blotting, and the membrane probed with a 600 bp digoxygenin-labelled aroQ fragment. 
It was anticipated that a single band of approximately 5 kb in length would light up in 
gDNA isolated from untransformed G216; gDNA from a single-crossover would 
contain three bands (totalling approximately 13-7 kb in length); the double-crossover 
would show two bands, approximately 1*3 kb and 5-4 kb in size [see Figure 3.3], 
However, all isolates showed the same single aroQ band, approximately 5 kb in length, 
as the untransformed G216 (Figure 3.9). Some of the isolates (particularly in lane 
10 of Figure 3.9) appear to show two bands to which the aroQ probe hybridises. 
However, as this pattern of banding does not comply with any of the anticipated 
patterns, it is assumed that the higher of the two bands was an artefact, and was 
possibly present due to only partial digestion of some of the gDNA in these lanes.
The filter was stripped to remove the labelled aroQ probe, and probed with the tsr 
gene(the BamH  I/Bgl II fragment of pLus801) which had been labelled with 
digoxygenin. It was anticipated that the tsr control and the putative single-crossover 
would show a single band. However, only the tsr control lit up (Figure 3.10).
A further 10 jig of the total DNA from each isolate was digested with SstI, run out on a 
0-8% TAE gel, along with 1 ng of the ermE gene (the 1*7 kb Kpn I fragment) as a 
control (Figure 3.11), and Southern blotted onto nylon membrane. The membrane 
was probed with a digoxygenin-labelled ermE fragment (the 1*7 kb Kpn I fragment of 
pIJ4026).
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Figure 3.8 gDNA from G216 isolates
lanes 1 and 12: XIHind III markers
lane 2: 5 ng ermE  (1-7 kb Kpn I fragment of pIJ4026)
lane 3: 5 ng tsr (M  kb BcimW I/Bgl II fragment of pLus801)
lanes 4-11 and 13-23: gDNA from putative disruptants, cut with Sst I
lane 24: gDNA from putative G216/pPM3 isolate, cut with Sst I
lane 25: gDNA from untransformed G216 isolate, cut with Sst I
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Figure 3.9 Autoradiogram  of m em brane carrying gDNA from G216 
isolates probed with a fragm ent containing the aroQ  gene of 
S .co e lico lo r  
(lanes as in Figure 3.8)
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Figure 3.10 Autoradiogram  of m em brane carrying gDNA from  G216 
isolates probed with the tsr gene
(lanes as in Figure 3.8)
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F igure 3.11 gDNA from G216 isolates
lanes 1 and 14: XIHind III markers 
lanes 2 and 15: ~1 ng of ermE
lanes 3-12 and 16-24: gDNA from putative disruptants, cut with Sst I 
lanes 13 and 26: gDNA from untransformed G216, cut with Sst I 
lane 25: gDNA from putative G216/pPM3 isolate, cut with Sst I
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F igure 3.12 A utoradiogram  of m em brane carrying gDNA from G216
isolates probed with the ermE  gene
(lanes as in Figure 3.11)
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It was anticipated that the ermE control (1-7 kb in size) and the putative single- and 
double-crossovers (both approximately 5-4 kb in length) would show a single band to 
which the ermE probe hybridises. However, only the ermE control lit up on the 
autoradiogram (Figure 3.12). These results imply that the putative double­
crossovers and the putative single-crossover were actually wild-type for aroQ and 
provides more evidence that ermE is not a reliable resistance marker in S.coelicolor.
3.2.2 Attempted disruption of aroQ  with grmA
The aminoglycoside group of antibiotics, which includes streptomycin, neomycin, 
kanamycin and gentamicin, are antibacterial agents which inhibit protein synthesis by 
causing premature chain termination and misreading during translation, and block the 
initiation of replication of DNA. They also cause the incorporation of aberrant proteins 
into the cytoplasmic membrane, increasing its permeability which subsequently results 
in an increased uptake of the aminoglycosides.
The gentamicin-resistance gene had previously been cloned from the gentamicin 
producer Micromonospora purpurea and found to induce resistance to both gentamicin 
and kanamycin in M.purpurea, and also in S.lividans [Thompson et al., 1985]. In 
S.lividans strains containing the gentamicin/kanamycin resistance determinant, 
resistance to these aminoglycosides is due to methylation of the 16S ribosomes [Skeggs 
et al., 1987]. This gentamicin/kanamycin resistance determinant has been subcloned 
into the multicopy streptomycete plasmid pIJ702, and has been shown to encode a 
rRNA methylase protein which methylates a guanosine nucleoside of the 16S 
ribosomes, producing 7-methyl guanosine. This clone has subsequently been 
sequenced and named grmA (gentamicin resistance methyltransferase) [Kelemen et al., 
1991].
An alternative method of providing resistance to gentamicin exists in Gram-negative 
prokaryotes. The transposon Tnl696  was originally isolated from Pseudomonas 
aeruginosa due to its ability to induce transfer of plasmid R1033, into which it had 
inserted, between Gram-negative species [Rubens et al., 1979]. The transposon 
encodes resistance to gentamicin, streptomycin, chloramphenicol, sulfamethoxazole 
and mercuric chloride. It contains a gene, aacC l, which confers resistance to 
gentamicin in E.coli, and its product functions by acetylation of gentamicin. This gene 
has also been shown to induce gentamicin resistance in certain Streptomyces strains, 
including S.lividans [Muth et al., 1989], The bifunctionality of this gene would allow 
selection of a plasmid-borne gene disruption event in E.coli before transformation into
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Streptomyces.
3.2.2.1 D isruption of a plasm id-borne aroQ  gene with grmA
grmA is contained within an approximately 1-5 kb Sph UBamH I fragment of the 
pLST14 insert. This fragment has previously been subcloned, via the vector pIBI24 
along with a polylinker fragment from vector pLus801 creating p503, into the vector 
pGEM7 to generate plasmid p504. grmA was subcloned into pIBI24 to create pPM2 
using the Xba I and Pst I restriction endonucleases. The BamH I fragment of this 
plasmid contains the resistance gene, and was used to disrupt the plasmid-borne 
dehydroquinase-encoding gene (aroQ) of Streptomyces coelicolor by insertion into the 
internal BamR I site of this gene, creating plasmid pPM19 (Figure 3.13).
Plasmid pPM19 contains the origin of replication (ori) from E.coli, and all of the above 
subcloning procedures were performed in E.coli. However, this plasmid does not 
contain the Streptomyces ori, so will not replicate in a Streptomyces strain, and 
therefore should function as a suicide vector in S.coelicolor.
As a control, the actl region from S.coelicolor was also disrupted by the grmA gene. 
The actl gene cluster had previously been subcloned into the pUC18 vector and 
subsequently disrupted by insertion of the ermE  gene, encoding erythromycin 
resistance, into its coding region, creating plasmid pIJ5604. The ermE gene was 
removed from pIJ5604, and was directly replaced with the Kpn I fragment of p504, 
disrupting the plasmid-borne actl cluster with the gentamicin/kanamycin resistance 
marker, and creating plasmid pPM20. Like pPM19, pPM20 carries only the E.coli 
origin of replication, and also should function as a suicide plasmid in S.coelicolor.
3.2.2.2 Selection for grm A
The minimum inhibitory concentration (MIC) of gentamicin for protoplasts of 
S.coelicolor G216 was calculated by the growth of such protoplasts on R2 medium 
overlaid with varying amounts of gentamicin. Protoplasts grew on plates overlaid with 
10 |Lig/ml, but not on plates overlaid with 25 |Hg/ml or any greater amounts. The 
concentration of drug chosen for addition to plates was twice the lowest concentration 
on which untransformed protoplasts were unable to grow. Therefore, a concentration 
of gentamicin of 50 jig/ml agar was used for all subsequent S .co e lico lo r  
transformations. This figure was also the concentration chosen for selection in 
S.lividans [Skeggs et al., 1987].
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Figure 3.13 Disruption of a plasm id-borne aroQ  gene with grm A
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In order to allow transformation of protoplasts of S.coelicolor G216, the plasmids 
pPM19 and pPM20 were transformed into the dam' E.coli strains MB5386 and CB51, 
to circumvent the restriction barrier of S.coelicolor.
Transformants were selected by growth on L agar supplemented with ampicillin, and 
were streaked, along with DS941 as a negative control, onto L agar supplemented with 
gentamicin at concentrations ranging from 5 |Lig/ml to 20 |Lig/ml. Although all three 
strains grew on L agar without supplement, none of them grew on the gentamicin- 
containing agar, suggesting that (unlike the aacCl gene product) the grmA gene product 
is not expressed in E.coli, that its product does not methylate the 16S ribosomal 
component of E.coli, or that such methylation does not induce resistance to gentamicin 
in E.coli.
The ampicillin-resistant isolates of MB5386 were also streaked onto L agar 
supplemented with both chloramphenicol and ampicillin. Chloramphenicol selects for 
the transposon which is used for the insertion mutagenesis of the dam  gene of 
MB5386. Therefore, these two antibiotics, when used together, select for non- 
methylated pPM19 and pPM20 plasmids, which may be subsequently used for 
transformation of protoplasts of S.coelicolor. The dam' mutation in CB51 is a more 
stable, naturally-occurring mutation, and is non-selectable.
To test the efficacy of selection with gentamicin in S.coelicolor G216, protoplasts of 
G216 were transformed with pLST14, plated onto R2, and overlaid with thiostrepton 
(pLST14 is a derivative of pIJ702, and so contains a tsr resistance marker). 
Transformants were patched onto Soya supplemented with gentamicin or thiostrepton. 
All transformants grew on both plates.
3.2.2.3 Transformation of protoplasts of S.coelicolor  G216 with 
pPM19 and pPM20
Protoplasts of S.coelicolor G216 were transformed with approximately 5 |ig of non- 
methylated pPM19 or pPM20 plasmid DNA (isolated from either MB5386 or CB51 
E.coli transformants). Transformants were plated on R2 medium, supplemented with 
the aromatic amino acids for pPM19 transformations, and selected by overlaying with 
gentamicin after 16-20 hours incubation at 30°C.
These protoplasts were also transformed with 100 ng of pIJ487 plasmid DNA, plated 
on R2 medium and selected by overlaying with thiostrepton, to test the transformation 
competency of the protoplasts. The transformation efficiency of these protoplasts was
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calculated as approximately 3xl05/pg.
110 colonies from the G216(MB5386)/pPM19 plates, 20 colonies from the 
G216(CB51)/pPM19 plates, 13 from G216(MB5386)/pPM20 plates and one from the 
G216(CB51)/pPM20 plates were picked, and patched onto Soya agar supplemented 
with either gentamicin or no drug. One G216(CB51)/pPM20 colony [C20] was 
identified which grew on Soya supplemented with gentamicin. Three 
G216(MB5386)/pPM19 colonies [M19-1, M19-2, M19-4] grew on Soya 
supplemented with gentamicin but not with thiostrepton, as did one of the 
G216(CB51)/pPM19 colonies [C l9]. As no colonies grew on Soya supplemented 
with thiostrepton (an anticipated result in the control transformations since pPM20 does 
not contain the tsr resistance marker), these cells showed the resistance profiles of 
double-crossovers. However, since no single-crossovers (which it is anticipated are 
more likely to occur) were obtained, it was anticipated that these five isolates may have 
undergone a spontaneous mutation to produce resistance to gentamicin. To test their 
resistance profiles, the cells were again streaked onto Soya supplemented with either 
gentamicin or thiostrepton. All five isolates again showed resistance to gentamicin 
only.
These five isolates were grown in YEME liquid medium containing MgCl2 , glycine and 
gentamicin, and were grown to stationary phase at 30°C. Untransformed G216 
mycelia was grown in YEME supplemented with MgCl2 and glycine. Total DNA was 
prepared from each culture, and approximately 3 pg of DNA from each culture was 
digested with either Sst I or Sal I and run out on a 0-8% TAE gel. 5 ng of pLST14 
digested with Xho I (as a control for the grmA gene) and pIJ487 digested with Xba I 
(as a control for the tsr gene) were also run on the gel (Figure 3.15).
The DNA on the gel was transferred to nylon membrane by Southern blotting, and the 
membrane probed with radiolabelled aroQ from S.coelicolor. Genomic DNA isolated 
from the parental G216 strain would be expected to show two bands of unknown size 
when digested with Sal I, and a single 5 kb band when digested with Sst I. It was 
anticipated that the gDNA isolated from disruptants (double-crossovers) would show 
two bands (one the same as one of the bands from parental gDNA, the other 1 *7 kb 
larger than its parental copy) on an autoradiogram when digested with Sal I, and a 
single band (approximately 5 kb in size) when digested with Sst I. gDNA from an 
integrant (a single-crossover) would be expected to show three bands of unknown size 
when digested with Sal I, and two bands (approximately 4-5 kb and 7 kb in size) when 
digested with Sst I [see Figure 3.14], However, when the DNA was digested with
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Figure 3.15 gDNA from G216 isolates
lane 1: XIHind III
lane 2: 5 ng pLST14 cut with Xho I (-8-8 kb)
and 3 ng pIJ487 cut with Xba I (-6-2 kb) 
lanes 3, 9: gDNA from untransformed G216 cut with Sst I or Sal I respectively
lanes 4, 10 
lanes 5, 11 
lanes 6, 12 
lanes 7, 13 
lanes 8, 14
gDNA from M19-1 cut with Sst I or Sal I respectively 
gDNA from M l9-2 cut with Sst I or Sal I respectively 
gDNA from M l9-4 cut with Sst I or Sal I respectively 
gDNA from C 19 cut with Sst I or Sal I respectively 
gDNA from C20 cut with Sst I or Sal I respectively
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Figure 3.16 A utoradiogram  of m em brane carrying gDNA from G216 
isolates probed with a fragm ent containing the aroO  gene from 
S .co e lico lo r  
(lanes as in Figure 3.15)
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was digested with Sal I, all six lanes exhibited the same two bands, approximately 3 kb 
and 1-5 kb in size, suggesting that the five gentamicin-resistant isolates were actually 
wild-type for aroQ (Figure 3.16).
3.2.2.4 A ttem pted insertion of a Streptomyces ori into pPM19
An alternative method for disruption of the chromosomal copy of aroQ would be to 
transform protoplasts of G216 with a plasmid which replicates stably in S.coelicolor, 
and contains a disrupted copy of the aroQ gene. Transformants could be grown on a 
non-selective medium, which would allow plasmid loss. It is possible that a copy of a 
plasmid could become integrated into the chromosome due to homologous 
recombination between the chromosomal and plasmid-borne copies of aroQ , 
particularly when selection for maintenance of the plasmid in the cell is removed.
Therefore, insertion of a Streptomyces plasmid origin of replication (ori) into pPM19 
was desired. This would prevent the plasmid from functioning as a suicide vector, and 
hopefully increase the likelihood of recombination between the plasmid and 
chromosome. After growth (up to three rounds) on a non-selective medium, cells 
would be patched onto selective media to screen for those which had not lost one or 
even both of the resistance genes on the plasmid. Colonies which had lost neither 
resistance would undergo further rounds of growth on a non-selective medium, 
followed by growth on selective media; those which had lost resistance to thiostrepton 
would be investigated for the possibility of having undergone a double-crossover 
event.
To convert plasmid pPM19 into a vector which was able to replicate stably in 
S.coelicolor, the streptomycete plasmid origin of replication, contained in the 
Streptomyces essential region, was isolated from pIJ487 by digestion with Sst II, and 
subcloned into pBluescript II, generating pPM32 (Figure 3.17). The origin was 
isolated from pPM32 using Kpn I and Sst I, and subcloned into pMTL23, creating 
pPM33. Both of the subcloning procedures described above were performed in the 
E.coli strain DS941.
The streptomycete plasmid origin was isolated from pPM33 (isolated from MB5386, as 
restriction by Xba I is partially-sensitive to Dam methylation) by digestion with Xba I 
and Sea I (Sea I cuts the vector DNA into two fragments, each having Xba VSca I 
ends, preventing either of these fragments from ligating to the Xba I-restricted pPM19 
DNA), and was ligated to pPM19 (isolated from MB5386) which had been digested
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Figure 3.17 Insertion of a Streptomyces ori into pPM19
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with Xba I and had also been dephosphorylated, to create pPM36. It was thought to be 
possible to transform the ligation mix into E.coli, select with ampicillin, and isolate 
plasmid DNA from transformants to analyse for insertion of the streptomycete ori. 
Plasmid DNA showing the correct restriction pattern could then be transformed into a 
non-methylating strain of E.coli, and subsequently be transformed into protoplasts of 
S.coelicolor. However, no transformants of E.coli containing pPM36 were generated.
Alternatively, as both plasmids pPM19 and pPM33 were isolated from a non- 
methylating strain of E.coli prior to digestion and ligation to generate pPM36, the 
ligation mixture could be transformed directly into protoplasts of S.coelicolor. Any 
true transformants would contain either a stably-replicating plasmid (pPM36) or an 
integrated plasmid (either pPM36, or pPM19 produced by religation). However, this 
method of disruption was unsuccessful since no transformants were obtained when 
protoplasts of G216 were transformed with the pPM36 ligation mixture.
A third method of transformation of S.coelicolor with pPM36 was also attempted, 
involving transformation of the pPM36 ligation mixture into a non-methylating strain of 
E.coli (MB5386), dilution of the transformation mixture with 1 ml of 2xYT medium 
supplemented with ampicillin, and growing the culture directly at 37°C until the cells 
reached stationary phase. Plasmid DNA was subsequently isolated from this culture, 
and transformed directly into protoplasts of S.coelicolor G216, which were plated onto 
R2 medium and overlaid with thiostrepton. However, again no transformants were 
obtained using this method. Thus, none of the three methods attempted for subcloning 
of the streptomycete plasmid ori into pPM19 were successful.
3.3 Discussion
These results suggest that S.coelicolor has a high rate of spontaneous mutation to 
produce resistance to erythromycin and possibly also to gentamicin (although when 
tested, no non-transformed protoplasts of G216 grew when overlaid with a 
concentration of gentamicin higher than 10 (ig/ml (see section 3.2.2.2). Therefore, 
these antibiotics appear not to be good selecting agents in S.coelicolor under the 
conditions used in this work. Resistance to thiostrepton also appears to occur 
spontaneously in S.coelicolor. However, as this antibiotic has long been used as a 
reliable selecting agent in S.coelicolor, it is possible that spontaneous mutations 
induced by growth in the presence of erythromycin or gentamicin induce multiple 
resistance to antibiotics. This situation is most likely to occur through either mutations 
in membrane proteins which prevent the uptake of antibiotics, or mutations which
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increase the rates of efflux of the antibiotics. However, it is also possible that the dual 
spontaneous resistance to erythromycin and thiostrepton could arise by spontaneous 
changes in the ribosomes of resistant cells, as resistance to both of these antibiotics may 
be brought about by methylation of adenosine residues in the ribosomes (see 
3 .2 .1 .1 ) .
Although transformants showing resistance to antibiotics may arise through 
spontaneous mutations, it might also be anticipated that some cells exhibiting the correct 
resistance profile for a disruptant would have occurred due to double recombination 
events, causing insertion of the resistance gene into the chromosomal copy of aroQ. 
The lack of such disruptants may be due to the existence of a functional dehydroquinase 
being essential to the survival of the cell. Although mutations in the aroD gene of 
E.coli have arisen, which are auxotrophic for the three aromatic amino acids (or the 
end-product of the shikimate pathway, chorismate), no aroD disruptants have been 
produced in E.coli, despite the efforts of three separate research groups. This implies 
that a null mutation of the gene encoding dehydroquinase is lethal to the cell. This, in 
turn, would suggest that the aroD mutants which have been identified contain a leaky 
mutation which allows a low but sufficient level of flux through the pathway to produce 
some other essential product of the pathway (see Figure 1.3 for examples), but not 
sufficient flux for the synthesis of the required amounts of the aromatic amino acids. 
However, a null mutation would prevent any flux through the pathway, and thus 
impede the synthesis of this essential product (or at least a product which has not been 
supplied in any of the growth media which have been used when trying to isolate null 
mutations of the aroD or aroQ genes from E.coli and S.coelicolor, respectively).
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4.1 Introduction
As the type II 3-dehydroquinase enzyme from S.coelicolor has a high Km, it is possible 
that it may also have a high flux control coefficient, and exert a high level of control 
over flux through the shikimate pathway, particularly when the rate of flux is high (for 
example during secondary metabolism). Therefore, it is desirable to overexpress the 
dehydroquinase enzyme in an attempt to upregulate the flux.
It was intended to achieve overexpression by subcloning of the aroQ gene, which 
encodes the type II dehydroquinase of S.coelicolor, into high copy-number 
Strep tom yces  vectors. pIJ487 was chosen as the most suitable vector for 
overexpression. It is a plJlOl-based vector which contains an E.coli transcription 
terminator upstream of the multiple cloning site, and a promoterless aminoglycoside 
phosphotransferase gene, neo, downstream of the cloning site [Ward et al., 1986]. 
Therefore, this plasmid is a suitable vector for the overexpression of a gene from its 
own promoter, and also for use as a promoter-probe vector.
The plasmid pUGTl is a pIJ487-based vector into which the thiostrepton-inducible 
tip A promoter has previously been subcloned [Ingham et al., 1995]. This promoter 
allows transcription towards the neo gene, and lies on the far side of the multiple 
cloning site relative to the neo gene. Therefore, a promoterless gene may be expressed 
from pUGTl, its expression being regulated by the presence of thiostrepton in the 
medium.
4.2 Results
4.2.1 Construction of plasmids facilitating overexpression
The 3 kb Hind III/ZscoR I fragment containing the aroQ  gene from S.coelicolor 
[P.White, unpublished results] was isolated from pPW63, subcloned into the pGEM7 
vector to generate pPM26 (Figure 4.1), transformed into E.coli DS941 competent 
cells, and plated onto L agar supplemented with ampicillin. The aro<2-containing insert 
was isolated from pPM26 using the Sst I restriction enzyme, and was subcloned into 
pIBI25 which had been linearised by Sst I and dephosphorylated, creating plasmid 
pPM265. The insert was re-isolated from pPM265 by digestion with Hind III, and 
was ligated into pIJ487 which had been digested with Hind III and dephosphorylated, 
creating plasmid pPM27. Alternatively, the aro<2-containing fragment was isolated 
from pPM26 with the Sst I restriction enzyme, and ligated into pUGTl which had been
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Figure 4.1 Construction of plasmids enabling overexpression of dehydroquinase
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linearised with Sst I and dephosphorylated, creating plasmid pPM28.
4.2.2 Transformation of protoplasts of S.lividans
Since both ligation mixes contained DNA which had been isolated from a dam- 
methylating E.coli strain DS941, and any resultant plasmids would therefore be 
degraded if transformed directly into protoplasts of S.coelicolor, the resultant plasmids 
were initially transformed into protoplasts of S.lividans strains TK54 or TK64. The 
transformation mixtures were plated onto R2 regeneration medium supplemented with 
thiostrepton to select for transformants. A single thiostrepton-resistant transformant 
was obtained when protoplasts of TK54 were transformed with each of the pPM27 and 
pPM28 ligation mixes, and a single putative pPM27-containing colony was obtained 
from transformation of protoplasts of TK64.
4.2.3 Investigation of overexpression of dehydroquinase
In order to ascertain whether any of the transformants contained plasmids which were 
not merely religations, the three colonies were grown in liquid medium supplemented 
with thiostrepton, and isolation of plasmid DNA was attempted from each. Although 
alkaline lysis using the methods of both Birnboim & Doly (2.4.2.4) and Kieser 
(2.4.2.5) were attempted, plasmid DNA could not be obtained from any of these three 
cultures.
An alternative method to investigate whether any of these three isolates was 
overexpressing the type II dehydroquinase enzyme by running the total cellular protein 
extracts on a denaturing polyacrylamide gel was subsequently attempted (2.5.4), 
Although neither the putative TK64/pPM27 isolate nor the putative TK54/pPM28 
isolate exhibited overexpression of a protein of the appropriate size on the gel, the 
putative TK54/pPM27 isolate did show an overexpressed protein of approximately 15- 
18 kDa in size (the type II dehydroquinase enzyme from S.coelicolor was estimated at 
16 kDa [White et al., 1990]). This isolate was, therefore, confirmed as TK54/pPM27.
To ensure that this protein was due to the presence of an insert in pIJ487, protein 
extracts from TK54/pPM27, untransformed TK54 and TK24/pIJ487 were run out on a 
gel by SDS-PAGE (Figure 4.2). The overexpressed protein which had been 
identified previously was only evident in the extract from TK54/pPM27. Therefore, it 
was assumed that this isolate was indeed overexpressing the type II dehydroquinase 
from S.lividans.
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Figure 4.2 Crude protein extract from TK54/pPM27 exhibiting
overexpression of the dehydroquinase from  S.coelicolor
lane 1: VII-L protein m arkers (14-2 / 20 1 / 24 / 29 / 36 / 45 / 66 kDa)
lane 2: approx. 50 fig crude protein extract from TK24/pIJ487
lane 3: approx. 50 pg crude protein extract from TK54
lane 4: approx. 50 pg crude protein extract from TK54/pPM27
lane 5: low molecular weight protein m arkers
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4.2.4 Assaying for dehydroquinase activity
TK54 and TK54/pPM27 were grown in 200 ml YEME supplemented with glycine and 
magnesium chloride (and also with thiostrepton in the case of the overexpressing 
strain). Crude protein extracts were obtained from these cultures (2.5.1), which were 
assayed for the presence of dehydroquinase, with each assay being repeated a minimum 
of three times and the averages calculated (2.5.2). Total protein concentrations from 
each of the crude extracts were calculated using the Bradford's assay.
Strain Activity 
(Units / ml)
Protein cone 
(mg / ml)
Specific activity 
(Units / mg)
Standard
Deviation
(°n-l)
TK54 1*9 7-3 0*26 014
TK54 / pPM27 5-0 2*6 1-92 0*27
Table 4.1 Activities of dehydroquinase and total protein 
concentrations in the crude extracts
N.B. One unit of enzyme activity is defined as the amount of enzyme required 
to catalyse the conversion of ljLtmol of substrate or the synthesis of ljimol of 
product in one minute.
As can be seen from Table 4.1, the overexpressing strain (TK54/pPM27) exhibits an 
elevated level of dehydroquinase activity compared to the untransformed strain of 
S.lividans (TK54). The specific activities for the two strains were calculated by 
dividing the activities derived from the assays by the protein concentrations estimated 
by the Bradford’s assay. The TK54/pPM27 strain shows a 7-38-fold increase in 
activity relative to the untransformed TK54 strain. Therefore, it may be concluded that 
the plasmid pPM27 contained in this strain is indeed causing overexpression of an 
active form of the type II dehydroquinase enzyme from S.coelicolor.
4.3 Discussion
The type II dehydroquinase enzyme from S.coelicolor has been overexpressed in 
S.lividans, and produced greater than a 7-fold increase in dehydroquinase activity in 
this strain relative to its untransformed parent strain. It was intended that this plasmid 
would subsequently be transformed into S.coelicolor, but this experiment has yet to be
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attempted due to the difficulty in isolating plasmid DNA from the overexpressing strain. 
This experiment would facilitate analysis of the flux through the shikimate pathway to 
identify whether an increase in the activity of the dehydroquinase enzyme would 
produce any consummate increase in metabolic flux through this pathway.
pPM27, which facilitates the overexpression of dehydroquinase, is a pIJ487-based 
plasmid. pIJ487 is a multicopy Streptomyces vector which lacks a promoter 
immediately upstream of the multiple cloning site, and therefore should not cause any 
vector-driven transcription of genes in a fragment which has been inserted into the 
multiple cloning site. Thus, any expression from a gene (or genes) contained on such 
an insert must be due to the existence on the insert of a promoter which lies in the 
correct orientation with respect to the gene, and is functional in the particular strain in 
which the construct is analysed. Therefore, expression of the type II dehydroquinase 
from S.coelicolor in TK54/pPM27 must be due to the presence of a promoter upstream 
of, and in the correct orientation to, the aroQ gene on the inserted fragment. This 
promoter is presumably the natural promoter for the aroQ gene in S.coelicolor.
As there is apparently only a single protein which is overexpressed in TK54/pPM27 
(relative to the untransformed TK54 strain), it is assumed that the aroQ gene of 
S.coelicolor does not exist as part of an operon which is wholly, or at least partially, 
contained on this 3 kb fragment, and therefore that this promoter lies immediately 
upstream of the aroQ gene on this fragment. It is feasible that another protein lies 
downstream of, and is transcriptionally coupled to, the aroQ gene, but that only its 5' 
end lies on this fragment, as there are approximately only 800 bp downstream of the 
aroQ  gene on this fragment. This could mean that only the N-terminus of this 
downstream protein is actually expressed from the insert in pPM27, and might not be 
seen on the protein gel.
The regions upstream and downstream of aroQ are currently being sequenced in this 
laboratory to ascertain the existence of other genes, and in an attempt to identify any 
potential promoter-like sequences.
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5.1 Introduction
The aroA gene of S.coelicolor encodes the enzyme EPSP synthase, which catalyses 
the conversion of shikimate-3-phosphate to EPSP. This enzyme has been widely 
studied as it is the target of glyphosate, which has herbicidal activity. Therefore, the 
aroA gene is a target for mutation to produce a glyphosate-resistant enzyme in crop 
plants. aroA has also been disrupted in virulent bacteria for use as live vaccines [for 
example, Hoiseth & Stocker, 1981].
Cloning of aroA would allow gene disruption to be performed, which would cause a 
blockage late in the pathway (EPSP synthase catalyses the fifth step of six in the 
shikimate pathway), and allow analysis of flux through the majority of the pathway. 
Chorismate synthase is a notoriously difficult enzyme to assay for, and so was not 
chosen. EPSP synthase was chosen for investigation as it is the enzyme immediately 
preceding chorismate synthase.
Ideally, purification of EPSP synthase from S.coelicolor, followed by N-terminal 
protein sequencing, would have enabled the design of oligonucleotides against this 
protein sequence. Such oligonucleotides would have then been used for PCR cloning 
or genomic cloning of aroA from S.coelicolor. However, EPSP synthase has not been 
purified from Streptomyces, and so alternative approaches were utilised.
5.2 Results
5.2.1 Design of oligonucleotides primer 1 and primer 2
At the beginning of this investigation, deduced amino acid sequences were available 
of the EPSP synthase enzymes from nine species of prokaryotes, lower eukaryotes 
and plants. When these amino acid sequences were lined up, they showed extremely 
good similarity across a number of highly conserved regions (Figure 5.1). Two of 
these regions were used for the design of oligonucleotide primers. Using a codon 
preference table compiled from 67 streptomycete coding regions (Figure 5.2) 
[Taylor, 1992], the most likely DNA sequences which could encode these predicted 
amino acid sequences were derived, and were used as templates for the design of 
oligonucleotides (Figure 5.3).
Prim er 1 w a s d esig n ed  against a reg ion  o f  seq u en ce (NAGTAMRP, resid u es 176-183 in  
Figure 5.1) w h ich  is  ex trem ely  w e ll con served  in  the n in e seq u en ces  a v a ila b le , and is
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A .nidulans 
S. cerevisiae 
E .coli 
S . typhimurium 
P .hybrida 
P .sativum 
L .esculentum 
A. thaliana 
B .pertussis
1 50
KCLAAYGLPT SLKDARIRKL TAGKHCSVDQ LMFNMALDKK NDGPKKKIVL 
KILVAYGLPV SPDEKWFKEL TLHKKTPLDI LLKKMSIDKK NEGSKKKW I
........... MAQIN NMAQGIQTLN PNSNFHKPQV PKSSSFLVFG SKKLKNSANS
. MAQISSMAQ GIQTLSLNSS NLSKTQKGPL VSNSLFFGSK KLTQISAKSL
. MAQVSRICN GVQNPSLISN LSKSSQRKSP LSVSLKTQQH PRAYPISSSW
51 100
A.nidulans LSAIGTPYET RASW ANEDI R W L A P S IE V  H PG V A ..H SS NVICAPPGSK
S .cerevisiae LESIGKCYGD SAQFVSDEDL RFILTDETLV YPFKDIPADQ Q K W IPPG SK
E.coli  ME SLTLQPIARV DGTINLPGSK
S . typhimurium  ME SLTLQPIARV DGAINLPGSK
P.hybrida MLVLKKDSIF MQKFCSFRIS ASVATAQKPS E IV L Q P IK E I SGTVKLPGSK
P. sativum  KPSTAP E IV L E P IS E I  SGTITLPGSK
L.esculentum GVFKKDSVLR W R K S S F R IS  ASVATAEKPH E IV L X PIK D I SGTVKLPGSK
A. thaliana GLKKSGMTLI GSELRPLKVM SSVSTAEKAS E IV L Q P IR E I SGLIKLPGSK
B.pertussis  MSGLA YLDLPAARLA RGEVALPGSK
A .nidulans 
S .cerevisiae 
E.coli 
S. typhimurium 
P .hybrida 
P .sativum 
L .esculentum
A. thaliana
B . pertussis
101
SISNRALVLA
SISNRA LILA
TVSNRALLLA
SVSNRALLLA
SLSNRILLLA
SLSNRILLLA
SLSNRILLLA
SLSNRILLLA
SISNRVLLLA
ALGSGTCRIK
ALGEGQCKIK
ALAHGKTVLT
ALPCGKTALT
ALSEGTTW D
ALSEGTTW E
ALSEGRTW D
ALSEGTTW D
ALAEGSTEIT
NLLHSDDTEV
NLLHSDDTKH
NLLDSDDVRH
NLLDSDDVRH
NLLSSDDIHY
NLLDSEDIHY
NLLSSDDIHY
NLLNSDDINY
GLLDSDDTRV
MLNALERLGA
MLTAVHELKG
MLNALTALGV
MLNALSALGI
MLGALKTLGL
MLEALKTLGL
MLGALKTLGL
MLDALKRLGL
MLAALRQLGV
150
ATFSWEEEGE 
ATISWEDNGE 
SYTLSADRTR 
NYTLSADRTR 
HVEEDSANQR 
RVEDDKTTQR 
HVEDDNENQR 
NVETDSENNR 
S V ................GE
A .nidulans 
S .cerevisiae 
E .coli 
S. typhimurium 
P . hybri da 
P.sativum 
L . esculentum 
A. thaliana 
B . pertussis
151
VLWNGKGGNL 
TVWEGHGGST 
C E I I . GNGGPL 
C D IT . GNGGAL 
A W E . GCGGLF 
A W E . GSGGLF 
A IV E . GCGGQF 
A W E . GCGGIF 
V A D .. GCVTIE
Q A SS SP . . . .  
LSACADP. . .  
HAEGAL. . . .  
RAPGAL. . . .  
PVGKESKEEI 
PTGRESKDEV 
PVGKKSEEEI 
PASID SK SD I 
GVARFPTEQA
. LYLG
. LYL
ELFL
ELFL
QLFL
NLFL
QLFL
ELYL
G N. 
G N.
AGTA
F L T . TVAT
If l t s l a a l
AGTA M RPL.AA.AL 
GlNAGTA M RPL.AA.A L 
GNAGTA MRP LTAAVTV 
GNAGTA MRP LTAALVA 
GNAGTA MRPLTAAVTV 
GNAGTA MRPLTAAVTA 
ELFLG N A G T^m hPtLTAALAL
2 0 0
LANSSTVDS 
VNSTSSQKY 
CLGSND. 
CLGQNE. 
AGGNSR. 
AGGNTR. 
AGGHSR. 
AGGNAS. 
MGGDYRLS
A .nidulans 
S .cerevisiae 
E.coli 
S . typhimurium 
P . hybri da 
P . sativum 
L . esculentum
A. thaliana
B . pertussis
2 0 1
SVLTGNNRMK 
IVLTGNARMQ 
IVLTGEPRMK 
IVLTGEPRMK 
YVLDGVPRMR 
YILDGVPRMR 
YVLDGVPRMR 
YVLDGVPRMR 
. . . GVPRMHE
QRPIGDLVDA
QRPIAPLVDS
ERPIGHLVDA
ERPIGHLVDS
ERPISDLVDG
ERPIGDLVSG
ERPIGDLVDG
ERPIG D LW G
RPIGDLVDAL
LTANVLPLNT
LRANGTKIEY
LRLGGAKITY
LRQGGANIDY
LKQLGAEVDC
LKQLGADVDC
LKQLGAEVDC
LKQLGADVEC
RQFGAGIEYL
SKGRASLPLK 
LNNEGSLPIK 
LEQENYPPLR 
LEQENYPPLR 
FLGTKCPPVR 
FLGTNCPPVR 
S LGTNC P PVR 
TLGTNCPPVR 
GQAGYPPLRI
250
IAASGGFAGG 
VYTDSVFKGG 
. . LQGGFTGG 
. . LRGGFTGG 
IVSKGGLPGG 
IIG K G G LPG . 
IVSKGGLPGG 
VNANGGLPGG 
GGGSIRVDGP
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A .nidulans 
S .cerevisiae 
E.coli 
S. typhimurium 
P.hyhrida 
P.sativum 
L .esculentum
A .thaliana
B .pertussis
251
NINLAAKVSS
RIELAATVSS
NVDVDGSVSS
DIEVDGSVSS
KVKLSGSISS
KVKLSGSISS
KVKLSGSISS
KVKLSGSISS
VRVEGSVSSQ
QYVSSLLMCA
QYVSSILMCA
QFLTALLMTA
QFLTALLMTA
QYLTALLMAA
QYLTALLMAA
QYLTALLMAA
QYLTALLMSA
FLTALLMAAP
PYAKEPVTLR
PYAEEPVTLA
PLAPEDTVIR
PLA PK D TIIR
PLALGDVEIE
PLALGDVEIE
PLALGDVEIE
PLALGDVEIE
VLARRSGQDI
LVGGKPISQP
LVGGKPISKL
IKGDLVSKPY
VKGELVSKPY
IID K L IS V P Y
IID K L IS V P Y
IID K L IS V P Y
IVDKLISVPY
T IE W G E L IS
300
YIDMTTAMMR 
YVDMTIKMME 
ID ITLN LM . K 
ID ITLN LM .K  
VEMTLKLMER 
VEMTLKLMER 
VEMTLKLMER 
VEMTLKLMER 
K PY IEITLN L
A .nidulans 
S . cerevisiae 
E.coli 
S. typhimurium 
P . hybri da 
P. sativum 
L. esculentum
A . thaliana
B .pertussis
301
SFGIDVQKST
KFGINVETST
TFGVEIENQH
TFGVEIANHH
FGISVEHSSS
FGVSVEHSDN
FGVFVEHSSG
FGVSVEHSDS
MARFGVSVRR
TEEHTYHIPQ 
TEPYTYYIPK 
YQQFW  . . . K 
Y Q Q FW . . . K 
WDRFFV. . . R 
WDRFLV. . . H 
WDRFLV. . . K 
WDRFFV. . . K 
DGWRAFTIAR
G . . RYVNPAE 
G . . HYINPSE 
GGQSYQSPGT 
GGQQYHSPGR 
GGQKYKSPGK 
GGQKYKSPGN 
GGQKYKSPGK 
GGQKYKSPGN 
DAVYRGPGRM
YVIESDASCA
YVIESDASSA
YLVEGDASSA
YLVEGDASSA
AFVEGDASSA
AFVEGDASSA
AFVEGDASSA
AYVEGDASSA
AIEGDASTAS
350
TYPLAVAAVT
TYPLAFAAMT
SYFLAAAAIK
SYFLAAGAIK
SYFLAGAAVT
SYFLAGAAVT
SYFLAGAAVT
SYFLAGAAIT
YFLALGAIGG
A .nidulans 
S . cerevisiae 
E.coli 
S . typhimurium 
P.hybrida 
P .sativum 
L.esculentum
A . thaliana
B .pertussis
351
GTTCTVPNIG 
GTTVTVPNIG 
GGTVKVTGIG 
GGTVKVTGIG 
GGTITVEGCG 
GGTITVIGCG 
GGTVTVEGCG 
GETVTVEGCG 
G P . VRVTGVG
SASLQGDARF 
FESLQGDARF 
RNSMQGDIRF 
RKSMQGDIRF 
TNSLQGDVKF 
TSSLQGDVKF 
TSSLQGDVKF 
TTSLQGDVKF 
ED SIQ G D V ..
AVE. . . . VLR 
A R D .. . . VLK
AD.............VLE
AD.............VLE
A E .............VLE
A E .............VLE
A E .............VLE
A E .............VLE
A F . . . . AATL
PMGCTVEQTE 
PMGCKITQTA 
KMGATICWGD 
KMGATITWGD 
KMGAEVTWTE 
KMGAKVTWTE 
KMGAEVTWTE 
KMGCKVSWTE 
AAMGADVRYG
400
TSTTVTGPSD 
TSTTVSGPPV 
D Y I S C T . . . .  
D F I A C T . . . .  
NSVTVKGPPR 
NSVTVTGPPR 
NSVTVKGPPR 
NSVTVTGPPR 
PGWIETRGVR
A .nidulans 
S .cerevisiae 
E.coli 
S. typhimurium 
P.hybrida 
P.sativum 
L .esculentum
A .thaliana
B .pertussis
401
GILRATSKRG 
GTLKPLKHVD 
. . . . RG 
. . . . RG 
SSSGRK 
DSSGRK 
NSSGMK 
DAFGMR 
VAEGGR
Y . . GTNDRCV 
MEPMTDAFLT 
ELNAIDMDMN 
ELHAIDMDMN 
HLRAIDVNMN 
VLQGIDVNMN 
HLRAIDVNMN 
HLRAIDVNMN 
. LKAFDADFN
PRCFRTGSHR 
ACW AAISHD 
HIPDAAMTIA 
HIPDAAMTIA 
KMPDVAMTLA 
KMPDVAMTLA 
KMPDVAMTLA 
KMPDVAMTLA 
LIPDAAMTAA
PMEKSQTTPP
SDPNSANTTT
TAALFAKGTT
TTALFAKGTT
WALYADGPT
W ALFANGPT
W ALFADGPT
W ALFADGPT
TLALYADGPC
450
VSSGIANQjRV 
IE .G IA N O R V  
RLRNIYNpRV 
TLRNIYN WRV 
AIRDVAS WRV 
AIRDVAS WRV 
TIRDVASWRV 
TIRDVAS WRV 
RLRNIG3WRV
A .nidulans 
S .cerevisiae 
E . coli 
S . typhimurium 
P . hybri da 
P.sativum 
L .esculentum 
A . thaliana
B .pertussis
451
IKAMK 
I  LAMA 
LFAMA 
LFAMA
k e t e p Jm i a i c
KETEFMIAIC
KETEFMIAIC
KETEFMIAIC
K E T D F
K E T D F
IHAMH
DELAKFGVIC
TELAKFGVKT
TELRKVGAEV
TELRKVGAEV
TELRKLGATV
TELRKLGATV
TELRKLGATV
TELRKLGATV
TELEKLGAGV
REHDDGLE...................IDGIDR
TELPDGIQVH GLNSIKDLKV
EEGHDY.........................IR IT P P
EEGHDY.........................IR IT P P
EEGPDY........................ C I IT P P
EEGPDY........................ C V ITPP
VEGSDY........................ C I IT P P
EEGSDY........................ C V ITPP
QSGADW........................ LEVAPP
500
SNLRQPVGGV 
PSDSSGPVGV 
EKLNF. . AEI  
AKLQH. 
EKLNV. 
EKLNV. 
EKLNV. 
KKVKT.
ADI 
T D I 
. T S I  
T E I 
. A E I
E P G G W D . A H I
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501
A.nidulans FCYDDHRVAF S F S V .............. LSLVTPQ
S.cerevisiae CTYDDHRVAM SFSLLAGMVN SQNERDEVAN
E .coli ATYNDHRMAM C F S ................. LVALSDT
S . typhimurium GTYNDHRMAM C F S ................. LVALSDT
P . hybri da DTYDDHRMAM A F S ................. LAACADV
P.sativum DTYDDHRMAM A F S ................. LAACGDV
L .esculentum DTYDDHRMAM A F S ................. LAACADV
A. thaliana DTYDDHRMAM A F S ................. LAACADV
B .pertussis GTWDDHRMAM C F L ................. LAAFPAA
551 559
A .nidulans LRQLFKVKL
S.cerevisiae LH
E.coli LARISQAA. .
S . typhimurium LARM STPA..
P. hybri da LQQYSKH. . .
P .sativum LE RF TKH . . .
L .esculentum LQKYSKH. . .
A.thaliana LERI TKH. . .
B .pertussis YAGLLAARD.
550
P T L IL E K E ^ / Gp!]wP3WWDT 
PVRILERH StI QKT|jpbwWDV 
PVTILDPKST AKTFPdIyFEQ 
PVTILDPKCT AKTFPDj'
PVT INDPG FTTT3KTF P &
PVTIKDPGCT 
PVTIKNPGCT 
PITINDSG CT 
v.RiLDPqdv
YFEQ 
JYFDV
r k t f p d I y f q v
RKTFPDYFEV
RKTFPD^FQV
skTFPD(yFDV
Figure 5.1 Line-up of the deduced amino acid sequences of the EPSP 
synthases from nine species of bacteria, plants and lower eukaryotes
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completely conserved in six of these sequences. It contains a proline residue 
(conserved in seven of the sequences), substitution of which with serine induces an 
increase in tolerance to glyphosate [Stalker et al., 1985; Sost & Amrhein, 1990; 
Stallings et al., 1991]. This consensus region also contains a glycine residue (Gly-96 
in E.coli) which is conserved in all nine sequences, and which has also been 
implicated in the binding of both PEP and glyphosate to the enzyme, since 
substitution of this amino acid induces an increase in tolerance to glyphosate of up to 
500-fold [Sost & Amrhein, 1990; Padgette et al., 1991]. Indeed, the region against 
which primer 1 was designed is included in a highly conserved consensus region 
(90LxLGNAGTAxRxL102, where x denotes a non-conserved residue) identified in an 
alignment of the EPSP synthase sequences from Gram-negative bacteria, plants and 
lower eukaryotes [Padgette et al., 1991].
Primer 2 was designed against the consensus region CTAKTFPD (residues 539-546 in 
Figure 5.1), which is fairly well conserved amongst the nine enzyme sequences, and 
is completely conserved in two of the three bacterial sequences. This region contains 
a cysteine which has been suggested as lying proximal to the binding-site for S3P 
[Padgette et al., 1988a].
These oligonucleotides were intended to be used as primers for PCR cloning of the 
aroA gene. Therefore, primer 1 (the N-terminal oligonucleotide) was designed to 
anneal to the coding strand of the DNA, and primer 2 (the C-terminal 
oligonucleotide) designed against the reverse of the coding strand, so that it anneals to 
the non-coding strand (see Figure 5.4).
The alanine residues contained in the region against which primer 1 was designed 
may be encoded by any one of four nucleotide triplets, which differ only in the 
nucleotide in the third position. According to the codon preference table, the two 
triplets encoding alanine which are most commonly used in Streptomyces genes, GCG 
and GCC, encode approximately 92% of the alanine residues in the proteins analysed 
to date. Therefore, (GC) degeneracies were incorporated into the oligonucleotide to 
represent the third nucleotide of these alanine codons (Figure 5.3). A similar 
situation occurred with the triplets encoding the glycine and arginine residues, where 
(GC) degeneracies were also used to represent the third nucleotides of these codons.
At the third residue of the region against which primer 2 was designed, there are four 
different amino acids in the nine sequences (glycine in the two eukaryote sequences, 
alanine in two of the bacterial sequences with serine in the other one, and arginine in 
the four plant sequences). Alanine was included in the predicted protein sequence at
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G A T C
G ly 19 G lu 81 V a l 39 A la 33 G
G ly 10 G lu 19 V a l 2 A la 4 A
G G ly 8 A sp 4 V a l 4 A la 3 T
G ly 64 A sp 96 V a l 56 A la 59 C
A rg 6 L y s 95 M et 100 T h r 30 G
A rg 1 L y s 5 H e 3 T h r 3 A
A S e r 3 A sn 4 l i e 5 T h r 2 T
S e r 28 A sn 96 l i e 92 T h r 65 C
T rp 100 END 14 Leu 3 S e r 26 G
END 83 END 3 Leu 0 S e r 3 A
T Cys 13 T y r 5 Phe 1 S e r 1 T
Cys 87 T y r 95 Phe 99 S e r 39 C
A rg 36 G in 93 Leu 55 P ro 52 G
C
A rg 5 G in 7 Leu 0 P ro 2 A
A rg 7 H is 6 Leu 2 P ro 3 1
A rg 46 H is 94 Leu 39 P ro 43 C
Figure 5.2 Codon preference table for 67 genes from Streptomxces 
N.B. a) The first nucleotide of each codon is provided in the left-hand 
column; the second nucleotide is shown in the top row; the 
third nucleotide is shown in the right-hand column
b) The figures show the relative use (expressed as a percentage) 
of each nucleotide triplet in encoding each amino acid in the 
67 genes analysed 
Data taken from Taylor, 1992
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Primer 1:
Predicted protein sequence:
N 176-Asn Ala Gly Thr Ala Met Arg Pro-183 C
Derived DNA sequence (non-coding strand):
5' -AAC GCn GGn ACn GCn ATG CGn CCn- 3'
Primer sequence:
5' -AAC GC(GC) GG(GC) AC(GC) GC(GC) ATG CG(GC) C- 3'
96% 92% 83% 95% 92% 100% 82% 100%
Primer 2:
Predicted protein sequence:
N 539-Cys Thr Ala Lys Thr Phe Pro Asp-546 C
Derived DNA sequence (non-coding strand):
5' -TGC ACn GCn AAG ACn TTC CCn GAC- 3'
Derived DNA sequence (coding strand):
3' -ACG TGn CGn TTC TGn AAG GGn CTG- 5'
Reverse of derived DNA sequence (coding strand):
5' -GTC nGG GAA nGT CTT nGC nGT GCA- 3’
Primer sequence :
5' -GTC (GC)GG GAA (GC)GT CTT (GC)GC (GC)GT GC- 3' 
96% 95% 99% 95% 95% 82% 95% 87%
Figure 5.3 Design of primer 1 and primer 2 for cloning of aroA.
a) (GC) denotes degeneracies, where 50% of the oligonucleotides 
synthesised have a G at this position, the other 50% a C
b) Figures presented under the primer sequences are the percentage use 
of each codon for the amino acids which they encode in the 67 
streptomycete coding regions used in the codon preference table 
[Taylor, 1992] (Figure 5.2).
c) n denotes that more than one of the four bases could occur in this 
position
d) Residue numbers in small block font refer to the amino acid residues in
Figure 5.1
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this position as this amino acid is conserved in two of the three bacterial sequences, 
and it was anticipated that the EPSP sequence from S.coelicolor would show greater 
similarity to other bacterial sequences than to the enzymes from the eukaryotes and 
plants. In the DNA sequence of primer 2, (GC) degeneracies were used to encode the 
nucleotides in the third positions of the triplets encoding the threonine, alanine and 
proline residues.
The melting temperatures (Tm) of the oligonucleotides were calculated using the 
formula:
Tm= 59-9 + 0-5(G+C)% - 600/L 
where L is the length of the primer (in numbers of nucleotides).
The primers were designed to produce Tm's as close as possible to each other, 
allowing PCR to be performed as close as possible to the optimum Tm of each 
oligonucleotide. Each degeneracy in a primer sequence doubles the number of 
oligonucleotides synthesised for that sequence; an optimal primer sequence will 
contain no degeneracies, so that only a single oligonucleotide is synthesised for this 
sequence.
Primer 1 was 22 nt in length, contained four degeneracies (producing 16 individual 
oligonucleotides), was 77% G+C rich, and had a calculated Tm of approximately 
71°C.
Primer 2 was 23 nt in length, also contained four degeneracies, was 70% G+C rich, 
and had a calculated Tm of approximately 69°C.
5.2.2 Attempted PCR-cloning of aroA with primer 1 and primer 2
The Polymerase Chain Reaction (PCR) allows two primers, which anneal to opposite 
strands of a denatured DNA duplex, to prime DNA replication from the duplex, 
which acts as a template for binding of the primers (Figure 5.4). The first round of 
replication produces two partial duplexes, each consisting of a single strand of 
template DNA and a newly-synthesised strand with one of the primers at the 5' end. 
For each duplex thus produced, a second round of denaturation, followed by primer 
binding and DNA replication, will produce a duplex identical to the template for the 
second round of replication, and a duplex consisting of one strand which was 
synthesised during the first round of replication (with one of the primers at its 5' end) 
and its complement, which was synthesised during the second round of replication, 
and has the other primer at its 5' end. Further rounds of replication will cause further
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amplification of this novel duplex (the PCR product), with one of the primers at each 
5' end.
Typically, PCR using Taq polymerase produces a product with a single A base 
overhanging at the 3' end of the product. This base may be removed for ligation to a 
blunt-ended, linearised vector; or the PCR product may be ligated into a linearised 
vector which has a single overhanging T base at both 3' ends. All of the ligations of 
PCR products described in this thesis used the latter method of ligation.
The PCRs described in this section were performed using S.coelicolor genomic DNA 
(gDNA) as the initial template, and primer 1 and primer 2, either singly (for single 
primer controls) or in tandem. The PCRs were performed according to section 2.4.25, 
using an annealing temperature of 64°C, and a 60 second extension. The lOx Taq 
buffer used contained no Mg2+, so MgCh was added to supplement the PCR reaction 
cocktail at concentrations of Mg2+ ranging from 0-5 mM to 3 mM. Each PCR 
reaction was covered with a single drop of mineral oil to prevent evaporation during 
the reaction. After the initial denaturation step, 1 U Taq polymerase was added to 
each reaction to catalyse polymerisation. It was anticipated that these primers would 
direct the synthesis of a PCR product of between 950 and 1100 bp in length.
PCR of 1147 gDNA using either 2 or 2-5 mM Mg2+ produced two PCR products of 
approximately 0-5 to 1 kb in size. These two products were ligated into the vector 
pDKlOl which had been digested with the restriction endonuclease Xcm  I (this 
digestion produces a single base-pair stagger at the restriction site, with an 
overhanging T at the 3' end of the DNA, to which the single overhanging A at the 3' 
end of the PCR product can ligate [Kovalic et al., 1991]), transformed into competent 
E.coli TG-1 cells, and the transformation mixture was plated onto L-agar plates 
supplemented with ampicillin to select for transformants, and with X-gal and IPTG to 
screen for transformants carrying plasmids which contain inserts (i.e. not merely 
religated plasmid). Of the putative transformants, only one contained the smaller 
PCR product (approximately 800 bp in length), and none of the transformants 
contained the larger product. The plasmid containing the insert was named pTA+800.
pTA+800 was sequenced by the double-stranded sequencing protocol using T7 
polymerase and T7 primer. 54 nt of insert sequence were derived (Figure 5.5). The 
first 22 nucleotides showed complete identity to the primer 1 sequence. The deduced 
amino acid sequence from this insert lying downstream of the region against which 
primer 1 was designed showed no similarity to that of any of the deduced protein 
sequences in Figure 5.1. Therefore, this PCR product was rejected as containing part
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of the aroA gene.
1 AACGCGGGGACGGCGATGCGGCGCnCGGCCAGGCGGCCCnnCAGTTCCCTCACC 54
N A G T A M R R ? A R R P ? S S L T  
T R G R R C G A R P G G P  ? V P S  
R G D G D A A ? G Q A A ? Q F P H
Figure 5.5 Partial DNA and deduced amino acid sequence of pTA+800
N.B. Primer 1 sequence is denoted in bold type
5.2.3 Design of oligonucleotide primer 4
Primer 4 was designed against a region (WRVKET(D/E)R) of deduced amino acid 
sequences for the EPSP synthase enzymes shown in Figure 5.1 (residues 448-455). 
Again, this region is highly conserved in all nine deduced amino acid sequences. 
Primer 4 was designed against the deduced DNA sequence of the coding strand, 
allowing it to anneal to the non-coding strand of the aroA gene and to allow DNA to 
be synthesised towards the 5' end of the gene (and therefore towards primer 1), thus 
providing an alternative to primer 2 as the C-terminal oligonucleotide. Therefore, 
primer 2 and primer 4 function as nested primers, permitting primer 4 to anneal 
towards the downstream end of the aroA PCR product formed using primer 1 and 
primer 2.
5.2.4 Attempted PCR-cloning of aroA with primer 1 and primer 4
In an attempt to prevent annealing of the primers at incorrect sites internal to the PCR 
product, and thus producing spurious smaller PCR products, "touchdown" PCR [Don 
et al., 1991] was performed with primer 1 and primer 4, either singly (single primer 
controls) or in tandem. In this method, the annealing temperature is gradually 
decreased during the PCR reaction, biasing the reaction towards longer (and 
hopefully correct) PCR products. The touchdown PCRs described below were 
performed using 100 ng of gDNA isolated from mycelia of S.coelicolor 1147 as 
template, and a 5 mins extension time. It was anticipated that these primers would 
direct the synthesis of a PCR product of 750-850 bp.
Touchdown PCRs were performed by decreasing the annealing temperature by 1°C 
every second cycle. The target temperatures (the temperature at which the primers 
anneal to the denatured DNA in the 30th cycle) were varied, in order to discover the
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Primer 4:
Predicted protein sequence:
N 448-Trp Arg Val Lys Glu Thr Asp/Glu Arg-455
Derived DNA sequence (non-coding strand):
5' -TGG CGn GTn AAG GAG ACn GAn CGn- 3*
Derived DNA sequence (coding strand):
3' -ACC GCn CAn TTC CTC TGn CTn GCn- 5'
Reverse of derived DNA sequence (coding strand):
5' -nCG nTC nGT CTC CTT nAC nCG CCA- 3’
Primer sequence:
5' -(GC)CG (GC)TC (GC)GT CTC CTT (GC)AC (GC)CG CC- 3'
82% 88-5% 95% 81% 95% 95% 82% 100%
Figure 5.6 Design of primer 4 for cloning of the aroA gene
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optimal temperature for this reaction, from 65°C to 68°C. Also, in order to 
circumvent primer-primer annealing or primer self-annealing, the primers were added 
together along with the dH20 required for the PCR, boiled for 10 mins to denature 
any such partial (or even complete) duplexes, and immediately placed on ice. The 
rest of the PCR cocktail (apart from the Taq polymerase, which is added after the 
initial denaturation step of the reaction) is made up on ice. However, no PCR 
products which were not single-primer products were identified.
5.2.5 Attempted PCR-cloning of aroA with primer 1. primer 2 and primer 4
PCRs were then performed with primer 1 and primer 2, using an annealing 
temperature of 60°C, and 0-5 to 3 mM Mg2+. After completion of the reactions, the 
PCR reactions were run out on agarose gels, and the products purified from the gels. 
These PCR products were then used as templates for secondary PCR reactions 
performed at identical Mg2+ concentrations. However, these secondary reactions 
were performed at an annealing temperature of 66°C, and primer 2 (which was used 
as the C-terminal oligonucleotide in the primary PCRs) was replaced by primer 4 in 
these reactions.
The products from these six secondary PCRs were electrophoresed on 0-8% TAE 
gels; a single band was isolated from the 0-5 mM Mg2+ reaction, and three bands 
isolated from the 2 mM Mg2+ reaction. However, all of these products were 
considerably smaller than anticipated, ranging up to only 500 bp for the largest of the 
three products from the 2 mM Mg2+ reaction. All four PCR products were purified, 
and were subsequently ligated into pIBI25 vector which had been digested with Hinc
II (which produces blunt-ended restriction fragments) and T-tailed (section 2.4.9), 
The resultant plasmids were transformed into competent E.coli DS941 cells, and the 
mixture plated onto L-agar supplemented with ampicillin, X-gal and IPTG. Only the 
largest fragment was cloned by this method, generating plasmid p41.
The insert was isolated from p41 by digestion with the restriction endonucleases Hind
III and EcoR  I, and subcloned into suitably-restricted M Bm p 18 and M Bm p 19, 
creating m41-18 and m41-19. Single-stranded DNA was prepared from each of these 
two vectors for sequencing with the universal primer.
The sequence derived from each of the two bacteriophages began with M13 
polylinker sequence, followed by pIBI25 sequence upto the triplet GTC, the 5' half of 
the Hinc II restriction site. This was immediately followed by the T nucleotide ligated 
onto the linearised pIBI25 vector by T-tailing, and subsequently by the insert.
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A A CG CSG G SA  C SG C SA TG C G  SC
I I I I M M  I * • • M i l l  : |
AACGCCGGGA C G . . CATGCG GCCACGCCCA 
TGA G CA CTCT G C TGG TG TCC CCCAGAACAC 
CGA CCGATCT CTCCATAGGG AGAAGACAGG
I I  M I N I  I I  I N I  I I I  M I N I
CGCG CGATCT C T . C A T A . . G A G . A G ACAG. 
CAGCCCCGAA CACCAATCCA GCCGCGACCA
I I I N I  I N I  I I I  I N I  I I
C . G . . C C G A . C A C . A . T . CA G C C G . G A . . .  
GCCCGCAGCC TAGCCCCG CT CACTCGATCA
I I  l l l l l l l  M i l l  I I I  l l l l l l l l l l
G C . CGCAGCC T A G C C C . GCT CACTCGATCA 
G G C G A T T G C . TGCACCGCCG C C TTG C TG G T
l l l l l l l l  I I I  I I I  I I  l l l l l l l l l l
. GCG ATTG CC T G C C C C G .C G  C C TTG C TG G T 
C A G G C T C T . T C .G G A G G .T G  G G A C C .G G .C
I l l l l l l  I I M i l l  I I  I I  I I  I I  I
C G G G C T C TT T  CCGGAGGGTG G G . CCCGGAC
ACCGGGTCGC TCGAGCGGCG GACAGAGCAG 
GA CCACTGTG CTGGCGGAGG ACTCCACGAG 
GTCGTAGGCG CATCGCGGTG CCGGCGTT
I M I  1 1 1  M  I M  M  1 1  M  1 1 1 1
G SC G  C A T SG C SG T S C C SG C G T T
primer 1
TCCA G CG TCA  AGCAGAAGAC m41-18 
TCCCAGTGA A CGACGAGAGA 
ACG TTAG TG A CGGATGTGAG m41-18
I I I  I I  I I I  l l l l l l l
A C G .A T G T .A  C G . ATGTGAG m41-19 
reverse/complement
GCCCCCAGCA TG A C C T T C A T
I l l l l l l l  1 1 1 1  I I I
. CTCCCA G C A  T G A C . . GCAT 
A G TT T TC C A A  CAG TCA CTG A
I I  l l l l l l  I I M I I M M
A G . . TTC C A A  CAG TCA CTG A 
C T T C G C T T G T  C . T C . TCCGA
I I M I I M M  I I I  M i l l
C T T C G C T T G T  C C TC C TC C G A  
G T T C T T G  m41-18
l l l l l l l
G T T C TT G C C G  GCGCCGCGCT m41-19 
reverse/complement
CCGCCACTGC CCGG CTTGCG
TTC C T T G C G C  GGCGCTCCAG
m41-19 reverse/complement 
primer 1 reverse/complement
Figure 5.7 Partial nucleotide sequence of the insert from p41
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The sequences derived from both m41-18 and m41-19 contained a region at their 5' 
end which bore considerable similarity to the primer 1 sequence. Therefore, it 
appeared that the insert contained in p41 has primer 1 at each end, and was generated 
by PCR using only a single primer.
The two sequences were translated to produce the amino acid sequence they encode 
[Figure 5.8]. The nucleotide sequence derived from m41-18, when lined up with the 
primer 1 sequence, contained an apparent 2 nt gap. This may be due to a sequencing 
error, as the PCR product must begin with a primer at each 5' end. Therefore, the 
adapted m41-18 sequence, beginning with the primer 1 sequence, was also translated. 
These derived amino acid sequences were used to search for similarity to any of the 
protein sequences lodged on the protein databases. However, no significant matches 
were produced with any of these sequences.
Amino acid sequence derived from m41-18 nucleotide sequence:
N A G T H A A T P I Q R Q A ED *A LC  W C P P E H S Q *T  T R D D R SLH R E  K TG R * *RM *A 
A P N T N PA A T S PQ H D LH A R SL A P L T R S S F P T  V T E A IA A P P P  C W SSL V S PT G  
V F Q Q S L R R L L  H R R L A G LR L S LRQALRRW DR R S
Amino acid sequence derived from the adapted m41-18 nucleotide sequence:
NAGTAM RPRP SSV K Q K T EH S A G V PQ N T PS E  R R E T T D L S IG  RRQDVSDGCE 
Q P R T P IQ P R P  A PSM TFM PA A  *P R S L D Q V F Q  Q SL R R L L H R R  L A G L R L SL R Q  
E F S N S H *G D C  C TA A LLV FA C  L SD R L FG G G T  GVL
Amino acid sequence derived from m41-19 nucleotide sequence:
NAGTAM RLRP G A PR K E L V E S S A S T W R K P G  SG G C S V R R SS D PV R A A PA R T 
S G P T L R K E P V  GGGQAKTSKA RGRQSLSDCW  N L IE * A G * A A  ACVMLGVRLM 
C R R S H R T S S V  S L * E I A
Figure 5.8 Amino acid sequences derived from the p41 insert 
N.B. * denotes a STOP codon
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5.2.6 Genomic probing with primer 1
Since cloning of aroA by PCR was not successful, it was decided to attempt the 
cloning of aroA directly from the genome by the screening of a genomic sub-library 
with the PCR primers already available. The library was produced by cloning a 
portion of the genome into a plasmid vector. The size of fragments required for 
cloning was determined by screening digests of genomic DNA isolated from 
S.coelicolor 1147 with the three primers described above. An oligonucleotide (or 
fragment of single-stranded DNA) which hybridises to the gene sequence should light 
up a small number of bands in the genomic digest which will contain all, or at least 
part of, the gene being sought. If a fragment contains only part of the gene, it may be 
used as a single-stranded probe for screening gDNA digested with another restriction 
enzyme.
Genomic DNA was digested to completion with a number of different restriction 
enzymes, singularly or in pairs, and the fragments produced separated by agarose gel 
electrophoresis. The DNA was transferred by Southern blotting to nylon membrane, 
and was fixed to the filter by baking at 80°C for 2 hours. The filter was prehybridised 
(see section 2.4.18) at 50°C, and probed with primer 1.
Primer 1 was radio-labelled using bacteriophage T4 polynucleotide kinase enzyme, 
which attaches the y-phosphate from a molecule of ATP to the hydroxyl group at the 
5' end of the oligonucleotide. Various hybridisation and washing conditions were 
used, with differing concentrations of salt and at various temperatures, with suitable 
conditions being identified as:
hybridise overnight at 50°C
wash twice for 20 minutes each at 58°C in lx SSC,
0-1% SDS,
0-1% sodium pyrophosphate. 
Hybridising fragments of a suitable size for cloning and further examination were 
identified in BamH 1/EcoR I and Pst I/Sst I double-digests (Figure 5.9).
5.2.7 Construction of genomic sub-libraries
Approximately 15 fig of S.coelicolor G-94 genomic DNA was digested to completion 
in pairwise fashion with either BamH  I and EcoR I, or Pst I and Sst I restriction 
endonucleases, and the fragments separated by electrophoresis through a 0-8% TAE 
agarose gel. Fragments of approximate size 4 to 4-5 kb were cut out of the gDNA 
which had been digested with BamH I and EcoR I; 3-5 to 4 kb fragments were cut out
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1 2 3 4 5 6 7 8 9 10 11 12 13 14
Figure 5.9 Probing with radio-lahelled nrimer 1 of a filter carrying gDNA 
from 1147 digested with a variety of restriction enzvmes
lanes 1&14: X/Hind III markers 
lane 2: 1147 gDNA cut with BamH I 
lane 3: 1147 gDNA cut with EcoR I 
lane 4: 1147 gDNA cut with Sal I
lane 5: 1147 gDNA cut with BamH \JEcoR I (boxed region ~4 to 4-5 Kb)
lane 6: 1147 gDNA cut with BamH IJSal I
lane 7: 1147 gDNA cut with EcoR USal I
lane 8: 1147 gDNA cut with Hind in
lane 9: 1147 gDNA cut with Pst I
lane 10: 1147 gDNA cut with Sst I
lane 11: 1147 gDNA cut with Hind HI/Pst I
lane 12: 1147 gDNA cut with Hind III/Sst I
lane 13: 1147 gDNA cut with Pst I/Sst I (boxed region ~3*5 to 4 Kb)
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A B C D E F G H I J
Figure 5.10 Probing of filter carrying putative pPM7-containing colonies 
with radio-labelled primer 1
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of the gDNA which had been digested with Pst I and Sst I. Both sets of fragments 
were eluted from the agarose, and ligated into suitably-restricted pIBI25 plasmid 
vector, producing genomic sub-libraries. The ligation mixes were transformed into 
competent E.coli DS941 cells, transformants with inserts being selected for by growth 
on L agar supplemented with ampicillin, and with X-gal and IPTG. 200 white 
(putative insert-containing) colonies from each transformation were crossed onto L 
agar supplemented with ampicillin for maintenance of stocks, and onto nylon 
membranes placed on top of L agar supplemented with ampicillin. This procedure 
allowed screening of the sub-libraries with primer 1 to identify transformants 
containing the fragments to which the primer hybridised during the probing of the 
genomic blot. The clones constituting the sub-libraries which had been plated onto 
nylon membrane had their DNA transferred to the membrane on which they had 
grown, and the filters probed with radio-labelled primer 1 by colony hybridisation 
(2.4.19). A single clone (colony H8 in Figure 5.10) containing a BamH UEcoR I 
fragment to which primer 1 hybridised was identified from the filters. The plasmid 
contained in the hybridising clone was named pPM7. No clones containing 
hybridising Pst l/Sst I fragments were obtained, despite repeated screening.
To investigate why the BamH VEcoR  I fragment contained in pPM7 was of an 
estimated length of 2-3 kb despite the DNA which was excised from the gel being 
approximately 4 to 4-5 kb in length, 5 |Xg of 1147 gDNA was digested with BamH I 
and/or EcoR I was run on a 0-8% TAE gel, along with 5 ng of pPM7 DNA which had 
been digested with BamH  I and EcoR  I to separate the insert and vector bands 
(Figure 5.11a). The DNA was transferred to nylon membrane by Southern blotting, 
the membrane probed with radio-labelled insert from pPM7 and subsequently washed 
at the conditions previously identified. From the autoradiogram (Figure 5.11b) it 
may be seen that an approximately 2-3 kb band lights up in the lane containing 
digested pPM7 DNA as anticipated. However, in the lane containing 1147 gDNA 
digested with both enzymes, a single band of approximately 3 kb in length lit up. As 
these two bands of DNA are likely to be the same fragment, it appears that the 
genomic DNA is running higher on the gel than anticipated from the X/Hind III 
markers. This result suggests that the insert in pPM7 is likely to be the fragment 
identified in the initial genomic DNA hybridisation, but that the gDNA runs 
aberrantly, possibly due to the high concentration of gDNA run on the gel.
5.2.8 Restriction mapping of pPM7
Plasmid pPM7 DNA was isolated from the hybridising clone, and was shown to 
contain an EcoR VBamH I genomic insert of approximately 2-3 kb in length. This
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a) Digests of 1147 gDNA and pPM7
1 2 3 4 5
Chapter 5
b) Autoradiogram
1 2 3 4 5
Figure 5.11 Digests of plasmid and genomic DNA probed with 
radiolabelled primer 1
lane 1: -5  ng pPM7 digested with BamH VEcoR I
lane 2: X/Hind III markers
lane 3: 1147 gDNA digested with BamH I
lane 4: 1147 gDNA digested with BamH VEcoR I
lane 5: 1147 gDNA digested with EcoR I
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a) Restriction digests of pPM7
1 2 3 4 5 6 7 8 9  10 11r  i
b) Autoradiogram
lane: 1 2 3 4 5  6 7 8  9 10 11
Figure 5.12 Probing of restriction digests of pPM7 with radiolabelled 
primer 1
lane 1 X/Hind III lane 7: pPMl/BamH l/Xho I
lane 2 pPM7/£c<?R VPst  I lane 8: pPM l/E coR  I/Sal  I
lane 3 p P U H P s t  I lane 9: pPMl/Sal  I
lane 4 pPMl/BamH VPst  I lane 10: pPMl/B amH  I/Sal  I
lane 5 pPM7/£ctfR IJXho I lane 11: pPM l/E coR VBamH  I
lane 6 pPM 7 /Xho I
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fragment was mapped with a variety of restriction endonucleases. Of those enzymes 
used, only Xho I, Sal I and Pst I were found to cut in this 2-3 kb fragment; there were 
three Xho I sites, along with one site for each of the other two endonucleases in the 
fragment.
The plasmid pPM7 was digested with these three endonucleases, either singly or in 
tandem with the endonucleases which cut at the ends of the insert (EcoR I or BamH 
I). The digests were then run out on a 0-8% TAE agarose gel, and the DNA 
transferred to nylon membrane by Southern blotting. The membrane was probed with 
radio-labelled primer 1. The smallest fragment which lit up on the autoradiogram 
was an approximately 1 kb EcoR I/Sal I fragment (Figure 5.12). From the restriction 
patterns produced by single and double digests using these three endonucleases, a 
restriction map was produced (Figure 5.13).
5.2.9 Further subcloning, partial sequencing and analysis of pPM7
The 2-3 kb insert was isolated from pPM7 by digestion with the BamH I and EcoR I 
endonucleases, and subcloned into the bacteriophage vectors M 13mpl8 and 
M 13mpl9, creating mPM7-18 and mPM7-19 respectively, for single-stranded 
sequencing using the M13 Universal primer. The M l3 bacteriophage vectors allow 
the isolation of single stranded DNA, when transformed into an E.coli strain carrying 
an F , for use in single-stranded sequencing reactions.
The 1 kb EcoR  I/Sal I fragment identified above (Figure 5.12) as containing the 
binding-site for primer 1 was isolated from pPM7 using the EcoR  I and Sal I 
endonucleases, and subcloned into suitably-restricted pIBI25, creating plasmid 
pPM16, and also into suitably-restricted M13mpl8, creating mPM16-18. This insert 
was not subcloned into M13mpl9, as analysis of this clone would produce the same 
sequence as that of mPM7-19.
5.2.9.1 Sequencing of mPM7-18
Single-stranded DNA was isolated from mPM7-18 (see 2.4.15.2), and sequenced 
using Universal primer. 348 nt of insert sequence were derived from mPM7-18, 
beginning with the BamH I restriction site (GGATCC) (Figure 5.14). This sequence 
confirms the position of the Pst I restriction site (CTGCAG; nucleotides 338-343 in 
Figure 5.14), previously identified by restriction mapping (see Figure 5.13), which 
lies in the 2-3 kb BamH \JEcoR I insert.
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This sequence was analysed using the BIBBPROG (Bibb et al., 1984). This 
programme analyses the average G+C percentage at each position to identify an open 
reading frame. The codons in genes from Streptomyces typically contain a relatively 
intermediate level (around 70%) of G or C nucleotides in the first position, a relatively 
low level (around 50%) in the second position, and a high level (90% or greater) in 
the third position.
1 G G A TC C TC TG A C TC C TC A C G AGCAGAGGCG CGAGCCCCGG C TATCACGA T
5 1 G TCCTCA G CA CACCAGGTCC GGCGACACGC G TC G TC C C TC GTCGATGCGG
1 0 1 A C A TC G TC G T CACCGCAACG TGCCTGACAG CGCCACGTCC TGCGGACCGC
1 5 1 CCGA CTCC GT CGCCGACTGG CGGCCGCGGA C C C TGCGGGC CAAACCGACG
2 0 1 AGGACCGAGC GCAACGCCTC GGCCCGACGG C TGGATGGGA C G A A C A TC TT
2 5 1 G CTGCTTGAG CCGCGCGGCG CGCTTGGTGC TTG GTGATGA ACAGACGCAG
3 0 1 CCGGCTCCAG GCGTCAGGCG CGCAGGTCGT C G G G T ST C TG CAGGCCGG
Figure 5.14 Partial nucleotide sequence of mPM7-18
The BIBBPROG analysis identified an open reading frame in this DNA sequence, 
which contains neither an in-frame start (ATG or GTG) or stop (TGA, TAG or TAA) 
codon. The DNA sequence was then translated to produce the putative amino acid 
sequence. This polypeptide sequence was used to search the NIH protein databases 
using the TBLASTN programme from the BLAST suite, to investigate whether it 
shows any significant similarity to any of the proteins contained in these databases. 
However, this putative polypeptide sequence showed no significant similarity to any 
of the deduced amino acid sequences on the database. This suggests that the putative 
open reading frame included in this sequence is likely to form part of a gene whose 
cloning and sequencing had not been reported previously, or whose gene product is 
not similar to any protein yet sequenced.
5.2.9.2 Sequencing of mPM7-19
Single-stranded DNA was isolated from mPM7-19, and sequenced using the 
Universal primer. 392 nt of insert sequence were derived from this clone, beginning 
with the EcoR I restriction site (GAATTC) (Figure 5.15). This sequence confirms the 
position of the Xho I restriction site (CTCGAG; nucleotides 36-41 in Figure 5.15), as 
estimated from the restriction map (Figure 5.13).
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Sequence analysis using the BIBBPROG suggests that this DNA contains a putative 
open reading frame, although no in-frame start or stop codons were identified. The 
DNA sequence was translated to produce an amino acid sequence, which was used to 
search the NIH nucleic acid databases using TBLASTN. This putative polypeptide 
sequence also exhibited no significant similarity to any of the proteins contained on 
the databases.
1 GAATTCG ATC TCGTGGTCGG CGCGGACGGG ATGCG CTCG A GCGTGCGCCG
5 1 G A TG GTGTTC GGTCCGGACG AG GACTACCT GGCGAACTGG AAGGCGATGA
1 0 1 TC TG C G C G T T CCAGATGAAG GAGCAGGTTC C CACCTACGA GGCGAGCGAC
1 5 1 A G CATCATCG TCTCG CG CCC CAAGCGTGCG A TG TGG GTGT TCGGA CTCG C
2 0 1 CGATCACGCG CCCTGCGTGC TGACCTACCG CACCGACGAC ATTCCGGA CC
2 5 1 GGTTCGCCGG GCCGTCGATC GAGCAGGTGC GCG CGGCCTT T TC C G G G TTA
3 0 1 GAGGACGACC C CGTGG TG CT ACA CTCCTGG A C T C T C TG G T AGCAGGCCCC
3 5 1 TGACCACGTG TTC G A TTA C G TACCATCAGG TGAAGATGGA CC
Figure 5.15 Partial nucleotide sequence of mPM7-19
5.2.9.3 Sequencing of mPM16-18
Single-stranded DNA was isolated from mPM16-18, and sequenced using the 
Universal primer. 313 nt of insert sequence were derived from this clone, beginning 
with the Sal I restriction site (GTCGAC) (Figure 5.16).
1 GTCGACCGCG GCCTGTCGGC CTCAGGGAAC AGCCCGACGA AG TA GCCCCC
5 1 GGTGCGCCGC TCGGGCGCCG TTCG ACGA TC ACCGGCGTCC AACCGGCCCG
1 0 1 GCG CASCGAT CGCCGCGGAC ATCCCGCG AT CCCGAGCCCC ACCACCAACG
1 5 1 C C C T C T T C T G CATGGCCGTC ACCG CG TCCT GCCGGAGGGG ACAGCGGCCG
2 0 1 CAGTCGGAGC CGCAGCCGCG TGAACTCGCG CAGCGCGTGG ACGACCTGCG
2 5 1 GACAGATCGA GAACGCCGAA ACCAGCACCT GACGCGCTGA CGTACGACGT
3 0 1 G T T G T T T G A T CGT
Figure 5.16 Partial nucleotide sequence of mPM16-18
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This nucleotide sequence contains a putative open reading frame, as suggested by the 
BIBBPROG, and so was translated in-frame to produce the amino acid sequence 
which is, putatively, encoded by this DNA sequence. This sequence lacks both a start 
and stop codon. The putative polypeptide sequence was used to search the NIH 
nucleic acid databases using TBLASTN. However, no significant matches were 
identified by this search. Therefore, this deduced polypeptide does not have 
similarity to any sequences already contained in the databases.
3 ' 5 '
1 5 0  GCCCTCTTCTGCA TG GCCGTCAC CGCGTCCTGCCGG AGG GG 1 9 0
: I I I I : I I : I I : M i l l
........................G S C G C A T S G C S G T S C C S G C G T T .............................................
Figure 5.17 Putative binding-site for primer 1 in the insert of pPM7
The nucleotide sequence derived from mPM16-18, and the 
reverse/complement of the primer 1 sequence, running 5' to 3', are 
shown above to demonstrate the similarity between primer 1 and the 
derived sequence. In the diagram above, primer 1 would be intended 
to anneal from nt 178 towards nt 150, and prime DNA synthesis 5' to 
3' as the sequence is written.
This nucleotide sequence contains the putative binding-site for primer 1. This 
putative binding-site contained 18 matches with the primer, including the five 
degeneracies in the primer (see Figure 5.17). However, two of the three nucleotides 
at the 3' end of the oligonucleotide did not match with the nucleotides in the derived 
binding site sequence. As probing of genomic DNA with primer 1 only lit up a single 
band, it is assumed that primer 1 only has a single binding-site in the genome. 
Therefore, the mismatches at the 3' end of the primer are likely to prevent this 
oligonucleotide from initiating any DNA replication in PCR.
5.2.10 Line-up of the new deduced amino acid sequences of EPSP synthases
Since the attempted cloning of the gene encoding EPSP synthase (as described above) 
was begun, a number of genes which encode EPSP synthase enzymes have been 
cloned and sequenced from Gram-positive and Gram-negative bacteria, lower 
eukaryotes and plants.
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1 50
B.subtilis   MKR DKVQTLHGEI HIPG DK SISH  RSVMFGALAA
Synechocystis  MALLSLNNHQ SHQRLTVNPP AQGVALTGRL RVPGDKSISH RALMLGAIAT
S. aureus  MVNEQII D ISGPLKGEI EVPGDKSMTH RAIMLASLAE
M. tuberculosis  MKTWPAP TAPTPVRATV TVPGSKSQTN RALVLAALAA
51 100
B.subtilis  . . . .GTTTVK NFLPGADCLS TIDCFRKMGV H I . EQSSSDV VIHGKGIDAL
Synechocystis . . . . G E T IIE  GLLLGEDPRS TAHCFRAMGA E IS E L N S E K I IVQGRGLGQL
S.aureus . . . .G V STIY  KPLLGEDCRR TMDIFRHLGV E IK E . DDEKL W T S PG Y .Q V
M. tuberculosis AQGRGASTIS GALRSRDTEL MLDALQTLGL RVDGVGSELT V S G R I E . . . .
101 150
B. subtilis KEPESLLDVp Wb'GTTlHLML G ILA G . RPFY SAVAGDESIA KRPMKRVTEP
Synechocystis  QEPSTVLDAjG N S G T T M R LML GLLAGQKDCL FTVTGDDSLR HRPMSRVIQP
Li LA GLLSGLGN.E SVLSGDVSIG KRPMDRVLRP
FVP P . LAALGSVP VTFDGDQQAR GRPIAPLLDA
S.aureus  NTPHQVLYTG  N S G T T T R  
M. tuberculosis PGPGARVDCgI lM tK / i I r
151 200
B.subtilis  LKKMGAKIDG RAGGEFTPLS VSGASLKGID YVSPVASAQI KSAVLLAGLQ
Synechocystis  LQQMGAKIWA RSNGKFAPLA VQGSQLKPIH YHSPIASAQV KSCLLLAGLT
S.aureus  LKLMDANIEG . IEDNYTPLI IK PSV IK G IN  YQMEVASAQV KSAILFASLF
M. tuberculosis LRELGVAVDG . . TGLPFRVR GNGSLAGGTV AIDASASSQF VSGLLLSAAS
201 250
B.subtilis  AEGTTTVTEP HKS R DHTERMLSAF GVKLSEDQT. . SVSIAGGQK
Synechocystis  TEGDTTVTEP A L S  R DHSERMLQAF GAKLTIDPVT HSVTVHGPAH
S.aureus S K E P T IIK E L  D VS R NHTETMFKHF N IPIEA E G L S INTTPEA IRY
M.tuberculosis  FTDGLTVQHT G SSLPSAPHI AMTAAMLRQA GVDIDDSTPN RWQVRPGP. .
251 300
B.subtilis  LTAADIFTVPG D I S S A A F F j L A  AGAMVPNSRI VLKNVGLNPT R T G .IID V L Q
Synechocystis  LTGQRWVPG D I S S A A F W L V  AASILPG SEL LVENVGINPT RTG. VLEVLA
S.aureus  IKPADFqVPG D I S S A A F F j l V  AALITPGSDV TIHNVGINQT R S G .I ID IV E
M. tuberculosis VAARRWDIEP tfTfiT^T^FILS AAWSGGTVR ITGWPRVSVQ PADHILAILR
301 350
B.subtilis  NMGAKLEIKP SADSGAEPYG D L IIE .T S S L  KAVEIGGDII P R L ID E IP I I
Synechocystis  QMGADITPEN ERLVTGEPVA DLRVR. ASHL QGCTFGGEII P R L ID E IP IL
S.aureus KMGGNIQLFN Q T . TGAEPTA SIRIQYTPM L Q PIT IE G E L V  PKAIDELPVI
M. tuberculosis Q LN A W  IHADS SLEVRGPTGY DGFDVDLRAV GELTPSVAAL
351 400
B.subtilis  ALLATQAEGT TVIKDAAELK VKETNRIDTV VSELRKLGAE IEPTADGMKV
Synechocystis  AVAAAFAEGT TR 
S.aureus ALLCTQAVGT S I
i Q j A A E l f n V K E SDRLAAI ASELGKMGAK VTEFDDGLEI 
j I K D A E E L K  V K E TNRIDTT ADMLNLLGFE LQPTNDGLII
M. tuberculosis AALAS. PGSV S R L S G n J^ lr^  GI-{e]tDRLAAL STEINRLGGT CRETPDGLVI
401 450
B. subtilis YGKQTLKGGA AVSSHGpHRI GHMIQTS|SCI T E E P IE IE H T  DAIHVSYPTF
Synechocystis  QGGSPLQ. GA EVDSL1 D H R I  AK0LAIAALG SGGQTIINRA EAAAISYPEF
S. aureus HP . SEFKTNA T . D IL I D H R I  GM M L^^CVL SSEPVKIKQF DAVNVSFPGF
M. tuberculosis .TATPLRPG. IWRAYADHpImTaE^ G M IG L R  VAG.VEVDDI AATTKTLPEF
451 485
B.subtilis  FEHLNKLSKK S ..........................................................................
Synechocystis FGTLGQVAQG .......................................................................... ..
S.aureus LPKLKLLQNE G ..........................................................................
M.tuberculosis  PRLWAEMVGP GQGWGYPQPR SGQRARRATG QGSGG.
Figure 5.18 Line-up of the protein sequences of the EPSP synthase enzymes 
from the Gram-positive bacteria and a cyanobacterium
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1  5 0
T o b a c c o  ........................................................................................................................................................
T o b a c c o 2  S IF IG S K K IT  QNSAKSLWVS KEDSVLRVAK S P F R IS A S W  TAQKPNEIVL
B.napus PFSVSLKTHQ PRASSWGLKK SGTMLNGSVI RPVKVTASVS TSEKASEIVL
S.typhi ........................................................................................................................................MESLTL
S.gallinarum ........................................................................................................................................MESLTL
K. pneumoniae ........................................................................................................................................MESLTL
Y. entero .......................................................................................................................................... MLESLTL
H. influenzae ........................................................................................................................................MEKITL
P.multocida  ........................................................................................................................  MIKDATAITL
A .  salmonicida ....................................................................................................................................... NSLRL
P .pseudomallei  ........................................................................................................................  MAFQWPRFPL
P.carinii MSIDKKNDSN NKKIVLLSAI GKTYEKKASS VSD D D IRTIL SQN ILLY G IP
D . nodosus  ..................................................................................................................................MMTNIWHT
5 1
t o b a c c o  ..........................
t o b a c c o 2  QPIKDISGTV
B.napus Q P IR E IS G L I 
S. typhi QPIARVDGAI 
S.gallinarum  QPIARVDGAI 
K .pneumoniae  QPIARVDGTV 
Y. entero. HPIALINGTV 
H.influenzae  A PISA V EG TI 
P.multocida N PISY IEG EV
A .salmonicida EPISRVAGEV 
P.pseudomallei QPWRHVTGHL 
P.carinii LNAFQKHTTI 
D.nodosus  APVSALSGEI
KLPGSKSLSN RILLLAALSK 
KLPGSKSLSN RILLLAALSE 
NLPGSKSVSN RALLLAALAC 
NLPGSKSVSN RALLLAALAC 
NLPGSKSVSN RALLLAALAR 
NLPGSKSVSN RALLLAALAE 
NLPGSKSLSN RALLLAALAK 
RLPGSKSLSN RALLLSALAK 
NLPGSKSVSN RALLLAALAR 
RLPGDKSISN RSLLLGALAE 
TLPG SKSISN  RALILASLSN 
TICGDKSMSH RALLLAALAE
100
GRTW DNLLS SDDIHYMLGA 
GTTW DNLLN SDDINYMLDA 
GKTVLTNLLD SDDVRHMLNA 
GKTVLTNLLD SDDVRHMLNA 
GTTVLTNLLD SDDVRHMLNA 
GTTQLNNLLD SDDIRHMLNA 
GTTKVTNLLD SDDIRHMLNA 
GKTTLTNLLD SDDVRHMLNA 
GTTRLTNLLD SDDIRHMLAA 
GVTEVTGLLD SDDARAMLNA 
GICYLKNFLH SDDTYYMLSA 
GQTEIRGFLA CADCLATRQA
101
t o b a c c o  
t o b a c c o 2
B .napus 
S . typhi 
S .gall inarum 
K . pneumoniae 
Y. entero. 
H. influenzae 
P.multocida
A .salmonicida 
P .pseudomallei 
P .carinii 
D .nodosus
1 5 0
. .L
LKTLGLHVED 
LKKLGLNVER 
LSALGINYTL 
LSALGINYTL 
LSALGVHYVL 
LQALGVKYRL 
LKALGVRYQL 
LKELGVTYQL 
LTQLGVKYKL 
LRDLGV. V IE  
LEKLNAAEFK 
LRALG. VDIQ
DNENQRAIVE
DSVNNRAWE
SADRTRCDIT
SADRTRCDIT
SSDRTRCEVT
SADRTRCEVD
SDD K TICEIE
SEDKSVCEIE
SADKTECTVH
GPHQGRCTVH
WEQDGDVLW
REKEIVTIRG
GCGGQFPVGK
GCGGIFPASL
GNGGPLRASG
GNGGPLRAPG
GTGGPLQAGS
GLGGKLVAEQ
GLGGAFNIQD
GLGRAFEWQS
GLGRSFAVSA
GVGLHGLKAP
KGKSGYLENP
VGFLGLQPPK
KSEEEIQ LFL 
DSKSDIELYL 
T L E . . . . LFL
ALE. 
ALE. 
PLE . 
NLS . 
GLA. 
PVN. 
PG P. 
QME . 
A PL.
. LFL 
. LFL 
. LFL 
.L F L  
. LFL 
. LFL 
. LFL 
.LYL 
. .NM
G NAGTAMRP 
G NAGTAMRP 
GNAGTAMRP 
GNAGTAMRP 
GNAGTAMRP 
GNAGTAMRP 
GNAGTAMRP 
G NAGTAMRP 
G NAGTAMRP 
G NAGTAMRP
t o b a c c o
1 5 1
TA A V A .., . .V AGGNSRYVLD
t o b a c c o 2 TAAVT. . , . .V AGGHSRYVLD
B .napus TAAVT. . , . .A AGGNASYVLD
S . typhi AAALC . LGQNEIVLT
S .gall inarum AAALC . LGQNEIVLT
K .pneumoniae AAALC . LGSNDIVLT
Y. entero. AAALC . LGKNDIVLT
H .influenzae TAALC. . . .LK GNHEVEIILT
P .multocida TAALCLSTPN REGKNEIVLT
A .salmonicida CAALC . LGSGEYMLG
P .pseudomallei SAA L ALQPFDTTLT
P .carinii TSICTLVQPN SRENHLILTG
D .nodosus AGILAAQRFE SVLCGDESLE
2 0 0
GVPRMRERPI GDLVDGLKQL GAEVDCFLGT 
GVPRMRERPI GDLVDGLKQL GAEVDCFLGT 
GVPRMRERPI GDLWGLKQL GADVECTLGT 
GEPRMKERPI GHLVDSLRQG GANIDYLEQE 
GEPRMKERPI GHLVDSLRQG GANIDYLEQE 
GEPRMKERPI GHLVDALRQG GAQIDYLEQE 
GEPRMKERPI GHLVDALRQG GAQIDYLEQE 
GEPRMKERPI LHLVDALRQA GADIRYLENE 
GEPRMKERPI QHLVDALCQA GAEIQYLEQE 
GEPRMEERPI GHLVDCLALK GAHIQYLKKD 
GDPRMSERPI NRLVDALREM GAVIEYLAQE 
SNRMKQRPIG PLVDALKNNG CCIEYLELEN 
KRPM QRIITP LVQMGAKIVS HSNFTAPLHI
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2 0 1  2 5 0
t o b a c c o  K C P P V R IV S K  GGLPGGKVKL S G S IS S Q Y L T  A LLM AA PLAL G D V E I E I I D K
t o b a c c o 2  N C P P V R IV S K  GGLPGGKVKL S G S IS S Q Y L T  A LLM AA PLAL G D V E I E I I D K
B .n a p u s  NCPPV RVNA N GGLPGGKVKL S G S IS S Q Y L T  A LLM AA PLAL G D V E I E I I D K
S . t y p h i  N Y P P L R .L R G  . G F IG G D IE V  D G S V S S Q F L T  A L L M T A PL A P E D . T IIR V K G
S . g a l l i n a r u m  N Y P P L R .L R G  .G F IG G D IE V  D G S V S S Q F L T  A L L M T A PL A P K D .T I I R V K G
K .p n e u m o n ia e  N Y P P L R .L R G  . G FTG GDV EV D G S V S S Q F L T  A L L M A SPL A P Q D .T V IA IK G
Y. e n t e r o .  N Y .R R C .I A G  . G FR G G K LTV  D G S V S S Q F L T  A LLM TA PLA E Q D .T E I Q I Q G
H . i n f l u e n z a e  G Y P P L A .IR N  K G IK G G K V K I D G S IS S Q F L T  A L L M SA PL A E  N D . T E I E I I G
P . m u l t o c i d a  G Y P P I A .I R N  T G L K G G R IQ I D G S V S S Q F L T  ALLMAAPMAE A D . T E I E I I G
A . s a l m o n i c i d a  G Y P P L V .V D A  KGLWGGDVHV D G S V S S Q F L T  AFLMAAPAMA P V I P R I H I K G
P . p s e u d o m a l l e i  G Y P P L T IR G G  G S V S S Q F L T A  L L M .................................................. T  A PM A S A Q IK SG
P . c a r i n i i  C L P L L IK P K E  IG L Y G G N IN L  SA T V SSQ Y V S S IL M C S P Y A K  T Q V T L S L IG G
D . n o d o s u s  S G R P L T G ID Y  A L P L P S A Q L K  S C L IL A G L L A  D G TTR LH TC G  ISR D H T E R M L
t o b a c c o
2 5 1
L ISV L Y V E M T L K L M E R F G IS V E H SSSW D R F W R G G Q K Y K S P G K . .
3 0 0
.A Y V E
t o b a c c o 2 L ISV P Y V E M T LKLM ERFGV S VEH TSSW D K F LVRGGQKYKS P G K . ,. .A Y V E
B .n a p u s L ISV P Y V E M T LKLM ERFGV S AEHSDSW DRF FVKGGQKYKS P G N . ,. .A Y V E
S . t y p h i E L V S K P Y ID I TLN LM KTFGV EIA N H H Y Q Q F W K G G Q Q Y H S P G R . .. . YLVE
S . g a l l i n a r u m E L V S K P Y ID I TLN LM KTFGV EIA N H H Y Q Q F W K G G Q Q Y H S P G R . .. . YLVE
K . pn eu m o n ia e E L V S R P Y ID I TLH LM KTFGV EVENQAYQRF IVRG N Q Q Y Q S P G D . .. .Y L V E
Y. e n t e r o . E L V S K P Y ID I TLHLM KAFGV D W H E N Y Q IF H IK G G Q T Y R S P G I . ., .Y L V E
H. i n f l u e n z a e E L V S K P Y ID I TLAMMRDFGV KVENHHYQKF Q V K G N Q SY IS P N K . .. .Y L V E
P . m u l t o c i d a E L V S K P Y ID I TLKMMQTFGV EVENQAYQRF LVKGHQQYQS P H R . .. . F L V E
A . s a l m o n i c i d a E L V S K P Y ID I T L H IM N S SG V V IE H D N Y K L F Y IK G N Q S IV S P G D . .. . F L V E
P .p s e u d o m a l l e i L L L S K P Y ID I TLN V M . PFG V P T R . D H T E R I F A V S A IR Y P S P A V . .. . L R L E
P . c a r i n i i K P IS Q P Y ID M T IS M M S S F G I K V TR SH SK EN T Y Y IP K G C Y T C P S E Y I I E G D
D . n o d o s u s P L F G G A L E IK K E Q IIV T G G Q K L H G C V L D IV
3 0 1
t o b a c c o  G D A SSA SY FL  
t o b a c c o 2  G D A SSA SY FL
B .n a p u s  G D A SSA SY FL  
S . t y p h i  G D A SSA SY FL  
S . g a l l i n a r u m  G D A SSA SY FL  
K .p n e u m o n ia e  G D A SSA SY FL  
Y . e n t e r o .  G D A SSA SY FL  
H . i n f l u e n z a e  G D A SSA SY FL  
P . m u l t o c i d a  G D A SSA SY FL
A . s a l m o n i c i d a  G D A SSA SY FL  
P .p s e u d o m a l l e i  G D A T SA SY FL  
P . c a r i n i i  A T S A T Y P L A I 
D . n o d o s u s  GDLSAAAFFM
AGAAVTGGTV T V E G C G T SS L  
AGAAVTGGTV T V E G C G T S S L  
A G A A IT G E T V  T V E G C G T T SL  
A A G G IK G G TV  K V TG IGGK SM  
A A G A IK G G TV  K V TG IG R K SM  
A A G A IK G G TV  K V T G IG R N S V  
A A A A IK G G TV  R V T G IG K Q S V  
A A G A IK G . KV K V T G IG K N S I 
A A A A IK G .K V  K V TG V G K N SI 
A A G A IK G . KV R V T G IG K H S I 
A A A G IK G ..V  PV T G IG R H SM  
A A IT G G S C T I SN V G SA SLQ G  
V A A L IA P R A E  W I R N V G I N P
3 5 0
QG DVKFAEVL EQMGAEVTWT 
QGDVKFAEVL EKMGAEVTWT 
QGDVKFAEVL EKMGCKVSWT 
Q G D IR FA D V L  HKMGATITW G 
Q G D IR FA D V L  EKM GATITW G 
Q G D IR FA D V L  EKMGATVTWG 
QGDTKFADVL EKM GAKISW G 
QG DRLFADVL EKMGAKITWG 
QGDRLFAD VL EKMGAHITWG 
G D IH F A D V L E  RMGARITW GD 
QG DSW FPRAL RRM G AR. SCG 
D S K F S E Y IL K  P M G C E W Q S P  
T R A A IIT L L Q  K M G G R IELH H
t o b a c c o  
t o b a c c o 2
B . n a p us  
S . t y p h i  
S . g a l l  inarum  
K . p n eu m o n ia e  
Y. e n t e r o .  
H . i n f l u e n z a e  
P . m u l t o c i d a
A . s a l m o n i c i d a  
P . p s e u d o m a l l e i  
P . c a r i n i i  
D . n o d o s u s
3 5 1
EN SV TV K G PP RNSSAM KHLR AIDVNMNKMP 
EN SV TV K G PP RNSSGM KHLR AVDVNMNKMP 
E N SV T V T G PS RDAFGM RHLR AVDVNMNKMP
DDF I  A C T ........................... RGELH A ID M D M N H IP
DDF I  A C T ........................... RGELH A ID M D M N H IP
E D Y IA C T ........................... R G ELN  A ID M D M N H IP
D D Y IE C S ........................... RGELQ G ID M D M N H IP
E D F IQ A E ........................... HAELN G ID M D M N H IP
D D F IQ V E ........................... KGNLK G ID M D M N H IP
D F IE A E Q G ............................PLH  GVDMDMNHIP
SS M IV C P R G E  ..................... LRA A V R S D S N S IP
T T T Y IK G P P K  G K L K S L G S IN  M ESM TD TFLT 
QRFW GAEPVA D IW Y H S K L R  G IT V A P E W IA
. . . DVAMTLA 
. . . DVAMTLA 
. . . DVAMTLA 
. . . D A A M TIA  
. . . D A A M TIA  
. . . D A A M TIA  
. . . D A A M TIA  
. . . D A A M TIA  
. . . D A A M TIA  
. . . DVGHDHS 
. . . DAAMTLA 
. . . AA V LA SV  
N A I D E L P I F F
4 0 0
W A L F A D G P T  
W A L F A D G P T  
W A L F A D G P T  
T T A L F A K G T T  
T T A L F A K G T T  
T A A L FA R G T T  
T T A L F A D G P T  
T T A L F S N G E T  
T T A L F A E G E T  
G Q SH C L PR V P 
T R S . . . AGAR 
A Y E E SK PY V T  
IA A A C A E G T T
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t o b a c c o  
t o b a c c o 2
B .napus 
S . typhi 
S .gallinarum 
K . pneumoniae 
Y. entero. 
H . influenzae 
P.multocida 
A .salmonicida 
P . pseudomallei 
P.carinii 
D .nodosus
401
AIRDVA3WRV KETEF 
AIRDVAS WRV KETEF 
TIRDVAS WRV KETEF 
TLRNIYIN WRV KETDF 
TLRNIYINWRV KETDF 
TLRNIYF WRV KETDF 
VIRNIYK WRV KETDF 
VIRNIYK WRV KETDF 
VIRJNIIYIs|wRV_ KETDF 
PHSQHLQL.
WAATANHI
K ITGISNQ
RV
M IAIC 
M IAIC 
M IAIC 
LFAMA 
LFAMA 
LFAMA 
LSAMA 
LTAMA 
,LTAMA 
RDDRCTPCTH 
AGEGDGSAVC
r F  (k^FM INAM V 
FVGNLSELRV KE^DrL aAMA
TELRKLGATV
TELRKLGATV
TELRKLGATV
TELRKVGAEV
TELRKVGAEV
TELRKVGAEV
TELRKVGAEV
TELRKVGAEV
TELRKVGAEV
GHRRAQAGVS
NVHGAGGGWR
CELKKFGIEA
QNLQTLGVAC
EEGPD Y CI.
V EGSDYCI.
EEGSDYCV.
EEGHDYIR.
EEGHDYIR.
EEGEDYIR.
EEGQDYIR.
EEGED FIRIQ
EEGED FIRIQ
EEGTTFITRD
ASGSRCWSSW
GELPDGIYVK
DVGADFIHIY
450
ITPPEKLNVT 
ITPPEKLNVT 
ITPPAKVKPA 
ITPPAKLQHA 
ITPPAKLQHA 
ITPPLTLQ FA  
W PPA Q LIA A  
PLALNQFKHA 
PLNLAQFQHA 
AADPAQ. .AR 
LPSARKW LR 
ALNTSNLPYS 
GRSDRQFLPA
t o b a c c o
451
E ID T . . YDDH RMAMAFSLAA C . ADVPVTIN
t o b a c c o 2 E ID T . . YDDH RMAMAFSLAA C . ADVPVTIK
B .napus E ID T . .YDDH RMAMAFSLAA C . ADVPVTIK
S. typhi D IG T . . YNDH RMAMCFSLVA L . SDTPVTIL
S .gall inarum D IG T . . YNDH RMAMCFSLVA L . SDTPVTIL
K . pneumoniae E IG T . .YNDH RMAMCFSLVA L .S D T P V T IL
Y. entero. E IG T . .YNDH RMAMCFSLVA L .S D T P V T IL
H. influenzae N IE T . .YNDH RMAMCFSLIA L . SNTPVTIL
P.multocida E L N I. . . HDH RMAMCFALIA L . SKTSVTIL
A . salmonicida RDRH. . LQRS RIAMCFSLVA L . SDIAVTIN
P. pseudomallei CAVPKRFPDG NVLLAASAWR TGCETSWIPA
P .carinii VEGINCYNDH RIAMSFSVLA C IS S K P T T IL
D .nodosus RVNS . . FGDH RIAMSLAVAG V.RAAGELLI
t o b a c c o
501
KH
514
500
NYFDVLQQYS
NYFDVLQQYS
DPGjCTtRlKTFP 
DPGCTRKTFP
DPGCTJFjKTFP DfiTFQVLESIT 
DPK 
DPK 
DPK 
DPK 
DPK
CTAKTFP D 
CTAKTFP D 
CTAKTFP D
CTAKTFP 
DPSCTAKTFP
fFEQLARMS
ZFEQLARMS
SfFGQLARIS
CTAKTFP DETFEQLARLS
TFFNEFEKIC
TFLILFTLN T
DPq C T S K T F P T |YFDKLASVS
A PTR R R IV IE  G G A I G S . . . .  
DKAEh ^ f m ^  YWWDILNSTF
d d g a \1a a v sm  p q f r d f a a a i
t o b a c c o 2  KH........................................
B.napus KH........................................
S . typhi T P A .....................................
S.gallinarum T P A .....................................
K.pneumoniae TLA .....................................
Y.entero. QA........................................
H.influenzae LKN.....................................
P.multocida REVA..................................
A .salmonicida QAV.....................................
P .pseudomallei .............................................
P.carinii K
D.nodosus GMNVGEKDAK NCHD. .
Figure 5.19 Line-up of the remaining deduced amino acid sequences of the 
EPSP synthase enzymes from plants, eukaryotes and Gram-negative 
bacteria
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These sequences were lined up, using the PILE-UP programme, to examine the 
similarity between them. Unexpectedly, the deduced EPSP synthase sequences from 
the three species of Gram-positive bacteria show similarity to each other, but not to 
the Gram-negative bacteria, plant or lower eukaryote enzymes (Figure 5.18). The 
protein sequence of the enzyme from the cyanobacterium {Synechocystis) also shows 
similarity to the enzymes from the three Gram-positive bacteria. However, the 
sequence of the M.tuberculosis enzyme only exhibits limited similarity to any of the 
other three enzymes in Figure 5.18, and shows even lower similarity to any of the 
other protein sequences available.
The three plant, one eukaryotic and nine Gram-negative bacterial EPSP synthase 
enzymes (i.e. those not shown in Figure 5.1), with the possible exception of the 
enzyme from D.nodosus , show significant similarity to each other, and to the nine 
sequences previously examined (Figure 5.19). As in Figure 5.1, the region against 
which primer 1 was designed (amino acid sequence NAGTAMRP; positions 142-148 in 
Figure 5.19) is conserved very highly, with complete conservation in ten of the 
twelve sequences containing this region. The region against which primer 2 was 
designed is also conserved fairly well (sequence CTAKTFPD; amino acids 484-491 in 
Figure 5.19), with complete conservation in four of these sequences. However, no 
conservation was apparent with the sequence from the enzyme of D.nodosus. The 
region against which primer 4 was designed (WRVKET(D/E)R; residues 408-415 in 
Figure 5.19) is completely conserved in nine of these thirteen sequences, poorly 
conserved in two, and not apparent in the other two sequences. The high levels of 
similarity in these three regions amongst most of the thirteen sequences in Figure 
5.19 lends support to the choice of these regions for the design of primers 1, 2 and 4.
The EPSP sequences from the Gram-positive bacteria and the cyanobacterium only 
show limited similarity to the regions against which primer 1 (residues 111-117 in 
Figure 5.18) and primer 4 (residues 370-376) were designed, and no apparent 
similarity to the region against which primer 2 was designed. As S.coelicolor is a 
Gram-positive bacterium, it was anticipated that the protein sequence of its EPSP 
synthase enzyme is most likely to show similarity to the sequences from the other 
Gram-positive bacteria.
5.2.11 Design of oligonucleotides primer 57 and primer 60
Since the protein sequences of the EPSP synthases from the Gram-positive bacteria 
show only poor similarity to the other EPSP synthase sequences available, it was 
assumed that the sequence of the enzyme from S.coelicolor is also likely to show only
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poor similarity to the enzymes from the Gram-negative bacteria, plants and 
eukaryotes. Therefore, it was considered that primers designed against regions of 
consensus from the Gram-positive bacteria and the cyanobacterium would be more 
likely to be successful in the cloning of the aroA gene of S.coelicolor.
Regions of consensus were identified in the sequences of the enzymes from the 
Gram-positive bacteria and the cyanobacterium, and primers were designed as before 
to allow a region of the aroA  gene to be duplicated by PCR. Two regions of 
consensus were identified: GNSGTT(I/M /T)R (residues 110-117) and DHRIGM M L  
(residues 417-424 in Figure 5.18).
Primer 60 was designed against the sequence GNSGTT(I/M/T)R, and acts as the N- 
terminal oligonucleotide (Figure 5.20). It was designed against the deduced DNA 
sequence of the coding strand, and was intended to anneal to the non-coding strand of 
aroA and to prime DNA synthesis towards the 3' end of the gene. Although this 
region is only poorly conserved in the enzyme from M. tuberculosis, seven out of the 
eight residues are completely conserved in the other three sequences in Figure 5.18. 
The N-terminal glycine residue in this region is the Gly-96 residue which has been 
identified as being involved in the binding of glyphosate to EPSP synthase [Sost & 
Amrhein, 1990; Padgette et al., 1991]. However, the proline residue (Pro-101) which 
has also been implicated in binding of glyphosate [Stalker et al., 1985] is not 
contained in any of the four amino acid sequences in Figure 5.18.
This oligonucleotide contains inosine nucleotides, which may base-pair with A, C, G 
or T nucleotides. Therefore, the use of inosines in a primer increases the likelihood of 
the primer binding to denatured (single-stranded) DNA. However, inosines also 
reduce the specificity of an oligonucleotide, due to their non-specific base-pairing.
The region of consensus against which primer 60 was designed contains a serine 
residue which may be encoded by any one of six nucleotide triplets. In the 
Streptomyces genes which have been analysed to date, three of these six codons each 
account for over 25% of the serine codons used (AGC: 28%; TCG: 26%; TCC: 39%). 
However, these three triplets show no conservation of nucleotides at any position. 
Therefore, it is extremely difficult to design a an oligonucleotide which will anneal 
only to a deduced DNA sequence encoding a serine for use in Streptomyces, as each 
position of this triplet requires the incorporation of either a degeneracy or an inosine. 
In the design of this oligonucleotide, it was decided to incorporate three inosine 
nucleotides for the triplet encoding the serine residue.
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Primer 60:
Predicted protein sequence :
N 11#-Gly Asn Ser Gly Thr Thr Ile/Met/Thr Arg-117 C
Deduced DNA sequence :
5' -GGn AAC nnn GGn ACn ACn Ann CGn- 3*
Prim er:
5' -GGI AAC III GGI AC(GC) AC(GC) A n CG- 3’
100% 96% 100% 100% 95% 95% 100% 93%
Primer 57:
Predicted protein sequence:
N 417-Asp His Arg lie Gly Met Met Leu-424 C
Deduced DNA sequence (non-coding strand):
5' -GAC CAC CGn ATC GGn ATG ATG CTn- 3'
Deduced DNA sequence (coding strand) :
3' -CTG GTG GCn TAG CCn TAC TAC GAn- 5'
Reverse of deduced DNA sequence (coding strand):
5’ -nAG CAT CAT nCC GAT nCG GTG GTC- 3'
Primer:
5’ -AG CAT CAT ICC GAT ICG GTG GTC- 3'
100% 100% 100% 100% 92% 93% 94% 95%
Figure 5.20 Design of primer 57 and primer 60 for cloning of aroA 
N.B. a) An I in the DNA denotes an inosine nucleotide, which may 
pair with all four of the other nucleotides, and therefore 
increases the likelihood of the primer annealing to DNA
b) Numbers in small block point represent the positions of amino acids 
in Figure 5.18
c) n denotes a position which could contain more than one of the four 
nucleotides
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The region of consensus against which primer 60 was designed also includes a non­
conserved residue (residue 116 in Figure 5.18). At this position, either an isoleucine 
(lie), methionine (Met) or threonine (Thr) occurred in the three sequences which 
exhibit significant conservation. In the Streptomyces genes analysed to date, 
isoleucine is typically (92%) encoded by ATC; methionine is only encoded by ATG; 
threonine is typically encoded by ACG (30%) or ACC (65%). Only the nucleotide 
occurring at the first position is conserved amongst these four codons; either inosines 
or degeneracies ((AT) in the second position, (GC) in the third) must be included at the 
other positions. In this oligonucleotide, it was decided to utilise inosines to solve this 
problem.
In order to increase the possibility of this oligonucleotide annealing to the anticipated 
sequence in the Streptomyces genome, inosines were also included at the third 
position of the two triplets encoding glycine residues. Although it is possible to 
include a (GC) degeneracy in this position, this would only account for 83% of the 
triplets which encode glycine, whereas the use of an inosine at this position would 
account for all of the triplets which encode glycine.
Melting temperatures for oligonucleotides containing inosine residues were calculated 
by ignoring any inosines. Therefore, primer 60 had an estimated Tm of 56-8°C, and 
was approximately 69% G+C rich.
Primer 57 was designed against the sequence DHRIGMML, and acts as the C-terminal 
oligonucleotide (Figure 5.20). It was designed against the deduced DNA sequence of 
the non-coding strand, and was intended to anneal to the non-coding strand of aroA, 
and to prime DNA synthesis towards the 5' of the gene (and therefore towards primer 
60). The region against which it was designed is well conserved amongst three of the 
sequences, and is completely conserved in two of these sequences. However, it is 
only poorly conserved in the sequence from M.tuberculosis (4 out of 8 residues).
As with primer 60, an inosine residue was included in this oligonucleotide at the third 
position of the triplet encoding the glycine residue in the consensus against which this 
oligonucleotide was designed. An inosine was also used at the third position of the 
triplet encoding the arginine contained in this consensus sequence. Use of a (G/C) 
degeneracy at this position would account for only an estimated 82% of the triplets 
which encode arginine, whereas use of an inosine accounts for approximately 93% of 
these codons. It also contains the Gly-418 residue which has been implicated in the 
binding of glyphosate to EPSP synthase [Huynh et al., 1988]. This oligonucleotide 
had an estimated Tm of 59-9°C, and was 57% G+C rich.
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5.2.12 Attempted PCR-cloning of aroA with primer 57 and primer 60
The PCRs described in this section were undertaken using primer 57 and primer 60 in 
an attempt to replicate an internal fragment of the aroA gene, using gDNA isolated 
from S.coelicolor G216, S.lividans TK24 or S.rimosus 4018 mycelia as the template. 
PCRs were performed according to section 2.3.24, and the generation of a product of 
850 to 950 bp in length was anticipated.
Initially, the PCRs were performed at an annealing temperature of 48°C, with a Mg2+ 
concentration of 1 to 2 mM. Although no obvious products were identified when the 
reaction using S.rimosus gDNA as template was run out on an agarose gel, products 
of approximately the anticipated size were identified from S.coelicolor gDNA and 
S.lividans gDNA (at 1-5 and 2 mM Mg2+). These products were still identifiable 
when the annealing temperature was raised to 52°C, but were also identifiable from 
reactions in which primer 57 only was used. Therefore, these products were being 
produced by a single primer alone, and so were not further investigated.
5.2.13 Design of oligonucleotides: primer A. primer B and primer C
These three oligonucleotide primers were also designed against regions of consensus 
in the amino acid sequences of the EPSP synthase enzymes from the Gram-positive 
bacteria and the cyanobacterium. They were intended for use not only as PCR 
primers, but also for use in genomic cloning of aroA, and were therefore longer than 
the oligonucleotides described above.
Primer A was designed against the deduced DNA sequence of the coding strand, to 
anneal to the non-coding strand, and to prime synthesis towards the 5' end of the gene 
in PCR. It was designed against the amino acid consensus sequence 
DH RI(G /A)M M LAIA (residues 416-427 in Figure 5.18), which is well conserved 
amongst the four sequences available. The glycine residue was previously identified 
as the Gly-418 residue which is implicated in the binding of glyphosate to EPSP 
synthase [Huynh et al., 1988].
The region against which this oligonucleotide was designed contains two positions at 
which the amino acids are the same in the sequences from B.subtilis and S.aureus 
(Gly and Met at positions 421 and 423 respectively), but are different to the two 
amino acids in the sequences from Synechocystis and M. tuberculosis (Ala at both 
positions). At position 421, the triplets encoding both amino acids have a G at the 
first position, so a G was used in this position in the oligonucleotide. All of the
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triplets encoding glycine have a G at the second position, which is replaced in all of 
the triplets encoding alanine by a C. Therefore, a (GC) degeneracy was introduced at 
the second position of primer A (Figure 5.21). A (GC) degeneracy was also 
introduced at the third position of this codon, which represents an estimated 83% of 
the triplets encoding glycine, and approximately 92% of those encoding alanine. Use 
of an inosine at this position would have represented all of the triplets encoding both 
amino acids and may, in retrospect, have been the preferable option in the design of 
this oligonucleotide. At position 423, only the methionine codon was represented, as 
the codons for these two amino acids have different nucleotides in the first two 
positions, so that three degeneracies or inosines would be required to represent the 
codons for both amino acids, which would significantly reduce the specificity of the 
oligonucleotide. Methionine was chosen as the amino acid represented at this 
position of primer A as it occurred in the sequences from B.subtilis and S.aureus, 
which are the two Gram-positive bacteria whose amino acid sequences show the 
greatest similarity throughout the entire coding sequence. Primer A had an estimated 
Tm of 75°C, and was approximately 66-7% G+C rich.
Primer B and primer C were designed as nested primers, against the coding strand, to 
initiate DNA synthesis towards the 3' end of the gene during PCR.
Primer B was designed against the consensus amino acid sequence IKDA(A/E)ELKVKE 
(residues 363-373 in Figure 5.18), which is very well conserved in three of the 
sequences available, and completely conserved in two of them. However, this 
sequence is not apparent in the enzyme sequence from M. tuberculosis.
At the fifth residue of this consensus sequence, three of the sequences have an alanine 
residue, whilst the other sequence, that of the enzyme from S.aureus, has a glutamine 
residue. It was decided to incorporate both of these possible residues into the 
oligonucleotide. All four of the triplets encoding alanine have the nucleotides G and 
C in the first two positions respectively, with the two glutamate codons containing G 
and A at these positions. Therefore, an (A C ) degeneracy was used in the second 
position of this triplet (Figure 5.21). A (GC) degeneracy in the third position of these 
codons represents an estimated 93% of the alanine codons and 81% of the glutamate 
codons in S trep to m yces  genes, and was therefore incorporated into the 
oligonucleotide at this position. However, use of an inosine nucleotide at this 
position would represent all six of these possible codons, and may have been a 
preferable option. Primer B had an estimated Tm of between 69-3 and 70-8°C 
(depending on whether an A or C is used at the 14th residue of this oligonucleotide) 
and was between 56*2 and 59-4% G+C rich.
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Primer A:
Predicted protein sequence:
N 417-Asp His Arg He Gly/Ala Met Met Leu Ala He Ala-427 C
Deduced DNA sequence (non-coding strand):
5' -GAC CAC CGn ATC G(GC)n ATG ATG CTn GCn ATC GCn- 3'
Deduced DNA sequence (coding strand):
3' -CTG GTG GCn TAG C(GC)n TAC TAC GAn CGn TAG CGn- 5’
Deduced DNA sequence (coding strand):
5' -nGC GAT nGC nAG CAT CAT n(GC)C GAT nCG GTG GTC- 3'
Primer sequence:
5' -(GC)GC GAT (GC)GC(GC)AG CAT CAT (GC)(GC)C GAT(GC)CG GTG GTC- 3' 
92% 92% 92% 94% 100% 100% 88% 92% 82% 94% 96%
Primer B:
Predicted protein sequence :
N -lie Lys Asp Ala Ala/Glu Glu Leu Lys Val Lys Glu- C
Deduced DNA sequence (non-coding strand):
5’ -ATC AAG GAC GCn G(AC)n GAG CTn AAG GTn AAG GAG- 3’
Primer sequence:
5’ -ATC AAG GAC GC(GC) G(AC)(GC) GAG CT(GC) AAG GT(GC) AAG GA- 3' 
92% 95% 96% 92% 87% 81% 94% 95% 94% 95% 100%
Primer C:
Predicted protein sequence :
N -Val Pro Gly Asp lie Ser Ser Ala Ala Phe Phe-C
Deduced DNA sequence (non-coding strand):
5' -GTn CCn GGn GAC ATC nnn nnn GCn GCn TTC TTC-3'
Primer sequence:
5' -GT(GC) CC(GC)GG(GC) GACATC I(GC)II(GC)(GC) GC(GC)GC(GC) TTC TTC-3' 
95% 94% 83% 96% 92% 100% 93% 92% 92% 99% 99%
Figure 5.21 Design of primer A. primer B and primer C for cloning of aroA
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Primer C was designed against the consensus amino acid sequence VPGDISSAAFF  
(residues 258-268 in Figure 5.18), which is also extremely well conserved in three of 
the sequences available, and is completely conserved in two of them. However, like 
the sequence against which primer B was designed, this sequence is apparently not 
conserved in the sequence of the M. tuberculosis enzyme. The region against which 
primer C was designed contains two serine residues, with the codons representing 
them both containing an inosine at the first position and a (GC) degeneracy at the 
second position. However, it was decided to use an inosine as the third nucleotide of 
the triplet encoding the first of the two serines, and a (GC) degeneracy in the third 
position of the triplet encoding the second serine residue. Primer C had an estimated 
Tm of 76-6°C, and was approximately 73% G + c rich.
5.2.14 Attempted PCR-cloning of aroA with primer A. primer B and primer C
Primer A, primer B and primer C were used in an attempt to amplify an internal 
fragment of the aroA gene from S.coelicolor. The template used in these PCRs was 
S.coelicolor G216 gDNA, and the reactions were performed according to section 
2.3.24, It was anticipated that PCR using primer A and primer C would give a 
product of approximately 500 to 550 bp in length, whilst PCR using primer A and 
primer B would give a product of 180 to 200 bp.
PCRs were initially performed at an annealing temperature of 56°C and at 1-5 mM 
Mg2+, with single-primer PCRs included as controls (Figure 5.22). Although primer 
A and primer B each created a product in single-primer controls, these products were 
significantly in excess of 500 bp, and so were discounted. The PCR using both 
primer A and primer B generated two products of estimated sizes of 500 and 200 bp. 
However, the PCR with primer B and primer C, which was intended merely as a 
negative control, also created a product, approximately 350 bp in length. This was an 
unexpected result, as primer B and primer C were both designed to anneal to the same 
strand. Since neither primer alone gave a product of this size, it appears that one of 
these two primers is annealing to the opposite strand of the genomic DNA. PCR with 
primer A and primer C did not generate any suitable products.
These PCRs were re-performed at MgCl2 concentrations ranging from 0-5 to 3-5 mM 
M g2+ (with increments of 0-5 mM Mg2+) (F igu re 5 .23). Although no obvious 
products were generated with any of the primers at 0-5 or 1 mM Mg2+, primer B and 
primer C together generated the previously-identified 350 bp product at 1-5 to 3-5 
mM Mg2+. Primer A and primer B together generated the 500 and 200 bp products at 
T5 to 2-5 mM Mg2+, with the 500 bp product being the major product, and generated
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a) 10 pi of each 50 pi sample
1 2 3 4 5 6 7
-500  bp
-3 5 0  bp
-200  bp
b) 20 pi of each 50 pi sample
1 2 3 4 5 6 7 8
bp
bp
bp
Figure 5.22 PCRs on gDNA from G216 at 56°C and 1-5 mM Mg2+
lanes 1 and 8: XI Hind III markers [lane 1 only in a)]
lane 2: primer A alone lane 5: primer A and primer B
lane 3: primer B alone lane 6: primer A and primer C
lane 4: primer C alone lane 7: primer B and primer C
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1 2 3 4 5 6 7 8 9 10 11 12 13 14
-5 0 0  b p  1
(lanes 5 and 11)
-200 bp
 -5 5 0  bp
(lane 12 only)
 -350  bp
Figure 5.23 PCRs on gDNA from G216 at 56°C and 2-2-5 mM Mg2+
lanes 1 and 14: XIHind III markers
lanes 2-7: 2 mM Mg2+ lanes 8-13: 2-5 mM M g2+
lanes 2 and 8: primer A alone lanes 5 and 11: primer A and prim er B
lanes 3 and 9: primer B alone lanes 6 and 12: primer A and prim er C
lanes 4 and 10: primer C alone lanes 7 and 13: primer B and prim er C
1 2 3 4 5 6 7 8 9 10 11 12 13 14
bp
bP
Figure 5.24 PCRs on 550 bp product at 56°C and 2-5 mM Mg2+
lanes 1 and 14: X/Hind III markers 
lanes 2-7: 10 pg 550 bp template 
lanes 2 and 8: primer A alone 
lanes 3 and 9: primer B alone 
lanes 4 and 10: primer C alone
lanes 8-13: 100 pg 550 bp template 
lanes 5 and 11: primer A and prim er B 
lanes 6 and 12: primer A and prim er C 
lanes 7 and 13: primer B and prim er C
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the 200 bp product alone at 3 and 3*5 mM Mg2+. Primer A and primer C generated a 
single product with an estimated size of 550 bp at 2*5 to 3-5 mM Mg2+ which was not 
synthesised in any of the single primer reactions.
The 550 bp product generated by PCR with primer A and primer C, using gDNA 
from G216 as the template, was purified from a TAE gel, and used as the template for 
a further series of PCRs at 2-5 mM Mg2+ (Figure 5.24), Again, all three primers 
were used, either singly or in pairwise combination, in these reactions. It was 
anticipated that PCR using primer A and primer C in combination would regenerate 
the 550 bp product, and primer A and primer B together would cause the synthesis of 
the 200 bp product.
The concentrations of template used were approximately 1 ng, 100 pg or 10 pg per 
reaction, and the annealing temperature was maintained at 56°C. At all three template 
concentrations, primer A and primer C in isolation regenerated the 550 bp product, 
which was therefore visible in all pairwise reactions. However, primer A and primer 
B also generated the 200 bp product at a higher level than the 550 bp product with all 
three concentrations of template. The same results were obtained at an annealing 
temperature of 57°C.
In an attempt to sequence the two PCR products generated by primer A and primer B 
(200 bp) and primer A and primer C (550 bp), they were both purified from a TAE 
gel and ligated into pIBI25, which had previously been digested with Hinc II (which 
produces blunt-ended ends) and subsequently T-tailed. The ligation mixture was 
transformed into competent E.coli DS941 cells, and the transformation mixture plated 
onto L agar supplemented with ampicillin. However, none of the resultant 
transformants contained inserts.
Cloning of the two purified PCR products was then attempted via ligation into the 
commercially-available pT7Blue T-vector (linearised by digestion with the EcoR V 
restriction enzyme, which also produces blunt ends, and then T-tailed). The ligation 
mix was transformed into competent E.coli DS941 cells, and the transformation mix 
plated onto L agar supplemented with ampicillin, X-gal and IPTG. However, the 
resultant white colonies again failed to contain any inserts.
Direct sequencing of the two PCR products was then attempted. Two PCR 
sequencing methodologies were utilised: cycle sequencing, and asymmetric PCR. In 
cycle sequencing, PCRs containing only one of the primers, one of the four ddNTPs
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and 32P-dATP are performed. Therefore, the products are radiolabelled, and DNA 
polymerisation is likely to be terminated by incorporation of a dideoxynucleotide into 
the newly-synthesised strand. As only one of the two PCR primers is used in the 
reaction, only one of the two strands is used as a template for polymerisation, so the 
reaction only yields sequence of its complementary strand.
Cycle sequencing, using the SequiTherm Cycle Sequencing Kit, was undertaken with 
primer A and primer B to generate sequence from both strands of each PCR template. 
The reactions underwent 30 cycles, each consisting of a denaturation step (95°C for 
30 secs), an annealing step (50°C for 30 secs) and an extension step (70°C for 1 min). 
Stop solution (containing electrophoresis dyes) was added after the reactions had 
ended, the products were denatured at 70°C, and the PCRs products separated by 
PAGE. However, no sequence could be read from the PCRs.
In asymmetric PCR, reactions are performed under normal conditions, but the 
concentration of one of the primers is limiting in the PCR (1 pmol, compared with 50 
pmol of the other primer). The reaction therefore synthesises an excess of one strand, 
which may then be sequenced according to the single-stranded sequencing protocol.
Asymmetric PCR was performed using both of the PCR products which had 
previously been identified (550 bp and 200 bp) as templates. The primer which was 
limiting in the asymmetric PCR was used as the sequencing primer, which had 
previously been radiolabelled with 32P-dATP. Again, no readable sequence was 
obtained from either template with either sequencing primer (primer A and primer C 
for the 550 bp product, and primer A and primer B for the 200 bp product).
The 550 bp and 200 bp PCR products were again purified from a 1-6% TAE gel, and 
ligated (to give p550 and p200 respectively) into pDKlOl which had previously been 
digested with Xcm I and gel-purified. The ligation mixtures were transformed into 
TG-1 cells, and the mixture plated onto L agar containing ampicillin, IPTG and X- 
gal. A single putative p200-containing colony and eleven putative p550-containing 
transformants were selected for further investigation.
These colonies were streaked to single colonies, one (per transformant) of which was 
resuspended in 100 |il of Doly I solution, and plasmid DNA isolated by the standard 
Birnboim-Doly procedure. The resultant pellets were resuspended in dH20 and used 
as templates for PCR reactions using primers A and B for the putative p200 plasmid 
DNA, and primers A and C for the putative p550 plasmid. 2-5 mM MgCh was used 
in all PCRs.
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Figure 5.25 PCR using primers A and C on putative p550 plasmids
lane 1: XI Hind III markers
lanes 2-10: PCRs on putative p550 plasmids
HNRHMMHHHSHHHSj................
, ' '  'wrnmWm
Figure 5.26 PCR using primers A and C on putative m550-18 and m550-19 
single-stranded DNA
lanes 1-4: PCR on putative m 550-18 templates
lane 5: XIHind III markers
lanes 6-8: PCR on putative m550-19 templates
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The products were run out on a 2% TAE gel (Figure 5.25). Although no product was 
observed with the putative p200, eight of the putative p550 plasmids gave a single 
product of the anticipated size.
The insert was isolated from one of these p550 plasmids by digestion with Sst I and 
Sph I, ligated into the M13mpl8 and M13mpl9 vectors (to give m550-18 and m550- 
19 respectively), and the mixtures transformed into TG-1 cells. Four white plaques 
were selected from each transformation, grown up as in the standard M13 protocol, 
and the supernatants used as templates for PCR reactions with primers A and C at 2-5 
mM Mg2+. The products were run out on a 2% TAE gel (Figure 5.26). Four of the 
putative m550-18 transformants and two of three putative m550-19 transformants 
gave a single product of the anticipated size. Single stranded DNA was therefore 
prepared from one each of the m550-18 and m550-19 transformants. The single­
stranded DNA was sequenced using the -40 primer. However, the sequence derived 
from m550-18 consisted of M13mpl8 polylinker sequence upto the Sph I restriction 
site, followed by pDKlOl polylinker sequence upto the Sst I restriction site, and then 
more M13mpl8 polylinker sequence. The sequence derived from m550-19 was the 
reverse-complement of this sequence. Therefore, it appears that the plasmid p550 
contains no insert DNA, and is actually pDKlOl. The m550-18 and m550-19 clones 
constructs merely contain the Sst l-Sph I polylinker sequence. This suggests that 
when pDKlOl was digested with the Xcm I enzyme, the enzyme only cut at one of its 
restriction sites in the polylinker, creating only a linear plasmid which had a single 
overhanging T at one end, but a single overhanging A at the other. Thus, a PCR 
product (which contains overhanging A ’s at both ends) would not be able to ligate to 
this linearised plasmid DNA, which must have merely undergone a religation event.
It also appeared that the approximately 550 bp PCR product generated with primers A 
and C using p550, m550-18 and m550-19 as templates was produced by one (or both) 
of the primers annealing to the vector DNA sequences outside of the polylinkers. To 
test this theory, PCR was performed on approximately 5 ng of pDKlOl and 5 ng of 
M13mpl8 using the same conditions as when genomic 1147 DNA (or p550, m550-18 
or m550-19) was used as the template. When the PCR reactions were run out on a 
2% TAE gel, both reactions were found to contain a single product of approximately 
550 bp in length (Figure 5.27).
167
Chapter 5
564 bp
Figure
lane 1: PCR on -5  ng pDKlOl 
lane 2: XtHind III markers 
lane 3: PCR on ~5 ng M 13m pl8
m arker— ►  pBfP S  ' t  .
■ — -550  bp product
5.27 PCR using primers A and C on pDKlOl and M 13mpl8
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5.2.15 Attempted cloning of aroA from a X library
Radiolabelled primer C was used to probe a fully-representative A,-Gemll genomic 
library of S.coelicolor, which comprised approximately 9000 plaques (Taylor, 1992). 
The filters were hybridised at 56°C in Quickhyb hybridisation buffer, and washed 
twice at 56°C in 4x SSC, 0-1% SDS, 0-1% sodium pyrophosphate. From this primary 
screen, five X plaques were identified which lit up on duplicate filters. These plaques 
were picked and replated in E.coli, and the sub-library blotted onto nylon membranes 
to allow a secondary screening to be undertaken.
These filters were also probed with radiolabelled primer C, this secondary screen 
identifying 1 0  clones (produced from only two of the initial five clones) which lit up 
on autoradiograms. Again, these plaques were picked from the secondary plates and 
replated, and blotted onto nylon membranes. However, when these filters were 
probed with radiolabelled primer C, no X plaques lit up on autoradiograms.
5.3 Discussion
Ideally, the EPSP synthase enzyme (encoded by aroA) of S.coelicolor would have 
been purified and N-terminal sequencing undertaken, allowing nucleotide primers to 
be designed against the deduced DNA sequence of the coding region of aroA. These 
oligonucleotides would then have been used to clone the aroA gene, either by PCR 
using genomic DNA isolated from S.coelicolor as template, or by probing genomic 
digests or A,-libraries. When the work described in this thesis was begun, it was 
anticipated that the EPSP synthase would be purified by collaborators with this 
research group from the Biochemistry Department of the University of Glasgow. 
However, such purification was not attempted. Therefore, alternative methods of 
cloning the aroA gene were undertaken.
Oligonucleotides were designed against DNA sequence derived from regions of 
protein sequence conserved across a number of EPSP synthase sequences. Initially, 
the only sequences available were from plants, Gram-negative bacteria and lower 
eukaryotes. Although PCR products of approximately the correct size were 
identified, two of which were cloned and sequenced, attempts at cloning a fragment 
of the aroA gene using the primers designed against these sequences were not 
successful.
169
Chapter 5
One of the oligonucleotides designed against these amino acid sequences was 
subsequently used in an attempt to clone the aroA gene from digests of genomic 
DNA. Two genomic DNA bands of a suitable size for cloning were identified, one of 
which was cloned. However, the DNA sequence of part of this fragment encodes an 
amino acid sequence which shows no similarity to the protein sequences from any 
other EPSP synthases.
While such attempts at cloning of the aroA gene were being undertaken, the cloning 
of the genes encoding the EPSP synthase enzymes from a number of other species, 
including plants, lower eukaryotes and Gram-negative bacteria, was reported. The 
deduced amino acid sequences from three Gram-positive bacteria and one 
cyanobacterium were also reported. Although the amino acid sequences from all of 
the other species exhibited significant levels of similarity to each other, the enzymes 
from the three Gram-positive bacteria and the cyanobacterium showed only limited 
similarity to the other enzymes, but significant similarity to each other (although the 
deduced protein sequence from the enzyme of Mycobacterium tuberculosis showed 
poor similarity to any of the other deduced protein sequences).
These four deduced amino acid sequences were lined up, and showed regions of 
consensus sequence, particularly across the enzymes from B.subtilis, S. aureus (both 
Gram-positive bacteria) and Synechocystis (the cyanobacterium). Since it was 
anticipated that the enzyme from S.coelicolor would show greatest similarity to those 
of other Gram-positive bacteria, oligonucleotides were designed against these regions 
of consensus, and again used for cloning of the aroA  gene from S.coelicolor. 
However, these attempts to clone aroA were also unsuccessful.
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CHAPTER 6
Expression of the 3-dehvdroquinase from E.coli  in
S.coel ico lor
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6.1 Introduction
6.1.1 Difference in K™ between the type I and type II dehvdroquinase 
enzymes
If the shikimate pathway is not functioning at its maximum capacity in S.coelicolor, 
then increasing the flux through the pathway may be facilitated by deregulation of the 
pathway, upregulation of each step of the pathway, or even by upregulation of the steps 
in the pathway which have high flux control coefficients, and are therefore involved in 
the control of the rate of flux through the pathway (see section 1.12.3). Methods of 
producing upregulation of a catalytic step include overexpression of the enzyme, or the 
introduction of a more efficient homologue of the enzyme, either as a replacement for 
the indigenous enzyme or in addition to it.
The type II dehydroquinase enzymes have higher Km's than those of the type I 
enzymes; the S.coelicolor enzyme has been reported as having a Km of 650 pM, which 
is approximately twenty times that of the E.coli type I enzyme [White et a l, 1990]. 
Due to the differing Km's of the two dehydroquinase enzymes, the type I enzyme is 
more capable of sequestering its substrate than its type II counterpart. It was therefore 
proposed that the E.coli type I enzyme may perform more efficiently in the shikimate 
pathway of S.coelicolor than the host type II enzyme, particularly during conditions of 
low substrate concentration which may occur during the life-cycle and lead to the 
initiation of differentiation, or during periods of high levels of flux through the 
pathway, for example during secondary metabolism. Therefore the working 
hypothesis for the experiments described in this chapter was that expression of the 
E.coli type I dehydroquinase in S.coelicolor might upregulate this particular step, and 
possibly increase the overall flux through the pathway. As the work for this thesis was 
undertaken as part of a project aimed at increasing the rates of synthesis of the 
intermediates and products of the shikimate pathway, which may then be used as 
substrates for the biosynthesis of secondary metabolites, increasing the flux through the 
shikimate pathway was one of the major aims of this work.
Expression of the E.coli aroD gene in a strain of S.coelicolor containing a disrupted 
aroQ gene would demonstrate whether the E.coli aroD gene is able to complement this 
mutation, and therefore whether a type I dehydroquinase is able to replace the type II 
enzyme in S.coelicolor. Complementation would also provide further evidence that the 
disrupted gene is involved in the conversion of DHQ to DHS, and is either a structural 
gene (likely to encode the dehydroquinase enzyme) or a regulatory gene acting on the 
expression of dehydroquinase.
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Since this research was begun, the aroQ gene of S.coelicolor has been expressed in 
E.coli, under the control of the inducible T7 promoter [G. Young, unpublished 
results]. This construct is able to complement the E.coli strain AB2848, which 
contains an aroD mutation. Also, when expression from the T7 promoter in this 
construct is induced in E.coli, a protein of the correct size for the S.coelicolor type II 
dehydroquinase was overexpressed. This protein was subsequently purified and 
characterised biochemically, and shown to be the S.coelicolor type II dehydroquinase 
enzyme.
6.1.2 The tac promoter
The tac promoter (Ptac) is a hybrid promoter created from two E.coli promoters, the trp 
and lac UV5 promoters [de Boer et al., 1983]. It consists of the -35 region from the 
strong trp promoter, and the -10 region from the lac UV5 promoter. In E.coli, it is 
repressed by the lac repressor, and derepressed by IPTG. It is stronger than both 
parental promoters.
It has been demonstrated that Streptomyces have an RNA polymerase holoenzyme 
which is capable of transcribing certain promoters from E.coli [Jaurin & Cohen, 1984]. 
Indeed, it was shown that Vtac was expressed in S.lividans [Horinouchi & Beppu, 
1985]. It has been suggested that Ptac shows a high level of similarity to the 
"consensus" promoter sequences of both E.coli and Streptomyces, and so its ability to 
function in S.lividans was not unexpected [Alves, 1989].
Ftac is repressed by the lac repressor (encoded by the lacl gene) and derepressed by 
IPTG in both E.coli and S.lividans. However, it has also been suggested that there is 
no naturally-occurring repressor capable of causing significant repression in S.lividans 
[Alves, 1989]. Therefore, although the addition of IPTG to an E.coli culture for 
transcription from Vtac is necessary, the same is not true for S.lividans. It was 
anticipated that the same situation exists in S.coelicolor as in S.lividans, and so no 
IPTG induction of the Ptac-aroD construct was attempted.
6.2 Results
The aroD gene of E.coli, encoding its type I 3-dehydroquinase, has been cloned 
[Kinghorn et al., 1981] and sequenced [Duncan et al., 1986; Chaudhuri et al., 1991]. 
It was previously subcloned into a pKK223/3 vector, bringing it under the control of 
the E.coli tac promoter (Ptac) 1° facilitate overexpression.
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The pWHM3 vector is a bifunctional E.coli-Streptomyces shuttle vector, containing a 
plasmid origin of replication (ori) from both species [Vara et al., 1989]. It also 
contains genes encoding resistance to ampicillin and thiostrepton, providing selectable 
resistance markers in E.coli and Streptomyces respectively. The Bel I fragment 
containing the thiostrepton resistance marker was removed previously, the plasmid 
religated, and the vph gene subcloned into the Sph I site, producing the bifunctional 
shuttle vector pKL69 [K.Linton, personal communication]. This vph gene, originally 
cloned from Streptomyces vinaceus [Thompson et al., 1982b], encodes the viomycin 
phosphotransferase enzyme which provides resistance to the antibiotic viomycin by 
phosphorylating the antibiotic, producing phosphoviomycin which has no antibiotic 
activity [Thompson et al., 1982c]. The vph gene, like tsr, functions as a selectable 
marker in Streptomyces.
6.2.1 Construction of a bifunctional vector allowing expression of the
3-dehvdroquinase from  E.coli
In order to express the Ptac~aroD gene construct in S.coelicolor, the construct 
underwent two subcloning steps to produce the restriction sites to allow it to be 
subcloned into the shuttle vector pKL69, ultimately producing plasmid pPM23 
(Figure 6.1). This plasmid was isolated from the E.coli TG-1 strain in which it had 
been constructed, and transformed into the E.coli aroD  strain, AB2848. Two 
transformants, along with two AB2848 colonies and a TG-1 colony were streaked 
sequentially onto minimal agar, minimal agar supplemented with the aromatic amino 
acids (phenylalanine, tyrosine and tryptophan), and L agar. The plates were incubated 
at 37°C for up to 2 days. Although non-transformed AB2848 did not grow on minimal 
agar due to its aromatic amino acid auxotrophy (one of the colonies grew very poorly 
on minimal agar, presumably due to the residual aromatic amino acids contained in the 
cells when streaked onto the minimal plate), cells transformed with pPM23 did grow, 
demonstrating that this construct was able to complement the aroD  mutation in 
AB2848, and therefore that the type I dehydroquinase was expressed from this 
construct from the Ptac promoter in E.coli [Figure 6.2], TG-1 was used as a positive 
control, and grew on minimal agar as anticipated. All five colonies grew on both 
minimal agar supplemented with the aromatic amino acids and on L agar.
6.2.2 Expression of the 3-dehvdroquinase from  E .coli in S .coelico lor
For transformation of protoplasts of S.coelicolor with pPM23, two methods of evading 
the restriction barrier of S.coelicolor were attempted: passage of plasmid from E.coli
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Figure 6.1 Construction of a bifunctional plasmid expressing the 
3-dehvdroquinase from E.coli
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A B
C
Figure 6.2 Complementation of an aroD  mutation in E.coli with 
pPM23
Plate A: Minimal medium + phenylalanine, tyrosine and tryptophan 
Plate B: Minimal medium 
Plate C: L agar
Strain 1: TG-1
Strains 2 and 3: AB2848/pPM23 
Strains 4 and 5: AB2848
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via S.lividans into S.coelicolor, and transformation of S.coelicolor  with non- 
methylated plasmid DNA.
For the first strategy, pPM23 was isolated from the methylating E.coli strain TG-1, and 
transformed into protoplasts of S.lividans TK64. The transformation mixture was 
plated on R2 regeneration medium and incubated at 30°C, with transformants being 
selected by overlaying with viomycin after approximately 18 hrs growth.
Two transformants were isolated, were grown in YEME liquid medium supplemented 
with viomycin, and plasmid DNA was isolated by alkaline lysis (see 2.3.2.4). This 
plasmid DNA was transformed into protoplasts of S.coelicolor G216, which were 
again plated on R2 and overlaid with viomycin. Three colonies were selected for 
further analysis (G216/pPM23-l, -2, -4).
For the second strategy, pPM23 isolated from E.coli TG-1 was transformed into 
MB5386, a dam~dcm~ E.coli strain. Protoplasts of S.coelico lor  G216 were 
transformed with pPM23 isolated from MB5386, and transformants selected by 
overlaying with viomycin. Two colonies were isolated (G216/pPM23-X, -Y).
These five isolates were grown in YEME supplemented with viomycin, and plasmid 
DNA was isolated using the Kieser method of alkaline lysis. As plasmid isolation from 
S.coelicolor was not particularly successful, and as pPM23 is a bifunctional E.coli- 
S.coelicolor shuttle vector, plasmid DNA rescued from these G216 isolates was 
transformed into competent E.coli TG-1 cells, and transformants selected by growth on 
L agar supplemented with ampicillin. Transformants were obtained with DNA rescued 
from the strains G216/pPM23-2, -X, and -Y. Plasmid DNA was isolated from these 
E.coli transformants, and digested with BamH I, which removes the complete Ptac~ 
aroD  fragment from the vector. The restriction map produced from the sole 
transformant from pPM23-2 was not consistent with it being the desired construct, and 
so pPM23-2 was not investigated further. However, plasmid DNA from all of the 
putative pPM23-X and pPM23-Y transformants which were tested produced the 
anticipated restriction map. Therefore, G216/pPM23-X and G216/pPM23-Y isolates 
both apparently contained the correct pPM23 construct.
6.2.3 Biochemical analysis of E.coli and S.coelicolor containing pPM23
The two G216 isolates containing pPM23 were grown in YEME liquid medium 
supplemented with viomycin, glycine and MgCl2 . Untransformed G216 and TG-1 
were grown in YEME and 2xYT respectively. TG-1/PM23-Y was grown in 2xYT
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supplemented with ampicillin. The TG-1 strains were grown in 100 ml of culture for 
approximately 7 hours; the G216 strains were grown in 200 ml of culture, and cells 
were harvested by centrifugation, the pellets resuspended in extraction buffer, and the 
cells lysed using the French press method. The lysates were centrifuged to remove cell 
debris, and the supernatant assayed for dehydroquinase activity. The dehydroquinase 
activities in the crude extracts were assayed on a spectrophotometer by measuring the 
rate of increase in OD at a wavelength of 234 nm when the substrate (DHQ) is added to 
a sample of enzyme contained in assay buffer (2.5.2). Typically, 0-05 M Tris-Cl (pH 
8-0) was used as the assay buffer (this is an assay buffer for a type II dehydroquinase 
enzyme) [White et al., 1990]. The activities were calculated as an average of at least 
three assay measurements using differing volumes of supernatant in the assay.
The protein concentration in the crude extract was estimated from a standard curve of 
BSA (bovine serum albumin) using the Bradford's protein assay, measured at OD595 
(2.5.3). From these estimated protein concentrations, the specific activity of 
dehydroquinase in the crude extracts (measured in Units of enzyme per mg of protein) 
was calculated.
The untransformed G216 mycelia contain only the heat-stable type II dehydroquinase, 
whereas the pPM23-containing G216 isolates were expected to also contain the heat- 
labile type I dehydroquinase activity. All three E.coli cultures were expected to contain 
only the type I dehydroquinase activity, but it was anticipated that the dehydroquinase 
would be overexpressed in the cells containing pPM23.
Type I dehydroquinase enzymes are known to be thermolabile, and so crude extracts 
were heated to 70°C for 15 mins to denature the type I dehydroquinase, followed by 
further assays of their dehydroquinase enzyme activity. Alternatively, the assays were 
performed in a potassium phosphate (pH 7-0) (the assay buffer for a type I 
dehydroquinase enzyme), in the presence or absence of 01  M KC1, which has 
previously been demonstrated to inhibit the type I dehydroquinase enzyme in E.coli 
[Chaudhuri et al., 1986], but not the type II enzyme in S.coelicolor [White et al., 
1990].
The TG-l/pPM23-Y isolate showed an approximately 2968-fold overexpression of 
the type I dehydroquinase relative to the activity in the untransformed strain (Table 
6.1). However, when the crude extract of TG-l/pPM23-Y was heated to 70°C, its 
dehydroquinase activity was reduced 1385-fold. When TG-l/pPM23-Y was assayed 
for activity in OT M potassium phosphate buffer containing 0-1 M KC1, no activity 
was detected. These results confirm that the type I dehydroquinase enzyme, when
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Strain
Assay
conditions
Activity
(Units/ml)
Protein
concentration
(mg/ml)
Specific
( u ^ a
Standard
Deviation
fan-l)
TG-1 005 M 
Tris-Cl (pH 8) 1-3 9 0 0 1 4 0*11
TG-1/
pPM23-Y
005 M 
Tris-Cl (pH 8) 41550 100 415*5 N/A
005 M Tris-Cl 
Heat: 70°C, 15 mins 3 0 100 0*30 0*005
01  M pot phos. 
(dH 7) +0*1 M KC1
0*35 100 0 0 4 0*07
G216 005 M 
Tris-Cl (pH 8) 4-0 3*5 1*14 0*40
G216/
pPM23-X
0 05 M 
Tris-Cl (pH 8) 1200 2-7 44*4 6*80
G216/
pPM23-Y
0 05 M 
Tris-Cl (pH 8) 8 0 1*5 5*33 0*45
Table 6.1 Activity of dehvdroauinase in E .coli and S.coelicolor
strains
N.B. pot. phos. denotes potassium phosphate
extracted from E.coli, is thermolabile and its activity is inhibited by KQ.
The G216 strains were grown until they formed a fairly dense culture but before they 
produced excessive amounts of pigment (which is indicative of them having undergone 
differentiation from primary to secondary metabolism). G216/pPM23-X cells showed 
an approximately 39-fold increase in activity, and G216/pPM23-Y an approximately
4-7-fold increase relative to the activity in crude extracts from the untransformed G216 
strain (Table 6.1). These results suggested that the type I dehydroquinase enzyme 
from E.coli is functional in S.coelicolor, and is expressed in this host from the Ptac 
promoter.
Approximately 50 |ig of protein from the crude extracts from these S.coelicolor strains, 
along with those from TG-1 and uninduced and IPTG-induced TG-l/pPM23-Y were 
run on a PAGE gel, using a 5% stacking gel and 12% running gel. As can be seen 
from Figure 6.3, the two TG-1 transformants overexpressed a single band of 
apparent molecular weight of approximately 25 kDa, which was not evident in the
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-25  kDa -
Figure 6.3
Lane 1: 
Lane 2: 
Lane 3: 
Lane 4: 
Lane 5: 
Lane 6: 
Lane 7: 
Lane 8:
Crude extracts from E.coli and S.coelicolor  with and 
without plasmid pPM23
VII-L protein markers (14.2 / 20.1 / 24 / 29 / 36 / 45 / 66 kDa) 
Approx. 50 pg total protein from T G -1
Approx. 50 pg total protein from TG-l/pPM 23-Y (non-induced)
Approx. 50 pg total protein from TG-l/pPM 23-Y (induced)
Approx. 50 pg total protein from G216
Approx. 50 pg total protein from G216/pPM23-X
Approx. 50 pg total protein from G216/pPM23-Y
Low molecular weight protein markers
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crude extract from the untransformed TG-1 strain. However, this protein was not 
visible in any of the crude extracts from the G216 strains.
When the assays were repeated using S.coelicolor cells grown to stationary phase (and 
producing considerable amounts of pigment), G216/pPM23-X exhibited the same level 
of activity as untransformed G216, and G216/pPM23-Y showed only an approximately 
1-3-fold increase in activity (Table 6.2). Therefore, it appeared that the activity of 
dehydroquinase in the overexpressing strains was reduced by the cells having 
undergone differentiation.
Strain Assay
conditions
Activity
(Units/ml)
Protein
concentration
(mg/ml)
Specific
Activity
(Units/mg)
Standard
Deviation
K - l )
G216 0 05 M 
Tris-Cl (pH 8) 2-3 5-2 0-44 0-49
G216/
pPM23-X
0 05 M 
Tris-Cl (pH 8) 1*6 3*7 0-43 0-31
G216/
pPM23-Y
0 05 M 
Tris-Cl (pH 8) 1*5 2-6 0-58 0-15
Table 6.2 Dehydroquinase activity in S.coelicolor  cultures having 
undergone differentiation
The three G216 strains were again grown in the appropriate liquid medium, but cells 
were harvested when they had only grown to a relatively low density. Their 
dehydroquinase activities were measured in 0-05 M Tris-Cl buffer, with G216/pPM23- 
X cells showing an approximate 3-5-fold reduction in activity, and G216/pPM23-Y 
cells exhibiting approximately the same activity as untransformed G216 cells (Table 
6.3).
The three G216 strains were once again grown in the appropriate liquid medium, and 
cells were harvested at an OD600  of between 0-35 and 0-45. The G216 cells (OD6 0 0  of 
0-35) had not excreted any pigment into the medium; the G216/pPM23-X cells (OD600 
of 0-4) had secreted very little, if any, pigment; the G216/pPM23-Y cells (OD6 0 0  °f 
0-45) appeared to have just begun to excrete pigment. The dehydroquinase activities 
were assayed in 0-05 M Tris-Cl, with the G216/pPM23-Y cells exhibiting 
approximately a 5-fold increase in activity relative to the untransformed G216 and the 
G216/pPM23-X cells(Table 6.4).
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Strain Assay
conditions
Activity
(Units/ml)
Protein
concentration
(mg/ml)
Specific
Activity
(Units/mg)
Standard
Deviation
(On)
G216 0 05 M 
Tris-Cl (pH 8 ) 0-16 0-75 0 ' 2 1 003
G216/
pPM23-X
0 05 M 
Tris-Cl (pH 8 ) 0-31 5 0 006 006
G216/
pPM23-Y
0 05 M 
Tris-Cl (pH 8 ) 0-94 4*4 0 - 2 1 005
Table 6.3 Dehydroquinase activity in growing cultures of S.coelicolor
Strain Assay
conditions
Activity
(Units/ml)
Protein
concentration
(mg/ml)
Specific
Activity
(Units/mg)
Standard
Deviation
(on)
G216 0 05 M 
Tris-Cl (pH 8 ) 1*3 6*75 019 0 - 2 0
G216/
pPM23-X
0 05 M 
Tris-Cl (pH 8 ) 1*5 8-75 017 0 1 2
G216/
pPM23-Y
0 05 M 
Tris-Cl (pH 8 ) 80 8'5 0-94 0*24
Incubated at 70°C for 15 mins:
Strain Assay
conditions
Activity
(Units/ml)
Protein
concentration
(mg/ml)
Specific
Activity
(Units/mg)
Standard
Deviation
(on)
G216 0 05 M 
Tris-Cl (pH 8 ) M 6-75 016 007
G216/
pPM23-X
0 05 M 
Tris-Cl (pH 8 ) 1*5 8-75 0*17 0*23
G216/
pPM23-Y
0 05 M 
Tris-Cl (pH 8 ) 1-4 8-5 016 0 - 1 1
Table 6.4 Dehydroquinase activity in cultures of S.coelicolor  grown 
to an OD^nn of 0*35 to 0*45
The crude extracts from the three strains were then heated to 70°C for 15 mins, and re­
assayed (Table 6.4). Neither of the extracts from the G216 or G216/pPM23-X 
cultures showed any significant decrease in activity, but that from the G216/pPM23-Y 
culture showed a decrease in activity of approximately 80%, falling to a level similar to
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that of the other two strains. This result suggests that G216/pPM23-Y was 
overexpressing the type I dehydroquinase from E.coli, but that the G216/pPM23-X 
strain was not, and contained only the native type II dehydroquinase activity.
The crude extracts were assayed for type I dehydroquinase activity in OT M potassium 
phosphate buffer [Chaudhuri et al., 1986] containing KC1 (Table 6.5). It was 
anticipated that all three extracts would exhibit the same level of activity in the presence 
of 01  M KC1, as KC1 inhibits the activity of the type I dehydroquinase enzyme. 
Although both of the strains not expressing the type I dehydroquinase under these 
conditions showed the same activity, the overexpressing strain had an approximately 
17-7-fold higher level than these two strains. This appears to suggest that KC1 was not 
exerting its usual inhibitory effects on type I dehydroquinase when this form of the 
enzyme was expressed in S.coelicolor. To quantify the inhibitory effect of KC1 on the 
type I dehydroquinase in S.coelicolor, the activity in the crude extract from 
G216/pPM23-Y was assayed in 0.1 M potassium phosphate containing increasing 
concentrations of KC1. The dehydroquinase activity appears to be inversely 
proportional to the concentration of KC1 in the assay buffer (Figure 6.4).
Strain Assayconditions
Activity
(Units/ml)
Protein
concentration
(mg/ml)
Specific
Activity
(Units/mg)
Standard
Deviation
(<Vl)
G216 0-1 M pot. phos. 
(nH 71 + 0*1 MKC1
0-29 6-75 0043 0 - 1 2
G216 / 
pPM23-X
O 'lM  pot. phos. 
(nH 71 + 0-1 MKC1
0-38 8-75 0043 0 - 1 0
0-1 M pot. phos. 
(nH 71 + 0-1 MKC1
6-5 8-5 0-76 0 1 0
G216 / 
pPM23-Y
0-1 M pot. phos. 
(nH 71 + 0-2 M KC1
6 0 8-5 0-71 003
0*1 M pot. phos. 
fnH 71 + 0-25 M KC1
5-4 8-5 0-64 0-27
01 M pot. phos. 
fnH 71 + 0-35 M KC1
4-8 8-5 0-56 006
0-1 M pot. phos. 
fpH 71 + 0-45 M KC1
4-2 8-5 0-49 015
Table 6.5 Dehydroquinase activity in crude extracts of S.coelicolor 
in the presence of KC1
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ocd
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0.45
o 8 8 8
KC1 concentration (mM)
Figure 6.4 Inhibition of dehydroquinase activity in G216/pPM23-Y 
bv KC1
The three crude extracts were frozen at -20°C for storage, but were thawed for assaying 
in the 01 M potassium phosphate (pH 7 0) buffer with and without KC1. They were 
also assayed in 0 05 M Tris-Cl (pH 8  0) buffer to allow comparison with the activities 
which had been determined previously. The crude extracts from both G216 and 
G216/pPM23-Y showed a significant decrease in activity in 0-05 M Tris-Cl relative to 
their activities before freezing (approximately 21% and 16% respectively) (Table 6.6 
relative to Table 6.4); the crude extract from G216/pPM23-X showed no significant 
decrease in activity (approximately 6 %).
The crude extracts from all three strains showed no significant decrease in activity in the 
01  M potassium phosphate (pH 7-0) buffer as they did before freezing (Table 6.6 
relative to Table 6.5).
The crude extracts from G216 and G216/PM23-X both showed slight increases in 
activity when assayed in OT M potassium phosphate buffer containing 01  M KC1 
when compared to their activities in the absence of KC1, further evidence that neither 
culture is overexpressing the type I dehydroquinase. Although the overexpressing 
strain (G216/pPM23-Y) showed a decrease of approximately 17% due to the addition 
of 0-1 M KC1 to the assay buffer, it still showed a 16-fold increase relative to that of
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Strain Assay
conditions
Activity
(Units/ml)
Protein
concentration
(mg/ml)
Specific
Activity
(Units/mg)
Standard
Deviation
(<*n)
G216
0 05 M Tris-Cl 
(pH 8 ) 1 0 6-75 0*15 0*23
01 M pot. phos. 
(pH 7) 0-24 6*75 004 004
0T M pot. phos. 
(pH 7 )+ 0T MKC1 0*28 6*75 004 003
G216/
pPM23-X
0-05 M Tris-Cl 
(pH 8 ) 1*4 8-75 016 0 - 2 1
01 M pot. phos. 
(pH 7) 0-17 8-75 0 0 2 006
01 M pot. phos. 
(pH 7 )+ 0T MKC1 0*24 8-75 003 004
G216 / 
pPM23-Y
0 05 M Tris-Cl 
(pH 8 ) 6-7 8-5 0*79 0-24
01 M pot. phos. 
(pH 7) 6-5 8-5 0-76 008
0T M pot. phos. 
(pH 7 )+ 0T MKC1 5-4 8-5 0-64 016
Table 6.6 Effect of 0*1 M KC1 on dehydroquinase activities in 
S .co elico lo r
G216 under the same conditions (Table 6.6).
These results suggest that KC1 does not have an inhibitory effect on the activity of the 
type II dehydroquinase in S.coelicolor, it does have an inhibitory effect on the activity 
of the type I dehydroquinase enzyme. However, although 01  M KC1 effects 100% 
inhibition in E.coli, it only exerted approximately 16% inhibition in extracts of 
S.coelicolor.
6.2.4 Analysis of the shikimate intermediates in crude extracts and 
supernatants
It had been shown previously that the concentrations of six of the seven shikimate 
pathway intermediates (all except for DAHP) can be measured by high-performance 
liquid chromatography on an Aminex HPX-87H column, by following the absorbency
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of the flow-through on a spectrophotometer at a wavelength of 215 nm [Mousdale & 
Coggins, 1985]. Therefore, approximately 10 pg of protein from the crude extract of 
the three cultures whose dehydroquinase activities were reported in Table 6.5 and 
6 . 6  were run down this column in 5 mM H2 SO4 . 100 pmoles of dehydroquinate and 
shikimate were also run separately on the column to correlate the retention times, which 
had been reported as 5-6 and 8-3 mins respectively, and were measured at 5-6 and 7*8 
mins respectively in this experiment.
The only obvious difference between the three chromatograms was that the crude 
extract from G216 contained excessive amounts of shikimate (approx. 110 mAbs units 
relative to 15 mAbs units in the extract from G216/pPM23-X and 6  mAbs units in that 
from G216/pPM23-Y) (Figure 6.5).
When the cultures were pelleted prior to French Pressing and assaying of their activity, 
they were diluted 1:1 with water to reduce the viscosity of the culture, and allow easier 
sedimentation of the cells. The supernatants of culture broth were frozen at -20°C for 
storage. 2 0  pi of the supernatant from each of the three cultures was also run down the 
Aminex column in 5 mM H2 SO4  to discover whether any of the shikimate pathway 
intermediates were being excreted in large volumes from the cells.
Again, little discernible difference was observed between the chromatograms, except 
that the peak corresponding to shikimate 3-phosphate/EPSP from the supernatant from 
exponentially-growing G216 cells was approximately twice as high as that from the 
other supernatants (Figure 6.6).
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G216/pPM23-Y:
mAbs
100 215a»
—
30
Figure 6.5 Chromatograms of crude extracts run on an Aminex amino 
exchange HPLC column in 5 mM H7SO4
S3P EPSP DHQ DHS Shikimate Chor ismatt
reported
retention
times 4-0 4-0 5 6 8-3 110 27-6
measured
retention
times
N/D N/D 5-6 7-8 N/D N/D
Table 6.7 Retention times (in minutes) of shikimate pathway
intermediates and product on an Aminex anion exchange 
HPLC column eluted with 5 mM FbSOa
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G216:
ckT 'IK S
G216/pPM23-X:
mAbs
20
10
• 1 0
mAbs
G216/pPM23-Y:
4 5  m i n s
Figure 6 .6  Chromatograms of supernatants run on an Aminex anion 
exchange HPLC column in 5 mM H7SO4
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6.3 Discussion
The type I dehydroquinase from E.coli has been expressed in S.coelicolor G216 from 
the hybrid Ptac promoter, and forms an active protein. It has been overexpressed by 
virtue of the gene encoding this protein, aroD, being carried on the multicopy 
bifunctional vector pKL69. Despite the apparently low level of transcription from the 
Ptac promoter in Streptomyces, cells expressing this type I dehydroquinase enzyme 
have been measured as exhibiting an almost 40-fold increase in the levels of 
dehydroquinase relative to the untransformed parental strain.
As anticipated, the type I dehydroquinase was thermolabile in S.coelicolor, but it 
appeared to be inhibited to a much lower level by the presence of Cl" anions in the 
assay buffer compared to the activity of the same enzyme in a crude extract from E.coli 
cells. It is feasible that the crude extract from S.coelicolor already contained significant 
levels of Cl" anions, levels almost approaching saturation for this enzyme, causing a 
limited inhibition of the activity by the addition of KC1 to the assay buffer. However, 
this appears unlikely, since this would imply that very large amounts of the type I 
dehydroquinase were present in these overexpressing cells, and no protein of the 
correct size was visible when crude extracts from such a strain were run on a SDS- 
PAGE gel. Also, 100 mM KC1 appeared to completely inhibit the activity of the type I 
dehydroquinase in a crude extract from E.coli containing the overexpressing plasmid, 
suggesting that this level of KC1 should also be sufficient to completely inhibit the type 
I enzyme in the crude extract from S.coelicolor.
Alternatively, it is possible that there is some other molecule sequestering Cl" anions in 
the crude extract of S.coelicolor which is able to titrate out these anions. This would 
mean that the concentration of Cl" anions available to inhibit the type I dehydroquinase 
would be significantly lower than that anticipated from the concentration of KC1 in the 
assay buffer. However, since there is incomplete inhibition at a KC1 concentration of 
up to 500 mM, this possibility appears to be unlikely. It is also possible that the type I 
dehydroquinase from E.coli, when expressed in S.coelicolor, is in some way protected 
from being bound by the Cl" anions.
Although the results described in this chapter are only preliminary, they appear to imply 
that the type I dehydroquinase is only expressed at significant levels around the 
transition from exponential to stationary phase, which roughly coincides with the 
transition from primary to secondary metabolism (biochemical differentiation). It is 
feasible that, during the approach to differentiation, the primary metabolic pathways are 
upregulated in order to provide elevated levels of their products and intermediates,
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which may then be used as substrates for the secondary metabolic pathways. The 
factors controlling such an upregulation event may induce the expression of the type I 
dehydroquinase.
Temporal regulation of the type I dehydroquinase in S.coelicolor would suggest either a 
transcriptional or translational control, or the inactivation of an inhibitor. The Ptac 
promoter apparently falls into the class of promoters which are capable of initiating 
transcription in both E.coli and Streptom yces [Horinouchi & Beppu, 1985]. 
Therefore, it is feasible that transcription from the Ptac promoter is regulated in a 
similar manner to a naturally-occurring Streptomyces promoter which it resembles, and 
which may be switched on around the time of the differentiation process. To test this 
hypothesis, it would be interesting to express the type I dehydroquinase from 
Streptomyces promoters which are known to initiate transcription at different stages of 
the life-cycle.
Translational regulation of the type I dehydroquinase in S.coelicolor, or the existence of 
a regulatable inhibitory substance, might imply that S.coelicolor contains a type I 
dehydroquinase enzyme, or that its ancestors contained such an enzyme, and that, 
while S.coelicolor may have lost this enzyme, it may have retained the controls for its 
expression. It is possible that S.coelicolor does contain a type I dehydroquinase, but 
that its expression is temporally regulated in the manner observed for the type I 
dehydroquinase from E.coli when expressed in S.coelicolor, and is expressed only 
transiently, and so has not yet been identified.
A more likely method for regulation of the activity of the type I dehydroquinase when 
expressed in S.coelicolor may be effected by the product of the bldA gene, which 
encodes the tRNAuuA which carries a leucine amino acid for insertion into the growing 
polypeptide chain during translation. This tRNAuuA is apparently extremely rare in 
Streptomyces, due to the temporal regulation of the expression from the bldA gene 
[Leskiw et al., 1991]. U U A  (leucine) codons occur only extremely rarely in 
Streptomyces genes, and are generally found only in genes concerned with antibiotic 
production or differentiation, i.e. genes which are expressed late in the growth cycle.
The mRNA produced by transcription of the aroD gene contains a UUA codon (TTA in 
the DNA sequence [Chaudhuri et al., 1991]) at nucleotides 736-738. Therefore, it is 
possible that the type I dehydroquinase is only expressed at the transition from 
exponential to stationary phase because the bldA product is only available in the cell at a 
significant concentration at this point in the cell cycle.
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Although G216/pPM23-Y is overexpressing the type I dehydroquinase, producing an 
approximately 5-fold increase in dehydroquinase activity relative to the untransformed 
G216 strain, there is no apparent build-up of any of the shikimate pathway 
intermediates in the crude extract of the overexpressing strain, and no excessive 
excretion of any of these intermediates into the growth medium. However, it is 
possible that an enzyme which functions earlier in the pathway is limiting the rate of 
flux through the pathway, preventing an increase in activity of dehydroquinase from 
having any effect on the pathway. The limiting enzyme may be DAHP synthase (which 
is believed in certain systems to be involved, through feedback inhibition, in regulation 
of the pathway) or dehydroquinate synthase. It is even possible that the availability of 
the precursors of DAHP (E4P and PEP) may be limiting the rate of flux through the 
shikimate pathway so that, under the growth conditions used, the whole of the 
shikimate pathway is not functioning at its maximum potential.
Another alternative is that increasing the dehydroquinase activity does cause an increase 
in the flux through the shikimate pathway, but that the product of the pathway, 
chorismate, is immediately converted to another metabolite as part of a different 
metabolic pathway, and is therefore not built up in, or excreted from, the 
overexpressing cells.
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7.1 Introduction
The overall aims of the experiments described in this thesis were to allow analysis of 
the rate of carbon flux through the primary metabolic shikimate pathway in 
S.coelicolor; to attempt to overexpress the dehydroquinase enzymes from both E.coli 
and S.coelicolor in S.coelicolor to ascertain whether any resultant increase in 
dehydroquinase activity produces an increase in the rate of flux through the pathway; 
and to clone the aroA  gene, encoding EPSP synthase enzyme, to allow gene 
disruption and the subsequent analysis of flux through the majority of the pathway.
7.2 Attempted disruption of aroO
To allow analysis of the flux through the first two steps of the pathway, it was 
intended to knock out the indigenous dehydroquinase enzyme by disruption of the 
aroQ gene of S.coelicolor via insertion mutagenesis. Initially, the ermE gene from 
S.erythraea, which encodes a gene providing resistance to erythromycin, was 
subcloned into the middle of the aroQ gene carried on a suicide plasmid. However, 
when protoplasts of S.coelicolor were transformed with this suicide plasmid, resultant 
transformants which showed the required antibiotic resistance profile (erythromycin 
resistant, thiostrepton sensitive) were found not to contain the ermE gene, and must 
have undergone spontaneous mutation to resistance.
The ermE  gene was subsequently replaced with the grmA gene, which induces 
resistance to gentamicin. Again, transformants showing the anticipated resistance 
profile were found, by probing of genomic DNA, not to contain the grmA gene. 
Therefore, in order to disrupt the aroQ gene in S.coelicolor, another more reliable 
resistance marker must be found.
Disruption via integration of an internal fragment of the required gene with a single 
recombination event has been shown to be successful in S.coelicolor [Buttner & 
Lewis, 1992] using 0C31 as the vector. This bacteriophage, or other unstable 
vectors, may be more useful delivery systems for promoting gene disruption than 
suicide E.coli vectors due to their relative longevity in the cell. However, disruption 
using gene replacement from a suicide vector has also shown to be successful in 
S.coelicolor [Khosla et al., 1992].
Since three separate research groups have unsuccessfully attempted to disrupt the 
aroD gene in E.coli (which encodes the type I dehydroquinase enzyme) despite the
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existence of aroD point mutations which cause auxotrophy for the three aromatic 
amino acids, it is possible that dehydroquinase is an essential enzyme, and therefore 
that null mutations in the genes encoding dehydroquinase are lethal. The aroD  
mutations which have arisen may be leaky, causing a low level of flux through the 
shikimate pathway to occur. This low level may be sufficient for the synthesis of 
another product (or by-product) of the shikimate pathway which is essential, and 
which has not been provided in the growth media used during the attempts at aroD 
and aroQ disruption. However, these point mutants do not allow sufficient flux 
through the shikimate pathway for the synthesis of the necessary quantities of the 
aromatic amino acids. It is anticipated that null mutations in the genes encoding 
dehydroquinase would prevent any flux through the shikimate pathway.
In order to test this theory, a copy of the aroQ  gene from S.coelicolor could be 
subcloned onto a bacteriophage which subsequently infects a cell of S.coelicolor and 
integrates into the chromosome. Gene disruption could then be performed. Cells 
with a disruption in either the original chromosomal copy of aroQ, or the copy carried 
on the bacteriophage, could then be cured of the bacteriophage. If the only cells 
which survive are those with a functional aroQ gene on the chromosome, this would 
suggest that the aroQ gene product is essential. This method may also be performed 
on cells carrying an aroQ gene on a stably-replicating plasmid, and selection for the 
plasmid relaxed after gene disruption to allow loss of the plasmid.
Disruption of aroQ could also be attempted in the S.coelicolor strain expressing the 
type I dehydroquinase from E.coli (G216/pPM23). If the aroD  gene is able to 
complement for a null mutation in aroQ, then the type I dehydroquinase would be 
capable of maintaining flux through the shikimate pathway, preventing disruption of 
the aroQ gene from being a lethal event.
Alternatively, disruption of the aroD  gene may be performed in E.coli cells 
expressing the type II dehydroquinase from S.coelicolor. The aroQ gene from 
S.coelicolor has already been shown to complement an aroD point mutation in E.coli 
[G. Young, personal communication]. Therefore, if a functional dehydroquinase 
protein is essential to the cell, this would be supplied by the plasmid-borne aroQ 
gene, allowing the indigenous type I dehydroquinase to be knocked out.
7.3 Overexpression of the type II dehydroquinase in S.lividans
Overexpression of the type II dehydroquinase enzyme from S.coelicolor  by
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transformation of S.lividans with pPM27 has produced a 7-fold increase in activity 
relative to the untransformed S.lividans strain TK54. The plasmid construction was 
performed in S.lividans as this strain may be transformed with DNA isolated from 
E .co li. Apparently, only a single protein, the type II dehydroquinase, is 
overexpressed from the 3 kb insert contained in this plasmid. Not only does this 
indicate that the aroQ gene is transcribed from a promoter contained on this fragment, 
but also suggests that it is not transcriptionally coupled with any other gene.
In order to attempt to upregulate the conversion of dehydroquinate to 
dehydroshikimate in S.coelicolor, this overexpressing plasmid, pPM27, must be 
isolated from TK54/pPM27 cells, and transformed into protoplasts of S.coelicolor. 
Such overexpression may produce an increase in metabolic flux through the shikimate 
pathway. Isolation of pPM27 from the S.lividans strain TK54/pPM27 was attempted 
during this research, but was unsuccessful.
7.4 Attempted cloning of aroA
Oligonucleotide primers were designed against consensus regions of amino acid 
sequences of EPSP synthase enzymes from plants, Gram-negative bacteria and lower 
eukaryotes; and from Gram-positive bacteria and a cyanobacterium. These 
oligonucleotides were used in an attempt to clone a fragment of the aroA gene by 
PCR using genomic Streptomyces DNA as template, and for probing of genomic 
digests and lambda libraries to clone the aroA gene. However, none of these 
experiments was successful.
Ideally, oligonucleotides would have been designed against the DNA sequence 
deduced from the N-terminal (and possibly internal) amino acid sequence of the 
EPSP synthase from S.coelicolor. However, this protein has not been purified. 
Future work, therefore, would be to purify the protein and clone the gene encoding it 
via the above route. Alternatively, the aroA gene from M.tuberculosis, the closest 
relative to S.coelicolor from which the aroA gene has been cloned, could be used as a 
probe to clone the aroA gene of S.coelicolor. This method was considered, but the 
aroA gene from M. tuberculosis was not available. It would be possible to clone a 
region of this gene from genomic DNA isolated from M. tuberculosis by PCR using 
primers designed against the published DNA sequence [Garbe et al., 1990], and to 
subsequently use this fragment for probing of genomic DNA or the cosmid library 
from S.coelicolor.
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A further method for the cloning of the aroA gene would be to create a library of 
genomic DNA from S.coelicolor, and to attempt complementation of an aroA mutant 
of E.coli. This approach has been successful for the cloning of the argCJB cluster 
involved in arginine biosynthesis in S.coelicolor [Hindle et al., 1994]. However, 
Streptomyces genes are usually only poorly expressed, or even not expressed at all, 
from their own promoters in E.coli. Indeed, the aroQ gene from S.coelicolor is not 
expressed from its own promoter in E.coli [P. White, Personal Communication]. 
When the aroQ gene was placed downstream of the T7 promoter, this construct did 
not complement an aroD mutant and it was only when the translation start site was 
engineered to have optimal spacing with regard to the E.coli ribosome binding site 
that complementation of the E.coli aroD mutant was achieved [G. Young, Personal 
Communication]. Also, attempts to clone genes involved in the shikimate pathway 
from S.rimosus by complementation of E.coli aromatic mutants were unsuccessful 
[Stuart, 1990]. Therefore, it is anticipated that this experiment would have a low 
probability of success, and was not undertaken.
7.5 Expression of a type I dehydroquinase in S.coelicolor
The type I dehydroquinase from E.coli was overexpressed from the hybrid Ptac 
promoter in S.coelicolor in an attempt to upregulate the conversion of dehydroquinate 
to dehydroshikimate, and possibly to increase the rate of flux through the shikimate 
pathway. Such expression produced an almost 40-fold increase in the 
dehydroquinase activity relative to that in the crude extract from untransformed 
parental cells. The type I dehydroquinase was thermolabile as anticipated, but was 
considerably more resistant to inhibition by Cl" anions than expected.
The type I dehydroquinase appears to be expressed only around the point of transition 
from exponential to stationary phase, which coincides approximately with the onset 
of secondary metabolism (the biochemical differentiation process). Although this 
transient expression may a promoter-specific phenomenon, it is more likely that, as 
the aroD gene from E.coli contains a TTA codon at nucleotides 736-738, it is due to 
translational control by the product of the bldA gene in S.coelicolor, the bldA gene 
encoding the leucine-carrying tRNAuuA. and which is apparently only expressed at 
significant levels towards the end of the growth cycle. To investigate this theory, it 
would be possible to mutate this TTA codon to a TTG codon, which also encodes a 
leucine, and so would function as a silent mutation. If expression of this type I 
dehydroquinase is indeed regulated by the product of the bldA gene, then it is 
anticipated that the mutant type I dehydroquinase would be expressed constitutively.
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This would increase the possibility of the expression of this type I dehydroquinase 
enzyme having any effect on the flux through the shikimate pathway in S.coelicolor.
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